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ABSTRACT 
 
In an environment where one article is published every 20 seconds, we cannot 
be certain all studies are upheld to the same high quality standard. Thus, there is 
growing speculation that much of what is published today may contain embedded 
biases that detract from the quality of science. Though aware of bias in research, we are 
ill-equipped to address, identify and mitigate bias from published literature. Therefore, 
the purpose of this dissertation is to (1) explore the complexity and saliency of bias in 
published work via two domains: bias in numeric data (numeric bias), and bias 
embedded in language patterns (language bias) and (2) test technological tools intended 
to detect bias more objectively— namely the Cochrane Institute’s GRADEPro, and 
topic modeling.  
Numeric bias was defined as bias within number data and detected via the 
Cochrane Institute’s GRADEPro software. To tout the effectiveness of using 
GRADEPro as a valid tool with which to detect number bias, this study used a heuristic 
example with currently published manuscripts on Pre-Exposure Prophylaxis (PrEP). 
Findings indicated, primarily, there were varying levels of evidence quality, ranging 
from Very High quality of evidence, to Very Low quality of evidence. Further, the 
efficacy of the medication in each study also varied by different extents.  
Language bias was defined as bias within written language and identified more 
objectively via topic modeling. To demonstrate the effectiveness of topic modeling, I 
compared corpora of text data among three bias-inducing variables—time, funding 
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source and nation of origin. For each corpus, language patterns varied among the bias 
inducing variables, suggesting, among other considerations, bias inducing variables 
influence the direction of language despite testing the same hypothesis.  
Overall, this dissertation sought to present tools outside of Public Health that 
could more objectively identify problematic issues within numeric and language data. 
For both types of bias, language and numeric, bias was identified and distilled in a 
more efficient and effective manner. Therefore, issues such as recurrent bias in Public 
Health should be addressed via these presented tools, as well as potential others, in the 
continued effort to uphold the integrity of science.  
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CHAPTER I 
INTRODUCTION 
Bias, a growing concern in 21st century academia, is defined here as any factor 
that sways credibility of scientific research outcomes (Delgado-Rodríguez & Llorca, 
2004). Though the extent of bias within the scientific community is currently unknown, 
scholars in various fields are attempting to address underlying mechanisms potentially 
contributing to increased instances of biased, or misleading work. Inferential 
statistician Nuzzo (2014), for example, contends outdated reported practices, such as 
null-hypothesis significance testing, oversimplifies the complexity of hypotheses. 
Marketing professor Hubbard (2015) claims that due to corrupt research agendas, 
scholars also may be manipulating data deliberately to attain a favorable end. 
Neuroscientist Ioannidis (2005) ultimately concludes, based on these claims and other 
factor, that much of published research findings are partially inaccurate or false. 
The drive to understand bias in scientific research stems, in recent times, from 
increased instances of manuscript retraction. Today, contrasted with the last decade, 
there has been a 44% increase in the amount of published research retracted by 
professional journals’ editorial boards due to a host of concerns such as false peer 
review, failure to disclose funding source, conflicts of interest, data manipulation, and 
honest error (Nunberg, 2002; Cokol, Ozbay, & Rodriguez-Esteban, 2008; Wiles, 
2012.). Therefore, as more instances of retraction occur, scholars have had a renewed 
interest into resolving such issues to uphold the credibility of science. 
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Many scholars (Barry et al., 2016; Nuzzo, 2014; Thompson, 2002) claim the 
current publishing system must address bias concerns by instituting reform. Thompson 
(1999), for instance, through the American Psychological Association, lobbied 
successfully in favor or requiring all manuscripts published in APA format include 
additional measures to denote study effectiveness, such as effect sizes. The Basic and 
Applied Social Psychology journal, in 2017, made a similar recommendation, 
contending significance tests hold no useful information and would be optional for 
future manuscript submissions (Trafimow & Marks, 2015).  
Despite increasing interest in studying (and detecting) bias, and despite editorial 
recommendations for reform in reporting practices for professional journals, bias 
persists as a threat to scientific credibility. Most likely, it is because current means of 
identifying and detecting bias are limited, that the threat persists. Bias is, occasionally,  
a vague construct, but it is always difficult to identify (Bollen & Paxton, 1998). More 
importantly, because people  differ in their beliefs and behaviors,  correctly identifying 
something as biased or not biased is, often, opinion-based and subject to disagreement 
(Cook, 2014). Therefore, more stable, objective tools with which to identify and detect 
bias are warranted.  
The purpose of this dissertation is two-fold: (1) expand the scope of research 
ethics to include language and numeric bias, and (2) showcase the utility of objective, 
technology driven tools – GRADEpro and Topic Modeling— with which to detect bias 
in numeric data and written language in published scientific reports The long-term goal 
of this project is to establish those tools—— as legitimate applications that should be 
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adopted by Public Health and other fields seeking to minimize bias within scientific 
reporting.    
To explore these objectives most effectively, this dissertation utilizes a journal-
article format. Each chapter will explore the following content: In Chapter 2 I will 
argue for expanding the scope of research ethics to include numeric and language bias 
as its components; components that should be considered as important as the rights of 
human and animal participants in research carried out in the 21st century. In Chapter 3 I 
demonstrate the utility and effectiveness of GRADEpro as a tool for detecting numeric 
bias in reported research. In Chapter 4 I present and demonstrate Topic Modeling as a 
language-bias detection tool and, Chapter 5 comprises conclusions and 
recommendations 
Bias as a Component of Research Ethics  
The first study, Chapter 2, seeks to frame bias in published work as a 
contemporary ethical concern. More importantly, this chapter also serves as the 
foundational backbone of the remaining two studies by defining terms, such as 
language bias and numeric bias, and introducing the theoretical perspective the 
remainder of the dissertation will follow. To introduce the concepts and frame bias as 
an ethical issue, I followed a multi-step process: (1) summarized, briefly, ethics and the 
importance of updating ethical codes of conduct, (2) defined what constitutes an ethical 
dilemma, and (3) logically mapped key points to determine if bias is, indeed, an ethical 
dilemma worthy of further attention.  
4 
Ethics is generally defined as the moral principles governing a person’s 
behavior to distinguish right from wrong (Corlett, 2005). Throughout the history of 
ancient and modern thought, various forms of ethics emerged to create a fair and 
balanced environment that attempts to maximize the greater good (Byrne, 1988). Many 
fields working directly with human populations— such as Medicine, Law, and Public 
Health— have benefited greatly from codes of conduct intending to protect human, and 
animal, rights from unethical behaviors. 
The drive to frame bias as a component of research ethics stems from multiple 
calls to update existing codes of conduct— Public Health, for example, has not updated 
its code of conduct since the early 2000’s (Cohen, 2002). Historically, codes of 
conduct in applied fields such as Medicine and Public Health, have focuses on the 
protection of animal and human subjects participating in research. There are concerns, 
however, that factors other than the protection of animal and human rights could, 
themselves, pose an ethical threat to the credibility of research. Therefore, framing bias 
– or, more specifically, numeric and language-related biases -- as falling under the
purview of research ethics validates its importance and allows for systematic 
examination of its occurrence and impact upon the current scientific enterprise. 
Numeric Bias Identification with GRADEpro 
Chapter 3 focuses specifically on numeric bias, or the bias embedded in 
numeric data and their statistical testing/reporting. Numeric bias is perhaps the most 
widely studied and commonly published type of bias in scientific studies. Calls for 
editorial reforms within professional scientific journals, for instance, are typically 
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supported by evidence generated through studies of p-value bias, or other biases related 
to statistical assumptions, data computation or results presentation (Ioannidis, 2005).  
The purpose of Chapter 3 is to introduce and demonstrate the use of tools to (a) 
assist in detecting numeric bias, and (b) objectively evaluate the quality of evidence, 
vis-à-vis the potential for bias in the reporting of findings. To accomplish these tasks, I 
thoroughly discuss common data-related biases and their salience in published 
research. Further, as a heuristic example to test the utility of GRADEpro— one of the 
tools I propose for the detection of numeric bias— I will analyze clinical studies 
published on one of the most recent interventions fueling health policy debate. 
Topic Modeling as a Language Bias Detection Tool 
Language bias refers to observable or non-observable language structures that 
ultimately shape a misleading message (Bollen & Paxton, 1998). Such biases can either 
be sub-conscious (i.e. the agent is not aware he/she is inherently biased) or conscious 
(i.e. there is a deliberate attempt by the agent to mislead an audience (Gambrill, 2011). 
Though words-based language is one of science’s main tools of communication (one 
could argue that mathematics – a number-based language – is, in fact, the language of 
choice for communicating science), studies of language bias are uncommon when 
compared to other types of biases, such as numeric bias (Zimbardo, 2010). Therefore, 
exploring language bias in greater detail can potentially give insight into how and why 
certain factors influence and shape scientific language, for promotion of specific 
research agendas.  
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The purpose of Chapter 4 , then, is to explore, in broad strokes, various bias-
inducing factors that affect the language in research reports: (1) time, (2) funding 
source, and (3) nation of origin (Clifford, Barrowman, & Moher, 2002). More 
importantly, this chapter introduces Topic Modeling— a series of computer algorithms 
programmed to dissect large collections of text into latent topics (Blei, Ng, & Jordan, 
2003)— as a novel tool with which to potentially detect nuances in published texts. 
Specifically, in that chapter I examine whether Topic Modeling can correctly 
identify nuanced changes in language (due to time, funding source, or country of 
origin) within large collections of texts in various health-related fields. I explore the 
following questions in this chapter:  (1) Can topic modeling identify changes in 
language over time in Ritalin research? (2) Can topic modeling identify nuances in 
federally- versus industry-funded studies on sugar consumption in the human diet, and 
(3) Can topic modeling identify differences between the United States and European 
Union language patterns for reporting on Pediatric/Perinatal Highly Active Anti-
Retroviral Therapy (P-HAART)?  
Overall, this dissertation seeks to create a well-rounded, conceptual 
understanding of bias and its presence in scientific research reporting. More 
importantly, this dissertation also seeks to highlight the utility of newer and more 
objective methodological tools for detecting and assessing potentially harmful biases in 
research. Results from this dissertation should contribute, at the very least, to the 
dialogue amongst scholars seeking reform for today’s current scientific environment. 
In an era in which one article is published every twenty seconds (Bowman, 2014), the 
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scientific community must be ever-vigilant for the potential for bias that can, 
ultimately, damage the credibility of science and the public’s well-being.  
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CHAPTER II  
BIAS AS A COMPONENT OF RESEARCH ETHICS 
With contemporary research issues such as experimental replicability 
(Ioannidis, 2005), false findings (Hubbard, 2016), and complications with the peer-
review process (Henderson, 2010) emerging in science, there is renewed interest in the 
conceptual understanding of research ethics as it applies to scientific inquiry. Research 
ethics has been traditionally defined as, “the ethics of the planning, conduct, and 
reporting of research…that…should include protection of human and animal subjects,” 
(Resources for Research Ethics Education, 2016).  
While definitions such as the one above are well established, mainly due to 
strong theoretical support and ethical protocols most of them tie research ethics to 
human or animal rights. Today, however, newer ethical challenges highlight the 
contention that research is evolving and, thus, in need of protocols and definitions that 
address these challenges.  Indeed, many groups and think-tanks are on the cusp of 
reconceptualizing research ethics to focus both on the dimension of the participant in 
scientific experiments (human or animal), and that of the researcher. For example, the 
Center for Research and Reform Education (CRRE) (2017) expanded its original 
definition (2000) to now state: 
not all researchers use human or animal subjects, nor are the ethical 
dimensions of research confined solely to the protection for research subjects. 
Other ethical challenges are rooted in many dimensions of research including 
the collection, use, and interpretation of data, [and] methods for reporting and 
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reviewing research plans for findings (retrieved from: 
http://archive.education.jhu.edu/research/crre/). 
 In its most recent iteration, the Declaration of Helsinki1 (DOH) (2013) 
included an addendum with a similar position on the reconceptualization of research 
ethics: 
Researchers, authors, sponsors, editors, and publishers all have ethical 
obligations with regard to the publication and dissemination of the results of 
research. Researchers have a duty to make publicly available the results of their 
research on human subjects and are accountable for the completeness and 
accuracy of their reports. All parties should adhere to accepted guidelines for 
ethical reporting. Negative and inconclusive as well as positive results must be 
published or otherwise made publicly available. Sources of funding, 
institutional affiliations and conflicts of interest must be declared in the 
publication. Reports of research not in accordance with the principles in this 
Declaration should not be accepted for publication (p.2194). 
Unfortunately, the drive to re-conceptualize research ethics stems from 
negative, rather than positive ideals. Driving many of these re-conceptualizing attempts 
is the growing influx of cross-disciplinary cases in which data appear manipulated, 
                                                 
1 The Declaration of Helsinki, a preceding set of codes following the Nuremberg Code, 
is a set of ethical guidelines created by the World Medical Association in response to 
unethical human experimentation during WWII. Today, the declaration is widely 
viewed as the cornerstone of human research ethics (Moreno, 2017). 
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mal-explained, or intentionally/unintentionally altered. More importantly, the rate at 
which manuscripts are retracted across disciplines also raise concern” (Wiles, 2014).  
The conceptual changes in the CRRE and the DOH’s stances on research ethics, 
however, reflect a paradigm shift in research ethics. Rather than focusing almost 
entirely on animal and human protection, today, methodological decision-making is 
emerging as an important ethical concern that must be addressed.  
The purpose of this chapter is to explore the theoretical underpinnings of the 
efforts to reconceptualize research ethics. To do so, I examine, in broad strokes, 
various methodological concerns that have surfaced in 21st century research. In effect, 
this analysis will highlight important reasons why research ethics should encompass 
both methodological decision- making alongside participants’ rights. Equally 
important, this analysis will focus on elucidating the problems surrounding specific 
methodological issues in contemporary research (in the sciences and social sciences), 
namely: replicability of research findings and the factors affecting studies’ replication 
such as manipulation of statistics, and researcher bias.   
Concerns in Today’s Research Climate  
While science continues to, and will constantly face ongoing ethical debates 
regarding human subjects (and animals) who take part in scientific experiments (e.g. 
stem-cell research, cloning) it is also continually facing new ethical challenges related 
to the actual practice of science. In other words, the manner in which science is 
conducting itself in the 21st century is raising eyebrows among scientists and ethicists, 
above and beyond concerns with the well-being of research study participants. 
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The sheer volume of the scientific enterprise provides ample fodder for 
problems and difficulties.  Consider, for instance, that current estimates suggest global 
scientific output doubles every nine years (Van Noorden, 2014).  According to Munroe 
(2013) “a new [scientific] paper is now published roughly every 20 seconds” (p.59) 
and, in 2014, there were as many as 28,000 journals available for publication (many of 
which are considered “predatory”, following unethical publication practices) (Larson, 
2010).  As the science industry continues to grow, more manuscripts are published than 
ever before, and more people seek doctorates (or research training degrees), today, than 
in the entire history of academia (Larson, Ghaffarazadegan & Xue, 2013).  
The growing volume of information and/or terminal degrees awarded are not 
concerns in themselves. Many scholars have been worried, for several decades now, 
about the unscrupulous methodological practices that can result from over-publishing 
and diploma-dispensing. Among these problems are the manipulation of statistics, the 
inability to replicate research results, and researchers’ biases. Rosnow & Rosenthal 
(1989), for example, expressed their concerns three decades ago regarding the 
manipulation of statistics, contending:  
We are concerned with the…strict logical consequences of statistical 
data analysis to shore up facts and inductive inferences.  Despite the 
great range of procedures employed, there are some common problems 
of methodological spirit and methodological substance that although 
they have been addressed before, nevertheless endure. They are (a) the 
overreliance on dichotomous significance testing decisions, (b) the 
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tendency to do many research studies in situations of low power, (c) the 
habit of defining the results of research in terms of significance levels, 
alone and (d) the overemphasis on original studies and single studies at 
the expense of replications (p.1276). 
 Nearly three decades after Rosnow and Rosenthal’s assertion, little has changed 
to address the four methodological concerns they raise, apart from modest reforms 
from journal publishers ‘encouraging’ better reporting (American Psychological 
Association, 2016). Consequently, there is growing speculation, and incidences of 
uncovering suspect findings in published investigations.  
 Attributed, at least partly, to lack of methodological reform, scholars are also 
growing increasingly concerned that much of the work already published may not be 
replicable. Currently, more replication trials than ever are attempting to uncover flawed 
science. Consequently, the publishing community is experiencing unrivaled rates of 
retraction in major academic journals (Marcus & Oransky, 2014; Steen, Casadevall, & 
Fang, 2013) .   
 The pursuant question, then, becomes:  what is driving ‘poor’ science and why? 
While many point to unintended error and oversight as major factors, others posit that 
perhaps implicit and explicit biases are to blame. For example, a researcher may be 
biased against certain groups, therefore, those groups are unintentionally omitted or 
ignored. Or, perhaps, the research is agenda-driven— meaning there is incentive to 
publish certain findings even if those findings do not adequately reflect the sample at 
hand. 
13 
Given the rise in instances related to the problems outlined above (for further 
details, see sections below) there is a renewed movement among scientists, researchers 
and scholars in various fields to have research ethics also address and guide 
methodological decision-making, with the goal of upholding the credibility and 
integrity of science (Gawande, 2016).  To illustrate this need for expanding research 
ethics’ scope, and to stand in support of groups that already have extended that scope, I 
will explore one current example and use its implications as a heuristic model to 
determine if methodological decision-making is, indeed, an ethical issue.  In effect, this 
example will illustrate the need to expand the scope of research ethics to also include 
methodological practices for the continued improvement and renewal of science. 
Replicability, Methodological Reporting, and Researcher Bias 
in Public Health Research 
Complications with Result Replicability 
The replicability crisis. Study replication is the hallmark of the scientific 
method (Open Science Collaboration, 2015). Science relies on replicable findings to 
uphold the generalizability of results reported in peer-reviewed manuscripts. While the 
process of replication has led to numerous advances in science, applied fields such as 
Psychology, Medicine, and Public Health are, today— according to many concerned 
researchers—at the cusp of a ‘replicability crisis’ (Diener & Biswas-Diencer, 2016). 
The replicability crisis, simply defined, is the increased difficulty in duplicating 
or reporting a particular study’s findings, even under identical study conditions (John 
& Loewentein, 2012; Cook, 2014).  Feilden (2017) contends, for instance, this growing 
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inability to replicate poses serious implications that could lead to lasting, negative 
consequences including: (1) potentially false, published information, (2) decline in 
quality of academic work, and (3) public mistrust of published data.  
To emphasize the inherent difficulty of replicating findings, social scientist 
Brian Nosek undertook an ambitious effort in 2011 to reproduce findings from 100 
studies published in top-tier journals in the field of Psychology (Open Science 
Collaboration, 2015). As he anticipated, much of the findings were problematic. Out of 
the 100 test studies, less than half (n=39) reproduced findings identical to the parent 
study.  
 After completing his investigation, Nosek effectively listed several factors 
explaining the inability to replicate, such as the difficulty in quantifying a behavior, 
research error, and change of variables across time, among others. Overall, however, 
Nosek’s conclusion was that even in the best cases of well-documented and ‘clean’ 
research, replication is difficult and hard to accomplish.  
On an even larger scale, a group of 270 authors led by Aarts et al. (2011) 
published an article in Open Science Collaboration discussing how well 100 high-
profile experimental findings in psychological sciences were replicated exactly as the 
original parent investigations. Similar to Nosek’s (2015) assessment, only one-third to 
approximately one-half of studies were reproducible at any level. Aarts and colleagues 
asserted: 
…collectively these results offer a clear conclusion: A large portion of 
replications produced weaker evidence for the original findings despite using 
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materials provided by the original authors, review in advance for 
methodological fidelity, and high statistical power to detect the original effect 
sizes. Moreover, correlational evidence is consistent with the conclusion that 
variation in the strength of initial evidence (such as original p value) was more 
predictive of replication success than variation in the characteristics of the 
teams conducting the research, such as experience and expertise (2012, 
p.aac4716-6). 
The investigations pioneered by Nosek and the Open Science Replication 
Collaboration provided important evidence for the current difficulties with replicability 
in science and its varied contributing factors. Though useful, both studies operated 
under the assumption that replicating findings was difficult because of (1) accidental 
error, and (2) external stimuli beyond the control of either the original research team or 
those replicating the findings.  
Inherently, valid scientific replication is difficult—especially in fields that deal 
with unpredictable variables such as human behavior (Artino, 2015). In replication 
studies among both the hard sciences and the social sciences, the goal is to produce 
findings identical to those in the parent investigation. However, in replications of social 
science studies, results tend to be not only marginally different, but also smaller in 
terms of effect sizes (measures of experimental effectiveness) due to the complexity of 
human behavior and other issues related to a particular sample (Bohannan, 2015).  
Beyond problems within the data, moreover, other external factors may also contribute 
to unintended changes in a study’s environment, which impact the final results (e.g. 
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timing, location, skills of the research team, among others). Thus, due to the 
complexity of human behavior, even the best replication attempts are still prone to 
achieving results that may not reflect the original investigation’s outcomes. 
There is no replicability crisis. Not everyone agrees, however, with the notion 
there might be a replicability crisis in the social sciences (in particular). Another 
growing body of scholars has actively pushed away recommendations and suggestions 
for editorial reform proposed by institutional and editorial boards such as AERA and 
APA, claiming concerns are exaggerated. Pashler & Harris (2012) contend that not 
only does the crisis not exist, but “…these arguments that we have heard most often 
from scientists who see the current outpouring of concern over replicability [are] 
greatly overblown” (p.531). Specifically, detractors of the replicability crisis argue: (1) 
risk of Type 1 and Type 2 error are  known conceptual flaws of p-values, however, 
researchers mitigate this issue by setting the threshold level for alpha at a tolerably low 
level of 5%, which allows Type 1 error to go unnoticed,  and (2) while replication trials 
are rarely conducted, “researchers frequently attempt (and publish) conceptual 
replications, which are more effective than direct replications for assessing the reality 
and importance of findings” (p.533), and (3) science will self-correct and false findings 
will eventually be discarded. 
Pashler & Wagenmakers (2012) explain journal editors’ decisions to enact 
strategies to enhance replicability and to enforce policies promoting effect-size 
reporting, alongside increased calls for editorial vigilance, are nothing more than “a 
crisis of confidence” (p. 530). Pashlet & Wagenmakers further argue, such efforts 
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directly breach intellectual freedom and foster unwarranted policing of scholarly work. 
Consequently, an increased surveillance of academic work can destroy the impetus to 
produce innovative and groundbreaking science, claims Healy (2007).  
Following a similar logic, Stroebe and Strack (2014) view ‘exact’ replications 
as unfair and impossible to accomplish in the social sciences. In effect, a replicability 
crisis cannot exist because the current standards are too high for social scientists. In the 
natural sciences, such as Chemistry or Physics, results from studies are easily 
replicated because the laws of nature are more stable. When dealing with human 
populations, as Stroebe and Strack (2014) contend, variables are more unpredictable, 
and a host of factors contributes to potential changes in the landscape of a study, 
ranging from characteristics of the sample to level of power selected for statistical 
analyses.  
 For example, studies testing the laws of physics, in theory, can easily replicate 
regardless of study conditions due to nature’s stability. However, even the most 
popular and widely used instruments are subject to unpredictable human behavior, 
wherein factors such as mood, time of day, or trauma can alter the answers between 
sequential iterations.  Thus, contends Peng (2015) instead of focusing on exact result 
replicability – researchers within the social and applied sciences should, instead, be 
concerned with conceptual2 replicability. 
                                                 
2 Conceptual replicability refers to applying the same theories and protocols in 
subsequent investigations, but ignores score reliability due to the unpredictability of 
human behavior (Pashler & Wagenmakers, 2012). 
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In sum, proponents of the ‘no crisis’ stance (in the replicability debate) claim 
there may be issues with replication, however, calling these issues a ‘crisis’ is 
inappropriate because (a) one cannot exactly replicate human behavior, and (2) science 
will self-correct by tried and true measures, such as blind peer review. Due to the 
complexity and variability of social sciences research, editors and researchers should 
allow science to stay as is. Any effort to increase vigilance or impose stronger editorial 
oversight will do nothing more than hamper the freedom of academia for no valid 
reason, claim the replicability crisis critics (Earm & Trafimow, 2015).  
Replicability as an Ethical Issue 
In effect, the replicability crisis is a complex and divisive issue among scholars. 
Regardless of the opinion one holds, however, complications with replication have 
both influenced and divided scientists on how research should be conducted. However, 
regardless of one’s stance on the issue, concern over replicability begs an important 
question: are contemporary issues of result replicability and research studies’ 
underlying methodological decision-making simply a squabble amongst intellectuals, 
or are they emblematic of more important ethical issues, warranting further 
assessment? 
19 
From what is known about ethics3, applied ethics4, and ethical frameworks (see 
Appendix A), there are multiple criteria distinguishing common problems from ethical 
ones. According to Braunack-Mayer’s (2001) guidelines on what constitutes ethical 
dilemmas in medicine, there are two steps to determine if a given situation constitutes 
an ethical issue. First, one must determine if the situation is even a problem by 
evaluating it against two tenets: (1) agents must have a choice to make, and (2) there 
must be many potential outcomes stemming from the eventual decision. 
Once classified as a problem, the situation can only be considered an ethical 
issue if the decision-making process is affected and influenced, by morality, values, 
and beliefs (Resnik, n.d.). In other words, when making a choice between one or more 
options, agents must carefully evaluate and choose between what is perceived as 
morally right and morally wrong. It is morality that uniquely distinguishes ethical 
issues from common problems (Mbidde, 1998). Unlike many common problems, 
which have definitive answers, ethical issues rarely have a perfect solution because 
moral judgement varies among agents (Braunack-Mayer, 2001). In other words, 
3 Ethics is broadly defined as a normative evaluation used to distinguish right from 
wrong based on varying dimensions, such as: morality, justice, obligation, and 
righteousness (Braunack-Mayer, 2001).  
4 Fields in the applied sciences, such as health promotion, Public Health, and medicine, 
among others, traditionally have relied on classical ethical thought to guide complex 
decisions. However, they often require a more “hands-on” or practical framework due 
to the nature of their practice (Resnik, n.d.). 
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regardless of the attempt to arrive at a fair and equitable solution to all parties, at some 
level, some agents stand to lose something. 
According to Braunack-Mayer’s listed criteria, issues with scientific replication 
constitute, at the very least, a problem in research (i.e., agents have choices and there 
are multiple potential outcomes for each choice).  However, concerns with replicability 
also have moral implications, indicating the replicability crisis is, indeed, an ethical 
problem. First, because producing credible science is the expectation of all agents, 
there is an implied moral principle that it is good, or ethically appropriate, to produce 
quality investigations and wrong (unethical) to produce questionable science. In other 
words, the choice to make science replicable is guided by morality and exercising this 
choice becomes, therefore, an ethics-guided behavior. 
Additionally (and, perhaps, more importantly), replication matters also are 
guided by morality when involving the lay public. If a scientist knowingly produces 
questionable or inaccurate research, there are moral implications when the general 
public is a consumer of that research. In the recent retraction by Springer of several 
Oncology research reports5, for example, there are serious implications with regard to 
treatment of a patient’s illness. 
If by employing Braunack-Mayer’s (2012) criteria we agree methodological 
practices affecting research replication can have significant ethical implications for 
5 In 2017, Springer Publishing Group retracted over 100 manuscripts, the largest 
instance of retraction in the history of science, due to allegations of false peer review. 
All manuscripts were published in Tumor Biology, often considered one of Springer’s 
most prestigious journals (Stigbrand, 2017). 
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both scientists and the lay public, what, then, are the steps for addressing these 
practices and implications? Hanson (2014) contends that in professional and business 
ethics (both considered applied fields) the most important action one must take to 
address a dilemma is to understand and properly identify the various factors causing 
the dilemma, then apply field-specific frameworks as guides to navigate the ethical 
issue. 
Unfortunately, many current frameworks for research ethics in the health 
sciences (our main area of concern) are primarily centered on the protection of human 
and animal subjects. For example, bioethics, the ethical framework guiding Medicine 
and, to an extent, Public Health, has numerous codes and strategies directly addressing 
human subjects (e.g. informed consent, and Institutional Review Boards). Thus, in the 
contemporary world of health-focused research, methodological concerns (or factors 
affecting replicability of findings) are studied from an ethics perspective far less 
frequently than concerns related to human or animal participation in research.  
Fortunately, however, alongside previously mentioned groups and think-tanks, 
several national organizations such as the National Institutes of Health (NIH), the 
National Science Foundation (NSF), and the Food and Drug Administration (FDA), 
among others, are now overemphasizing the importance of quality standards for 
research. On its research ethics webpage, the National Institute of Environmental 
Health (NIEH) recognizes the complexity of the research process and the need to 
behave ethically on multiple fronts in research: 
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Although codes, policies, and principles are very important and useful, like any 
set of rules, they do not cover every situation, they often conflict, and they 
require considerable interpretation. It is therefore important for researchers to 
learn how to interpret, assess, and apply various research rules and how to make 
decisions and to act ethically in various situations. The vast majority of 
decisions [need] straightforward application of ethical rules. (Resnik, 2015, 
retrieved from 
https://www.niehs.nih.gov/research/resources/bioethics/whatis/index.cfm) 
The acknowledgement by the NIEH that research is complicated and requires 
ethical parameters is emblematic of the growing movement in which methodological 
decision-making is viewed as equally important as patient/animal rights. Furthermore, 
because the NIEH is not the only major federal agency to voice similar concerns (e.g. 
NIH, NSF, and FDA have done so, also), these apprehensions further legitimize 
concerns over replication of investigations. Therefore, I briefly outline and discuss 
below several factors affecting replicability, in the continued bid to frame 
methodological decision-making as an ethical issue.  
Factors Affecting Replicability 
 Munafo & colleagues (2017) contend there are several factors that hamper 
replicability and, in and of themselves, contribute to the greater ethical challenges 
embedded in methodological decision- making. The discussion below focuses on the 
two most problematic factors : (1) manipulation of statistics reporting (accidental or 
intentional), and (2) underlying researcher bias (intentional or non-intentional). Both 
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issues, by nature, are extremely complex, and a full treatment of each is beyond the 
scope of this paper. However, examining specifically how these factors fuel broader 
ethical challenges within methodological practices is necessary to re-conceptualize and 
expand the scope of research ethics, as proposed earlier.   
Manipulation of Statistics Reporting 
 At its most primary level, the field of statistics relies on decision-making 
(Thompson, 2006). In any given investigation, the researcher must carefully select the 
appropriate methodological analysis tool with which to address the research question. 
In public health, researchers primarily rely on the General Linear Model (GLM) to 
address sample-and -level questions via correlation-type analyses (Pearson r, t-Test, 
ANOVA, regression, among others) (Hayat, 2017). 
While the logic of the GLM is sound due to its simplicity6, the model is not 
immune to common errors that affect presentation of results. Simply stated, all 
analyses in the GLM abide by the same logic, mathematical calculations, and 
assumptions regardless of the complexity of the analysis (Field, 2014). Therefore, 
contends Hubbard (2016), given the simplicity of the general linear modeling, over the 
years researchers have developed misconceptions that harm the validity of findings. As 
Ioannidis (2005) warns, if misconceptions within statistical frameworks go unchecked, 
the majority of published findings could be false. 
                                                 
6 The Logic of the GLM assumes all analyses are all special cases of each other. In 
other words, these analyses abide by the same logic/assumptions and should be used 
“as a unifying conceptual framework for teaching statistics and psychometric theory” 
(Thompson, 2015, p. 30).  
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Some scholars in the field of health promotion and behavior (Barry and 
colleagues, 2016) have conducted investigations to uncover patterns with reporting 
practices due to common misconceptions of the GLM. Barry et. al., along with other 
scholars across multiple disciplines,  uncovered  patterns related to statistical 
representations of data that warrant concern, such as: (1) overreliance and misuse of 
null hypothesis significance tests (Nuzzo, 2014, 2014a; Head, 2015); (2) 
underreporting of confidence intervals and effect sizes (Fan, 2001; Vacha-Haase & 
Thompson, 2004; Thompson, 2007; Barry et al., 2016; Barry, Valdez, Szucs, Reyes & 
Goodson (in press);  and (3) misunderstandings of common psychometric properties  
(Pickett, Valdez & Barry, 2017).   
Overreliance and misuse of null-hypothesis significance tests.  A statistical 
mainstay in Public Health, null-hypothesis significance tests (NHST) are defined, in 
simple terms, as the probability the result of a tested hypothesis did not occur by 
chance (Field, 2017).  Despite its common use in academia, however, criticisms of 
NHST, are almost as old as the method itself (Boring, 1919). Thompson (2002a) 
elaborates: 
Statistical significance estimates the probability (pCALCULATED) of sample results 
deviating as much or more than do the actual sample results from those 
specified by the null hypothesis for the population, given the sample size. In 
other words, these tests do not evaluate the probability that sample results 
describe the population…Instead, the tests assume [incorrectly] that the null 
exactly describes the population and then test the sample’s probability…This 
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logic is so convoluted that, as empirical studies confirm, many of the users of 
statistical tests indeed do not understand what these tests actually do. 
(Thompson, 2002a p. 65, comment and emphasis added).  
Dubious logic aside, p-values remain researchers’ primary and preferred 
statistic for reporting results across academic disciplines. The popularity of the p-value 
likely stems from the simple, dichotomous nature of its interpretation:  specifically, any 
probability greater than p=.05 renders a finding non-significant (Nuzzo, 2014). In other 
words, by relying on a simplistic ‘yes’ or ‘no’ framework, a p-value can very easily 
and simply inform whether a result did or did not occur by chance7 (Wasserstein & 
Lazar, 2016). Apart from assigning statistical significance, however, the p-value serves 
no other informational purpose. 
Due to the limited information provided by a p-value statistic, many scholars 
worry about how the practice of reporting p-values affects the quality of a study. For 
example, it is common knowledge that p-values are bound by sample size (e.g. an 
increase in sample size n leads to a smaller p-value) (Sullivan & Feinn, 2012). 
Therefore, if amending a non-significant finding is as simple as increasing the sample’s 
size, then how can we be certain some findings have not been, “p-hacked….to 
scientific glory? (Aschwanden & King, 2015, retrieved from:  
https://fivethirtyeight.com/features/science- isnt-broken/#part1) 
                                                 
7 A full discussion of the American Statistical Association’s position on p-values can 
be found at: 
http://amstat.tandfonline.com/doi/abs/10.1080/00031305.2016.1154108#.WpHGbKjwa
Uk 
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Despite providing relatively little information about the hypothesis, p-values 
remain the mainstay in Public Health, Health Education, and Health Promotion— 
primarily due to their ease of interpretation (Nuzzo, 2014). Furthermore, the simplicity 
in which one can attain a significant p-value has also fueled a bias against non-
significant findings (Levine, Asada & Carpenter, 2009). This bias, in which non-
significant p-values are deemed non-important, has two important implications across 
the social sciences: (1) researchers may be selectively reporting their findings and not a 
true overview of their results, and (2) scientists are potentially manipulating data to 
attain a significant finding (Aschwanden & King, 2015). Such issues with p-values are 
the primary reason Thompson (2003) and Field (2007) contend one should always 
report other metrics, such as confidence intervals and effect sizes, to better understand 
the underlying meaning and relative importance of significant and non-significant 
findings. 
Under-reporting of confidence intervals and effect sizes. Confidence 
intervals (CIs) and variance-accounted-for effect sizes (ES) have frequently been cited 
as plausible alternatives to significance testing (Fan & Thompson, 2001; Lee, 2016). 
Yet, these alternatives are often under-reported and under-utilized, further obfuscating 
research findings and their replicability (intentionally or not). 
CIs are used to help generalize the findings from a sample to a population 
(Thompson, 2006). More importantly, they also articulate the precision of a mean 
score/value, otherwise known as a point estimate. To calculate the statistic, all 
experiments must first be concluded. Upon successful completion of experiments, 
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researchers will set a series of parameters to capture a hypothetical population 
parameter from the experiment’s sample (Savage, 1972). First, they set a confidence 
level with which to test the hypothetical parameter (e.g. traditionally set at 95%, or 1-α 
– where α = .05) (Glover & Mitchell, 2015). The confidence level informs us that, in 
95% of cases, hypothesized means will land within a certain range from its original 
point estimate, or initial value (e.g. upper and lower bound limits). The resulting upper 
and lower bounds limit the range of a point estimate (Field, 2017).  
For example, let us imagine a group of researchers conducting experiments on a 
medication’s effectiveness. Researchers found that, on average, the medication was 
shown to be 90% effective within the tested sample. To determine the strength of the 
point estimate, the research team calculated a 95% confidence interval with upper and 
lower bound limits. If the confidence interval around the 90% point estimate was, 
hypothetically, 85%-95%, we can infer that in 95% of cases in our hypothetical 
population distribution, the range of effectiveness would fall between 85 and 95%. 
Conversely, if the researchers had arrived at the same point estimate (90%) but had 
wide margins in their confidence interval (e.g. if the  CI  was 21%-90%) we would 
infer that, if 100 samples were randomly selected from that population, in 95 of them 
the medication could exhibit varying levels of effectiveness, between 21% and 90% 
effectiveness—a finding that might change the view of the medication’s utility.  
While there are various types of effect sizes, the majority determine the 
magnitude of a treatment’s effect. In broad strokes, an effect size is generally viewed as 
the percent of variance explained by a given statistical model, or how well an 
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independent variable explains the variability in a dependent variable. All GLM 
analyses have a corresponding effect size. Within the GLM framework the effect sizes 
are analogous to each other.8 Because all GLM analyses share common traits, it is 
easier to compare effects across studies using ES, regardless of the analysis used. 
Updated reporting recommendations for the journal American Psychologist 
strongly encourage (Zimbardo, 2002) researchers to report, along with p-values, some 
measure of the magnitude of effectiveness. The purpose of providing an effect size is to 
furnish that measure of the magnitude of the effectiveness associated with a significant 
p-value. For example, if a study’s finding hypothetically attained a significant p-value 
(p<.05), but had an ES of .12 (or 12%),  how important would that finding be? In this 
specific example, we might not place much faith on that finding because, while 
significant, the size of the effect is quite small (Sullivan & Feinn, 2012).  
Though CIs and ES provide invaluable information beyond significance tests 
alone, they are reported much less frequently than significance tests. Barry and 
colleagues (2016), for instance, found that within 1,245 studies in five flagship Health 
Education and Promotion Journals less than half (47.9 %) reported an effect size, 
despite strong recommendations by the APA to do so. Unfortunately, the trend to 
underreport in Health Education and Behavior is not unique, as the majority of 
academic disciplines in the social sciences face similar difficulties (Trusty, Thompson, 
Petrocelli, 2004; Sullivan & Feinn, 2012).  
                                                 
8 Pearson Correlation (r ), t-Test (Cohen’s d), Analysis of Variance (Eta2), Regression, 
(R2) 
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Two implications stem from underreporting of CIs and ES. First, without the 
valuable information provided by these metrics, one cannot be certain about the 
validity or the practical importance of research findings. Second, without a 
hypothesized range from a hypothetical population parameter, or information about the 
percent of variance explained by the statistical model, replication studies are less 
effective. In other words, replications become difficult when there is not enough 
information available to compare to the replicated findings and determine, with any 
degree of confidence, whether the replicated results are identical to the original ones 
(Lackens, 2013).  
Misunderstandings of psychometric properties. Over-reporting of p-values 
and under-reporting of CI and ES relate to the presentation of a study’s results. The 
psychometric properties of data collected through survey-based research are equally 
important and problematic. None, however, cause as much confusion as unique score 
reliability (Vacha-Haase, 2002).  
 The score reliability statistic determines if answers given to survey questions 
follow similar or divergent patterns within the group (sample) responding to the survey 
(Thompson, 2000). Each group of respondents will exhibit its own distribution-of-
responses pattern, rendering reliability a characteristic of the data from a specific 
sample, and not of the instrument (or the questions/survey instrument).  Unfortunately, 
it is all too common for researchers to forgo reporting the score reliability coefficients 
of their own data and, instead, report a coefficient appearing in an accompanying 
testing manual or in previously published studies using the same survey questions 
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(Thompson, 2002b). Such actions are incorrect, as 100 samples will almost always 
yield 100 different reliability estimates (Vacha-Hasse, 2001; Tani, Logan, Woodall & 
Thompson, 2002). 
 To confirm the notion that reliability is a function of the sample, Pickett, 
Valdez & Barry (2017) examined the alpha9 reliability coefficient for measures of 
delinquency among teenagers from 8th, 10th, and 12th grade sub-samples across a 40-
year span from Monitoring the Future Survey. As expected, the alpha coefficients 
exhibited small fluctuations with every yearly iteration of the survey. One important 
distinction, however, was the 12th grade group, who had significantly lower levels of 
reliability over time, compared to  their 8th and 10th grade counterparts. This analysis 
begs the question, if ‘age’ was a strong enough variable to influence groups’ response 
patterns on a survey, might other variables such as ‘race’ or ‘sexual orientation’ affect 
score reliability of different groups? 
 Thompson (2002b) contends failure to understand score reliability, and the 
continued practice of reporting coefficients from prior studies and/or testing manuals, 
holds two implications for research: “poor score reliability may compromise…score 
validity [and] may compromise the ability of a study to yield noteworthy effects” (p.5). 
In other words, by reporting coefficients from previously-conducted studies, or failing 
                                                 
9 While there are many reliability coefficients, the most commonly applied in Public 
Health and Health Promotion and Behavior is Cronbach’s Alpha, which is a measure of 
how consistent the responses to a set of items are. If consistent, the responses are 
understood to be measuring a common, latent variable (in other words, the survey 
items are measuring the variable they intend to measure). (Thompson, 2002) 
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to report alpha coefficients all together, we cannot be certain the data, themselves, are 
valid. This leads to important consequences when attempting to replicate a study, given 
that many of the complications associated with the psychometric properties of the data 
will not emerge (or be identified) until the study is replicated.   
In response to concerns with unique score reliability, the APA Special Task 
Force (1999) suggests, “Interpreting the size of observed effects requires an assessment 
of the reliability of scores” (p.596). However, this recommendation, in concert with not 
relying on p-values as the sole criterion for an effective result, as well as encouraging 
the inclusion of more CIs and ES, are often ignored.   
Consequently, the inability to replicate continues to be fueled by these 
underlying issues that are known, but relatively unaddressed (particularly in health 
promotion and behavior research) Separately, these three issues— overreliance and 
misuse of NHST, underreporting of CIs and ES, and misunderstandings of 
psychometric properties— seem easily remedied through increased emphasis in 
statistics education. They are, however, issues coalesced into a much larger problem in 
which the quick proliferation of manuscripts is more important than study quality. As 
mentioned, concerns with methodological reporting are not new. Today, however, 
these concerns represent an emergent ethics consideration in the Health Sciences.  
Methodological Reporting and Bias 
 In scientific investigations, bias is best defined as any deviation from the truth 
in data collection, analysis, interpretation, and publication resulting in the presentation 
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of false conclusions as truth (Simundic, 2013). Smith and Noble (2014) elaborate that 
understanding and studying research bias in multiple contexts is important because: 
…first, bias exists in all research, across research designs and is difficult to 
eliminate; second, bias can occur at each stage of the research process; third, 
bias impacts on the validity and reliability of study findings and 
misinterpretation of data can have important consequences for practice (p.2, 
emphases added).   
Most scholars and consumers of scientific information understand that, at some 
level, personal or professional decisions may be driven by implicit biases that can 
potentially affect research.  There are, therefore, multiple protocols, procedures, and 
taxonomies in place intended to mitigate bias in scientific investigations. Though these 
protocols are intended to serve an important purpose (i.e. bias mitigation), they are, as 
with research reporting suggestions, merely recommendations that are oftentimes 
ignored. 
In research practice, perhaps the most sweeping taxonomy of bias is the work 
of Sackett (1979) who proposes nine different types of biases that can occur at 
respondent and investigator levels10. Updated in 2014 by Sarniak (to expand upon the 
effect of bias in research), these taxonomies hinge on the assumption that bias can be 
                                                 
10 The types of biases in Sackett’s taxonomy include: (1) Acquiescence bias, (2) Social 
Desirability bias, (3) Habituation bias, (4) Sponsor Bias, (5) Confirmation bias, (6) 
Culture bias, (7) Wording bias, (8) Question Order bias, and (9) The Halo Effect bias 
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identified and sorted into fixed groups. In reality, however, bias is far more complex 
and nuanced than these taxonomies would suggest. 
Hammersly & Gomm (1997) contend that apart from pre-existing taxonomies 
on bias, the study of bias itself “has been given relatively little attention in the 
methodological” sense (p.68). More importantly, due to its complex nature, there is 
still a lot to learn regarding the mechanics of how, practically and conceptually, bias 
affects the quality of research. 
Herein, I will argue, specifically, that bias affects the quality of research, and I 
will support this argument by examining bias as a complex phenomenon rooted in 
human behavior. This approach to viewing bias is paramount to: (a) mitigate bias more 
effectively, and (b) contribute to the greater debate of expanding the scope of research 
ethics. Effectively understanding how bias impacts research serves to potentially re-
evaluate our approach to studying bias in academic work. More importantly, having a 
fully realized and conceptual understanding of bias is key to understanding the need for 
a more comprehensive approach to research ethics. 
Intentional and Unintentional Biases. Staats & Patton (2014) posit that bias is 
inherently difficult to capture because most biases are implicit. In other words, biases 
are almost always internalized, and the manifestations of bias can occur at a 
subconscious (unintentional) rather than conscious (intentional) levels. Because bias is 
implicit and difficult to identify, there is frequent debate regarding what type of bias 
(intentional or unintentional) is more common in research. While both types of biases 
warrant concern among the academic community, successfully distinguishing between 
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unintentional or intentional bias is key in determining how to mitigate the interference 
of bias in published scientific work.  
Ransohoff (2005) contends that unintentional bias may not be malicious, 
necessarily, but may, rather, stem from tradition or from preferred practices. In 
statistics, for example, mean imputation is a proven liability for handling missing data, 
especially when the method is not disclosed in the published manuscript (Donders, van 
der Heijden, Stijnen & Moons, 2006).  Some scholars, however, may continue to 
employ this method without being fully informed about some of its inherent flaws. 
Mean imputation, then, can result in one, or many publications that are biased because 
the data are neither accurate nor truly reflect the sample (Allison, 2002).  
 In opposition to the notion that most biases are unintentional stand Gupta and 
associates, (2009), McArdle, (2011), and Newsome, (2015) who believe bias is 
intentional, purposeful and agenda-driven. In their view, many instances of biased 
work stem from a desire to produce outcomes that achieve some favorable end. In our 
mean imputation example, while one investigator may impute the means in his/her 
dataset due to lack of knowledge of the inherent flaws in the procedure, another 
researcher may use mean imputation to treat missing data knowing full well this choice 
can result in inflated Type-1 error and change the outcome of a hypothesis (Wicklin, 
2017).  
The scholars who believe in, and are currently addressing, the replicability 
crisis in science fall into this latter line of thinking— according to them, published 
findings are not replicable due to biases shaping (a) data collection, (b) statistical 
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calculations, (c) result reporting, or (d) peer-reviewing -- biases that represent 
deliberate attempts to boost metrics and/or handle external pressures and conflicts of 
interest. Conversely, those who contend the only ‘crisis’ in academia is a crisis of 
confidence stand with scholars who believe bias is a non-issue and, most likely, 
unintentional.  
 Regardless of motivations, both unintentional and intentional bias can be 
equally problematic. Though intentional bias may be associated with hidden political 
agendas (McGarity & Wagner, 2008), being uninformed about issues regarding bias 
could pose equal, or greater harm, especially in academic fields studying vulnerable 
populations (Ransohoff, 2005). For example, if a researcher is unintentionally biased 
against underrepresented minority groups but studies health disparities, to what extent 
does the work of that investigator truly reflect the population? In this example, the 
researcher may not be aware he/she is creating a biased environment in which groups 
may be treated differently (Burgess, Van Ryn, Dovidio & Saha, 2007). Conversely, 
however, manipulating data to gain a favorable hypothesis, whether through 
deleting/adding cases, applying inappropriate weights, or altering sample size to attain 
a favorable end pose serious implications for the credibility of science and its 
institutions (Simundic, 2013). In both instances, the biases built into the investigations 
can have damaging effects for those who participate in, or consume, the resulting 
findings.   
 Moreover, both situations outlined above are examples of poor judgement and 
lack of personal/professional reflection. Unintentional biases indicate poor personal 
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judgement that consequently affects the world around each respective agent. 
Intentional biases, such as data manipulation, are contributing to the increasing mistrust 
of academic institutions as well as to the increasing concerns of growing academic 
greed and flaws in the peer-review system (March, Jayasinghe & Bond, 2008; 
Bohannon, 2013). Yet, despite knowing, at least on some levels, of the existence of 
bias, calls or suggestions to improve bias detection are scant in the methodological 
literature. Yet, without working toward improved bias detection, problems with bias in 
academic work will remain ongoing (Sica, 2006). 
When attempting to detect, or identify, biases in research we are currently left 
with one approach: making moral judgement calls to determine if work is or is not 
biased (Chan & Altman, 2005). While this verdict-driven approach to handling bias has 
proven somewhat effective and successful in identifying problematic patterns in 
published work (e.g. Springers’ retraction of 107 articles due to fake peer review), it 
fails to address the complexity and multi-dimensional layers of bias and bias inducing 
factors, alongside failing to determine how those factors contribute to decision-making. 
Thus, by relying on a judgement/verdict approach (e.g. this is versus this is not biased) 
to identify bias we cannot definitively stake a claim that something is or is not biased 
without making challengeable assumptions about the accused individual/group’ 
decisions.  
Scholars have long been critical of current approaches to detect bias, citing the 
need for improved research practices and peer review via more sophisticated dynamics 
(Stoker, 1995; Smith, 1997; Casadevall, Fang, & Morrison 2009). I argue in support of 
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those scholars who contend bias detection should be as sophisticated as bias, itself. 
Without some type of reform, or at least improved capabilities to detect it, bias -- 
intentional or not -- will continue to limit trust in and continual development of the 
scientific enterprise.   
The subjectivity of bias. The most salient reason verdict assigning is 
ineffective at identifying and deterring bias stems from one common, inescapable 
element: bias identification is subjective (Bollen & Paxton, 1998). Simply put, what 
may seem biased, or exhibit indications of bias, to one researcher may be perfectly 
acceptable for the other due to a conceptual gray area in which personal and 
professional opinions influence key positions on important issues.  
In qualitative inquiry, for example, subjectivity is at the forefront of the 
investigation due to potential bias when interacting with participants, coding 
transcriptions, and interpreting results (Ahktar-Danesh & Bowman, 2008). 
Consequently, qualitative scholars must be constantly vigilant that their own personal 
or professional beliefs and factors do not play a role in shaping the outcomes of 
interview-based investigations (Collier & Mahoney, 1996). However, even if the 
qualitative scholar was thorough, careful, and completely stringent in guaranteeing 
his/her work is free of bias, the investigator is still not immune to critics seeking to 
discredit the quality and reliability of the evidence (Pope, 1995). The drive to discredit 
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someone else’s research could come from a strong concern or judgement call, but it 
could also stem from the critic’s own biases11(Ortlipp, 2008). 
Statistics Reporting and Research Bias in Practice: The Harvard Sugar 
Investigations 
To help argue in favor of a framework for research ethics that is inclusive of 
methodological decision-making, I established two underlying factors influencing 
replicability of scientific studies (particularly in the social sciences): manipulation of 
statistics reporting and methodological reporting bias. Until this point, I discussed both 
the reporting and bias from a conceptual and didactic standpoint, with the intent to 
highlight and explore the concepts and their characteristics. It is important, however, to 
understand these concepts through a concrete example. Thus, I will explore one 
historical case in which both manipulation of statistical reporting of data and researcher 
bias influenced the outcome of important work: namely, the Harvard Sugar Studies. 
Harvard Sugar Studies 
For decades, the Corn Refiners Association (CRA) in the US funded Harvard 
scientists to study the chronic effects of sugar consumption by adults, children, and 
animals (Kearns, Schmidt & Glantz, 2016). Findings from the investigations 
downplayed sugar’s role in negative health outcomes such as obesity, diabetes, and 
other co-morbidities. Instead, evidence pointed to other dietary and lifestyle variables, 
                                                 
11 One practical recommendation to add credibility to qualitative work, contends 
Ortlipp (2008), is to keep a detailed field journal and document actions during all 
stages of an investigation. 
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such as dietary fat and increased sedentary activity, as actual underlying mechanisms 
associated with overweight and obesity. Thus, from the 1970’s until the early 2000’s 
these Harvard-led investigations dictated the direction of food-based policy (e.g. the 
carbohydrate-driven food pyramid) and dietary fads (e.g. the low fat diets) which were 
marketed to the public as cornerstones to living a healthy life (Brinton, Eisenberg & 
Breslow, 1990).  
Conversely, when future investigators, free of CRA funding, began conducting 
replication trials of the original investigations, they found their results not only clashed 
with original reports but also were consistently demonstrating the findings from older 
investigations were untrue. Rather than having only a minimal role in negative health 
outcomes, these newer studies found high sugar intake linked to increased morbidity 
and diet-related diseases such as diabetes (Kearns, Schmidt & Glantz, 2016). Today, 
not only has the influence from the Harvard sugar studies waned, but newer diet trends 
and food-based policies are in place that reflect the shift in findings generated by the 
newer trials (e.g. low-carbohydrate diets, CDC food plate).  
Perhaps the most blatant answer to the question of why the initial Harvard 
Sugar Studies and subsequent replication trials differed and contradicted each other is 
that one of the two groups was biased, either intentionally or unintent ionally. Critics of 
the investigations, or of the CRA, are quick to highlight: because the Harvard 
investigators were funded directly by the CRA and the Sugar Industry, they were 
expected to produce findings that were in line with the industry’s agenda. However, is 
it fair to accuse one group of investigators of funding bias when the principal 
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investigators of the replication studies may have been intentionally or unintentionally 
biased against sugar, themselves? 
Though funding likely plays a large role in shaping the outcomes of an 
investigation (Lexchin, 2012) there is no other guarantee, or check, that can 
definitively say if either group is biased apart from relying on the current subjective 
verdict-driven judgement. However, under the scenario in which blame is allocated 
with underlying and undiscussed subjectivity, it is unlikely a fair and equitable 
resolution will ever be reached. The investigators on the Harvard research team are 
very unlikely to agree, let alone admit, their work was biased despite being funded by 
industry monies. The same can be inferred for the replication scientists— they will not 
view their work as biased, but as credible science that produced quality results 
contradicting the original investigations’ findings.  
Objective Assessment Tools for Methodological Reporting and Bias 
At a bare minimum, scientists need methodological tools to assist in mitigating 
subjectivity in bias detection, to prevent more cases similar to the Harvard Sugar 
Studies. As it presently stands, bias is something that is subjective and, consequently, 
very difficult to capture due to clashing opinions of scholars and a conceptual gap in 
understanding of how bias affects research. If subjectivity were removed (or 
minimized), the (a) abilities to confidently identify bias, and (b) the procedures 
regarding how to handle biased work could significantly improve. 
In research, scholars deal with two components in the reporting of their studies: 
(a) numbers, and (b) words. I contend that both components serve as potential domains 
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in which intentional and unintentional biases can manifest themselves. Henceforth, I 
will refer to these, as “numeric and language bias” 
Numbers and words are potential avenues for bias because one can manipulate 
numeric data or spin verbal arguments with flowery language, deliberately, to make the 
results of testing a hypothesis more attractive. Misrepresentations of numbers and 
words also can occur due to unintended bias—poor statistics education can lead to 
unintended error during the application of methods or presentation of findings. With 
word bias, we may unknowingly be using language patterns and structures to explain 
something incorrectly, or not be providing sufficient information to articulate an 
accurate representation of an idea. 
 Today, technology can assist with strategies that were previously impossible, 
for mitigating both numeric and word bias. Across multiple fields outside applied 
sciences, computer programmers have created various tools and algorithms intended to 
examine numbers and language from a more objective standpoint. In other words, 
rather than have researchers rely on subjective frameworks to detect bias, they now can 
rely on computers to assess quality of findings and to mitigate subjectivity. 
 If these tools allow for less subjectivity in bias detection, then perhaps 
applying them in Public Health research could help address research ethics issues. 
Therefore, below I briefly discuss: (1) assessment tools for detecting potential numeric 
bias, and (2) assessment tools for detecting potential language bias. The intent of this 
discussion is to highlight the underlying mechanics of these new technologies and to 
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argue for the adoption of these tools as legitimate strategies to aid in bias detection and 
mitigation.  
Assessment Tools for Numeric Bias 
Numeric bias can be categorized as any type of inaccurate representation of 
numeric data. Much of what is driving the replicability crisis is poor representations of 
data. Determining if data and their analyses are inaccurate, however, is a daunting task 
for any reviewer and involves full exchange of datasets— something many scientists 
would not, willingly, agree to (Corlett, 2005). Assessment tools for numeric bias not 
only make the task of finding errors in published work easier, they also serve as a 
validity check for anyone seeking to guarantee their work is free from error. 
Specifically, I will elaborate on two useful tools: (1) statcheck (sic) and (2) the Grading 
of Recommendations Assessment Development and Evaluation (GRADE) scale.  
Statcheck [sic].  statcheck[sic] is a free, downloadable program for the open-
source statistical programming software R, designed to re-calculate and, if necessary, 
correct, p-values in published manuscripts (Nuijten, 2017). Today, statcheck’s users 
rely on the program as a valid tool to check the accuracy of their reported findings. 
Though useful at mitigating unintended error by helping users report accurate p-values, 
statcheck’s programmers (Epskamp & Nuijten, 2015) contend their program has far 
greater capabilities, arguing: 
Conclusions in experimental psychology often are the result of null hypothesis 
significance testing. Unfortunately, there is evidence that roughly half of all 
published empirical psychology articles contain at least one inconsistent p-
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value, and around one in eight articles contain a grossly inconsistent p-value 
that makes a non-significant result seem significant, or vice versa. Often these 
reporting errors are in line with the researchers’ expectations, which means 
these errors introduce systematic bias…[therefore] statcheck can be used to 
evaluate the prevalence of reporting errors (Nuijten, Hartgerink, Van Assen, 
Epskamp, & Wicherts, 2016, emphasis added) (Retrieved from: 
https://mbnuijten.com/statcheck/. 
 To test the validity of statcheck as a tool for detecting number bias, Nuijten & 
Colleagues (2016) used the program to replicate an exhaustive study by Wicherts et al. 
(2011), which manually analyzed the accuracy of reported significance tests from eight 
major psychology journals ranging from 1985-2013.  Findings from Nuijten & 
Colleagues’ (2016) replication investigation found statcheck was able to successfully 
detect most of the same errors found in the manual version of the study. More 
importantly, “…statcheck found an inconsistency rate that was 4.7 percentage points 
higher than the one in the manual search” (p. 122).  
 One of the most salient criticisms raised against statcheck is, in its current 
version, that the program can only analyze results from manuscripts formatted 
according to the APA. That is, if the study is published in any different reporting style 
(e.g. American Medical Association, Chicago, among others), the algorithm will 
overlook that reported p-value. The program’s reliance on APA formatting is, by 
admission of the authors and programmers, perhaps the main reason why statcheck was 
unsuccessful at extracting all significance tests in their replication of Whichert’s et al. 
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(2011) investigation. However, those authors still managed to a large number of 
inconsistencies within Whichert’s investigation. 
 Regardless of this limitation, statcheck should be considered a useful tool in 
Public Health research. As with Psychology, Public Health and other Health-related 
academic fields often over-rely on significance tests to report results (Barry, et al., 
2016). Many flagship journals, namely the American Journal of Public Health and 
Health Education and Behavior, mandate that all manuscripts be presented in 
accordance with the recommendations from the APA. Thus, statcheck can readily be 
applied to journals currently utilizing APA format. A second practical remedy to 
statcheck’s limitation is to, theoretically, re-write the text to fit APA style by hand. 
Though potentially arduous, this approach can be utilized for other journals that do not 
rely on APA format.  
GRADE12 scale. The Cochrane13 Institute’s GRADE Scale, a mandatory 
component of all Cochrane Systematic Literature Reviews, is a series of parameters 
intended to objectively ‘grade’ the quality of a body of evidence. Once calculated by 
hand, today Cochrane’s online software interface (GRADEProGDT14) allows users to 
input numeric information on studies testing the same hypothesis (e.g. ‘medication X is 
                                                 
12 The section is meant to provide a brief overview of GRADE, the GRADE Scale, and 
online program GRADEpro. A full treatment of GRADE can be found in Chapter 3.  
 
13 Cochrane is a non-profit, non-governmental organization dedicated to evaluating 
medical research to facilitate strong, evidence-based decisions about health 
interventions http://us.cochrane.org/. 
 
14 A Link to GRADEProGDT can be found at: https://gradepro.org/  
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more effective than a placebo’). Extracting the numeric data from each study produces 
what is called a summary of findings table (SOF). The goal of the SOF table is to 
determine how precise the presentations of the data are, by assigning a ‘grade’ to the 
evidence’s quality: (1) High Quality, (2) Moderate Quality, (3) Low Quality, and (4) 
Very Low Quality.  
 Numerous criteria can improve or harm a study’s final ‘grade’. In an 
investigation titled: What is ‘Quality’ of Evidence and Why is it Important to 
Clinicians? Guyatt & Associates (2008) elaborate on what, exactly, elevates or 
downgrades evidence quality within the GRADE scale framework, contending: 
[1]Randomised (sic) trials begin as high quality evidence and observational 
studies as low quality evidence. [2] Quality may be downgraded as a result of 
limitations in study design or implementation, imprecision of estimates (wide 
confidence intervals), variability in results, indirectness of evidence, or 
publication bias. [3] Quality may be upgraded because of a very large 
magnitude of effect [effect size], a dose-response gradient, and if all plausible 
biases [were controlled for]. [4] Critical outcomes determine the overall quality 
of evidence (p.996).  
Since the establishment of the GRADE scale in 2002, researchers have 
employed it to test the validity of findings in studies across several academic 
disciplines. Many researchers (e.g. Guyatt & Oxman, 2016; Atkins, Best, Briss & 
Ecceles, 2004; Zhao, Liang, Fang & Liu, 2017) find the GRADE scale is better able to 
capture discrepancies in the presentation of findings than traditional reviews alone. 
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Puhan and colleagues (2014), for example, used GRADEpro software to analyze the 
cohesiveness of treatment effect estimates from meta-analyses in medicine on the 
subject of hospital networks. The authors concluded many of the analyzed studies were 
either inconsistent or missing critical values in their presentation of findings. More 
important was Puhan and colleagues using their findings to provide an objective 
assessment and practical recommendations on data reporting, contending:  
following the [five] steps15 [in the GRADE framework used to assess evidence 
quality] highlights the necessity for authors of NMA to present direct, indirect, 
and NMA estimates as well as quality ratings for all direct comparisons. If 
authors do not present these estimates, skepticism regarding any inferences 
from the NMA is warranted. (p.5) 
 The GRADE scale, however, is not immune to detractors who argue GRADE, 
in and of itself, is flawed. Kavanagh (2009) states, simply, the requirements of the 
GRADE scale are too complicated to be internally and externally consistent. 
Kavanaugh continues, there are several challenges that inhibit GRADE’s ability to 
detect inconsistencies (e.g. language barriers, international laws, international research 
standards). Therefore, contends Meader et al. (2014), there should be a check list to aid 
                                                 
15 The five steps in the GRADE scale used to evaluate quality of the evidence are: (1) 
Study design (e.g. randomized control, observational, among others) (2) Risk of Bias, 
(3) Indirectness (Did the study measure what it intended to measure?), (4) Imprecision 
(Were hypotheses tested in the same manner?) and (5) Inconsistency (Were findings 
consistent in all studies?). Depending on the answers, researchers cumulatively 
upgrade or downgrade the overall quality of the evidence as being either: (1) high, (2) 
moderate, (3) low, or (4) very low.  
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consistency and reproducibility of GRADE assessments. More importantly, more 
replication investigations of previous GRADE systematic reviews are needed to 
ascertain levels of replicability.  
 Because the nature of Public Health and other health related fields’ research 
involves human subjects, clinical trials, and large-scale interventions, the GRADE 
approach should be considered a viable component of systematic reviews and meta-
analyses. Through GRADE’s record of success, researchers can effectively assess the 
quality of a collection of numeric findings. The ability to assess the quality of findings 
holds important implications for the future direction of Public Health research— 
namely, the ability to ascertain quality through more objective frameworks. Despite its 
inherent limitations, employing the GRADE scale could eventually contribute to 
stronger reporting practices and more transparency in methodological decision-making 
in studies conducted in the future 
 In sum, while detection of numeric bias is inherently subjective, advances in 
technology are beginning to provide tools to capture this type of bias, more objectively 
than before. These two tools: (1) statcheck, and (2) the GRADE scale, rely on 
technology to extract, analyze, and recalculate evidence to assist with objectively 
assessing the validity of the data. I argue they should at least be explored further in 
Public Health research as a means of mitigating subjectivity in numeric bias detection, 
and improving the overall quality of research reporting.  
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Assessment Tools for Language Bias 
 Word bias is defined, here, as intentional or unintentional use of vocabulary and 
word patterns to sway interpretation of an outcome. Unfortunately, detecting language 
bias may be even more difficult than number bias, as accusing scholars of using false, 
or misleading words can be viewed as inflammatory behavior. Scholars, however, have 
tried. For instance, Egger and associates (1997) found when randomized control trials 
in Germany were translated into English, the language used in the English version 
overly-emphasized significant findings and often ignored important non-significant 
findings, or adverse effects. Egger contends this unethical behavior occurred, most 
likely, to secure publication in top journals within the United States. Though Egger had 
evidence of potential bias, little else could be done to stop the practice from occurring 
due to, at the time, limited understanding of how to handle biased language in a non-
subjective manner. 
 Unlike numeric data, which can be checked, re-analyzed, and corrected, it is 
much harder to ‘fix’ language patterns, if they are deemed biased (Mescasens, 
Danescu-Niculescu-Mizil & Jrafsky, 2010). Technology has been advancing to a point, 
however, where programmable computer algorithms can ‘map’ and ‘dissect’ language 
to more objectively determine if certain latent word patterns reflect embedded bias 
(Hu, Boyd-Graber, Satinoff & Smith, 2014). In the subsequent section, I will discuss a 
technique in Computer Sciences, named Topic Modeling (TM), and elucidate why TM 
holds important utility for language or word bias detection in Public Health.  
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Topic Modeling. Topic modeling refers to a series of algorithms that use 
matrix algebra to map latent language patterns from a large collection of text 
documents16 (known as a corpus) (Blei et al., 2001). Primarily used in Computer 
Science and Business Marketing, TM has been widely regarded as the premiere 
methodology for consolidating, mapping, and assigning structural meaning to an 
otherwise insurmountable amount of online data (Wallach, 2006).  
In Business Marketing, major retailers such as Amazon, seek to understand 
what/why customers prefer (or not) a popular product. To answer their query, the 
marketing team would likely turn to product reviews for the necessary information to 
reach an informed conclusion. Sorting through tens of thousands of reviews, however, 
is both time consuming, incredibly difficult for most humans, and most importantly for 
our purposes, subjective. The TM algorithm, however, can process these reviews in a 
matter of minutes, to create a model with a pre-specified number of ‘topics’ and a 
collection of words most commonly associated with each topic (Suominen & 
Toivanen, 2016). In other words, rather than sort a large mass of text manually, the 
algorithm has learned a general ‘snapshot’ of the most important pieces of information 
on what the full corpus represents. The marketing team can, now, reach an informed 
conclusion by interpreting a mathematical ‘reduction’ in the corpus rather than sifting 
through every product review. 
                                                 
16 This section is centered on providing a conceptual overview of topic modeling. A 
full treatment of the mechanics in TM can be found in Chapter 4 of this dissertation. 
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The process of topic modeling is surprisingly straightforward. First, one needs a 
large collection of text data— which can be anything from textbooks, social media 
posts, personal essays, or other formatted text. The text data are saved as one file, and 
fed through the statistical software program R. Once in the program, the text goes 
through a series of changes to prepare for analysis— e.g. punctuation, as well as 
unimportant words such as articles and suffixes are removed to make the corpus more 
concise. Once the data are cleaned, they are analyzed through an iterative Bayesian 
process that compares each word x to every other word y in the entire corpus. 
Words with high degrees of association (e.g. word a has a high probability of 
appearing with word b) are clumped together to form a latent theme, or topic. The 
clusters of words in each topic should be clear and interpretable and representative of a 
hidden theme within the broader corpus. For example, if we generated a topic model 
from books on international cuisine, we would likely identify one topic as ‘American’ 
or ‘Italian’ based on word clusters in each latent topic. 
 To demonstrate TM and argue for the application of this methodology in social 
sciences, Valdez, Pickett & Goodson (in-press) generated a topic model of the 
transcriptions for the 2016 Presidential Debates. The purpose for using the Presidential 
Debate transcriptions as a corpus was to answer two specific research questions: (1) 
Would emergent topics align with policy related concerns ahead of the presidential 
election, and (2) How differently do politicians react to the same question? Valdez et 
al. found that (1) the emergent policy-related topics aligned with the most highly 
searched Google items one week before the start of debate one, and (2) each 
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candidate’s respective topic model was composed of similar topics (i.e. policy related 
matters) but differed significantly in the words used to compose that topic.17 
As with any methodology, there are a series of limitations associated with TM. 
First, topic modeling is a divisive tool, causing debate over which algorithm works 
best. Currently, the two most widely used and recognized algorithms are the Latent 
Dirichlet Allocation, and Latent Semantic Analysis. While both algorithms perform the 
same task, they arrive at their conclusions via different mathematical calculations— 
LDA relies on Bayesian inferencing, and LSA on eigenvalues. Despite providing 
almost identical outputs (e.g. Anaya, 2011), LDA is widely preferred over LSA 
because the algorithm is driven by probability distributions and not GLM type analyses 
(Bergamaschi & Po, 2011). Unfortunately, conducting the more popular LDA requires 
familiarity with statistical software program “R”, which is sometimes viewed as a 
tedious resource by those unfamiliar with the language18.  
A second limitation of TM is that, even in cases with the most clear and 
interpretable of outputs, the researcher must ultimately define and assign meaning to 
each topic— a process similar to what is done in exploratory factor analysis (EFA) 
                                                 
17 For example, both Candidates Clinton and Trump had a “Second Amendment” topic 
in their respective topic models. Clinton’s Second Amendment topic included the 
following words (“gun”, “second amendment”, “loophole”, “close”) and Trump’s 
included words such as (“Second Amendment”, “Supreme Court”, “appoint”, 
“protect”, “guns”). Thus, the computer successfully mapped out the same topic for 
each candidate, but identified different words – and, therefore, different perspectives -- 
addressing each topic.  
 
18 LSA has a point and click interface on SAS. 
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(Gorsuch, 1988). In EFA, the researcher merely has ‘recommended cut off values’ to 
determine how many latent factors emerge among a collection of measures. In TM, we 
have a collection of seemingly similar words grouped together into latent topics. In 
both cases, the researcher must determine commonalities among the grouped 
measures/words and assign qualitative meaning to them.  
Despite these limitations, TM should be viewed as a legitimate tool in Public 
Health. Specifically, TM can be used to examine how certain variables, such as time or 
funding source, could influence and potentially bias the wording in published 
manuscripts. For example, how has language regarding HIV/AIDS in published studies 
changed from the start of the AIDS crisis in the 1980’s to today? Or, do manuscripts 
testing the same hypothesis result in different topics when they are funded by industry 
versus federal government grants (recall the Harvard Sugar Studies)?  
 In the HIV/AIDS example, the language embedded in published investigations, 
most likely has become softer, shifting away from pandemic language toward 
treatment, chronic disease management, and self-care. For the sugar example, the 
answer would likely be that studied funded by the sugar industry and by federal 
government sources might arrive at different conclusions because funding source is 
frequently cited as a bias-inducing factor (Barden, Derry, McQuay & Moore, 2006).  
By generating topic models for each group (e.g. topic models on sugar research 
funded by industry versus federal funding) researchers have a unique opportunity to 
compare these mathematically supported models to determine if the language suggests 
potential bias(es). For example, if the topic model for the studies funded by federal 
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monies used extremely critical language against sugar (e.g. “sugar”, “bad”, 
“adverse”, “sick”, “metabolic”, “disease”) but the industry model referred to sugar 
favorably (e.g. “sugar”, “fine”, “intake”, “juice”, “nutrition”), one could conclude 
the industry-funded studies are biased because it is generally accepted that high sugar 
intake is unhealthy 
Concluding Remarks on Research Ethics 
While in the academic world trained scholars can judge the quality and merit of 
scholarly work, the lay public cannot. Instead, the lay public relies on the practical, 
evidence-based recommendations from authoritative sources to guide their own 
lifestyle choices. But when bias plagues academic work, and current attempts to 
address bias in academia lead to finger-pointing and contentious backlashes, the lay 
public may not be receiving the best or most accurate advice when research guides 
legislation and policy development.19 
Even for those who contend methodological decision-making is not a major 
ethics issue, one cannot deny providing misleading information to the general public is 
a detriment to the public good. Therefore, at the bare minimum, at least acknowledging 
something in the system requires reform is key to progress. Until policy is guided by 
                                                 
19 On February 2nd, 2018, Raw Story reported corn syrup lobbyists were actively 
working with the current presidential administration to set USDA dietary guidelines 
citing research that downplayed negative health outcomes of increased high-fructose 
corn syrup (HFCS) consumption. 
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work that has minimum bias20, scholars should continue to pursue reform, or at the 
very least, uphold integrity when producing science.  
 The potential for harm to the general public via misinformation or public 
policy, and the morality of providing sound science, are precisely the reasons why 
methodological decision-making should be viewed as an extension of research ethics. 
Though the rights of animals and participants are inherently important, the proliferation 
of dubious science could pose equal, if not greater consequences both to the scientific 
enterprise and to the lay public. Therefore, when discussing, or debating, the practice 
of research ethics, methodological decision-making should be viewed as an issue that 
is, at the very least, as important as human or animal rights. 
 In this investigation, I argued there are two factors contributing to 
methodological decision-making as an ethical issue: (1) manipulation of reporting, and 
(2) researcher bias. Both factors can be either unintentional or deliberate— however, 
neither is worse or more harmful than the other. By understanding how these factors 
drive issues within the research system, we now have a conceptual understanding 
regarding the extent to which research is being harmed by the continued presence of 
underlying research bias and by the practice of poor methodological reporting habits.  
 Fortunately, to mitigate bias, technology has furnished increasingly reliable 
tools for assessing bias more objectively. Within two particular domains of bias –  
numeric bias and word bias – I described three potentially useful tools to assist in bias 
                                                 
20 Note: because it is a socially constructed phenomenon, science will never be 
completely bias-free. 
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detection: (1) statcheck (2) GRADE scale, and (3) topic modeling. Although each 
method has its own inherent limitations, their utility in Public Health and other health 
related fields is apparent. If these tools can potentially identify and reduce bias in 
research, they should, at the very least, be tested to examine the extent to which (1) the 
tools, themselves, are valid and (2) whether they can, indeed, capture and help mitigate 
bias in Public Health research. 
 Although none of these methodological tools are new, they are rather novel to 
Public Health and other health related fields. Therefore, I would strongly encourage 
that, moving forward, scholars use and apply these tools to evaluate their own 
research— even if they contend their work is free of bias. By engaging with these 
tools, and reflecting on their own research practices and habits, researchers can work to 
become more informed about bias and, hopefully, contribute to viewing and addressing 
methodological decision-making as a vital ethical issue for the scientific enterprise.  
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CHAPTER III  
NUMERIC BIAS AND GRADEPRO 
In 2017, after allegations of false peer-review and questionable reporting 
practices, publishing group Springers retracted 107 articles on innovative cancer 
pharmacotherapies from its top-tier Oncology research journals.  The retraction 
stunned many in the scientific community (Stigbrand, 2017). More importantly, 
though, were the subsequent discussions regarding the merit of other investigations 
testing new pharmacotherapies intended to contribute to the benefit of the public’s 
health.  
 With these discussions came the realization that Springer’s retraction is not a 
one-time phenomenon. It is, nonetheless, the largest instance of manuscript retraction 
in the history of academia. Springer’s example is the culmination of a growing concern 
in the research communities in the US, beginning in the 1970’s:  increased instances of 
manuscript retractions. Over the last decade, for example, manuscript retraction rates 
have increased ten-fold (Fang, 2011).  
There are at least two ways to interpret this increase in retractions of published 
scientific reporting: either (1) the self-correcting nature of science is improving, or (2) 
scholars are abusing the system and putting forth poor quality, biased work (Cokol, 
Ozbay & Rodriguez-Esteban, 2008). To better understand the retraction phenomenon, 
Fang, Steen & Cassadevall (2012) elected to review the 2,047 articles retracted by 
PubMed from 1973-2011. Those authors’ aim was to determine whether manuscripts 
were retracted due to underlying bias, or honest error. Results from their analysis 
 57 
 
indicated that, in 33.6% of cases, retraction was due to unintentional mistakes in data 
reporting. Conversely, the remaining 67.4% of cases were retracted due to fraud, 
suspected fraud, duplicate publication, or plagiarism. The findings from Fang and 
colleagues fueled the concern over the extent to which bias is present in published 
work, but remains undetected (Van Noorden, 2011). However, regardless of the reason 
a manuscript was retracted, Fang and colleagues ultimately concluded, intentional or 
not, the primary culprit behind retracted studies was biased data. 
The purpose of this investigation, therefore, is to raise awareness regarding the 
potential for number/numerical bias (cf. definition below) in large-scale health/drug 
studies. Specifically, in this chapter, I will argue for the importance of detecting 
numeric bias in academic/scientific work, by addressing: (1) how numeric bias can 
manifest itself in research, (2) the effect of numeric bias on public policy, (3) 
innovative approaches/tools to identify numeric bias and (4) a heuristic example using 
GRADEpro to assess potential bias in large-scale clinical trials of PrEP (Pre-Exposure 
Prophylaxis, an initiative to promote the use of HIV treatment drugs for preventing 
HIV infection, and one of the latest pharmacotherapies available in the United States).      
Numeric Bias in Research 
 Numeric bias was defined in the previous chapter as any intentionally or 
unintentionally inaccurate representations of numeric data in scientific research 
(Munafò et al., 2017). When referring to number bias, there are generally two 
categories: (1) unintentional numeric bias, and (2) intentional numeric bias.  
Unintentional numeric bias is best described as honest errors made by a researcher at 
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any stage of an investigation (Cook, 2014). A researcher may, for example, 
accidentally report the wrong p-value, or run an analysis that is inappropriate for the 
data at hand (e.g. conducting a t-test when there are more than two groups). 
Conversely, intentional bias refers to the direct manipulation of data to assist in falsely 
supporting a hypothesis. Common examples include: (1) adding, deleting, and carefully 
selecting cases to analyze, (2) purposefully reporting false findings, and (3) inflating 
sample sizes.  
 Regardless of intention, bias harms research in various ways, but especially 
through a decline in both the quality of scientific investigations and the general validity 
of findings. Ioannidis (2005) contends, for example, numeric bias has become so 
commonplace in the academy that, today, most findings in published research may be 
false. Hubbard (2014) adds that all academic disciplines are prone to numeric bias. He 
further cautions that so long as biases go unchecked, the quality of research, as a 
whole, will reach increasingly new lows. 
 Numeric bias is difficult to capture, for various reasons. Chief among them, is 
the sheer volume of scientific publications in professional journals— estimated at 
27,000 articles published every week— which allows for increased levels of 
questionable, or biased work to pass through the peer review system (Van Noorden, 
2011). Due to such proliferation of published studies, among other factors, the 
academic community cannot escape the reality there could be a potential correlation 
between increased volume of accepted manuscripts and increased instances of numeric 
bias.  
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 One manifestation of the link between publication volume and number bias is 
the amount of journal article retractions. While once a rare event, today the process of 
retracting an article from an academic journal is much more common (Finelli, 2013; 
Hesselmann, Gar, Schmidt & Reinhard, 2016). As mentioned above, within the last 
decade, retraction rates have increased ten-fold. In the 1970’s, for example, retraction 
rates from journals across academic disciplines nearly quadrupled despite increased 
editorial oversight and journal-wide reporting recommendations intending to improve 
study quality (Finelli, 2013). Granted: retractions are indicative of the self-correcting 
nature of science (Marckman, 2010), but their massive increase is fueling concerns 
regarding why poor research still permeates a system intended to uphold scientific 
integrity (Wiles, 2014).  
 Along with fast proliferation of manuscripts, a second reason number bias 
persists in research, observe Ortega & Navarette (2017), is the hegemony of 
significance testing— which is the dominance of null-hypothesis significance testing as 
the primary method to relay findings (Nuzzo, 2014). Barry et al. (2014) for example, 
reviewed 1,245 articles from flagship research journals to assess reporting practices of 
each study published between 2000 and 2012. They (Barry and colleagues) found that 
in 100% of the cases, significance tests were the primary statistic used to communicate 
findings, chosen more frequently than other more informative statistics such as effect 
sizes.  
The continued reliance on null-hypothesis significance testing (over other vital 
statistics such as confidence intervals and effect sizes) has led to some critical 
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implications in published research, namely: (1) bias against non-significant findings in 
academic journals (Easterbrook, Gopalan, Berlin, & Matthews, 1991; Csada, James, & 
Espie, 1996), (2) decreased use of other statistics that measure study quality (Calin-
Jageman, 2017), (3) decreased replicability of study findings (Loken & Gelman, 2017), 
and (4) public mistrust of research due to lack of reproducible findings (Scharff et al., 
2010). Therefore, if significance testing remains the primary reporting tool, there will 
always be a risk of bias in research (Stern & Smith (2001).  
Though poor reporting practices and fast proliferation of manuscripts challenge 
the production of quality science21, researchers’ continued reliance on outdated 
methods such as significance testing is emblematic of a larger issue within all academic 
disciplines— namely, the extent to which number bias is potentially embedded in 
literature, yet scantly detected or addressed, until long after a questionable study has 
been published (Young, 2009). Consequently, much of the ‘suspect’ work persists as 
credible evidence, to be read, cited, sourced, and used as support when forming 
evidence-driven policy or treatment-related decisions (Gino & Bazemann, 2009). 
The Effect of Number Bias on Public Policy 
To propose new policies supporting the public’s health, policy makers must look to 
scientific literature for a platform on which to anchor their recommendations (“From 
                                                 
21 “Quality research...pertains to the match between the methods and questions, 
selection of subjects, measurement of outcomes, and protection against systematic bias, 
nonsystematic bias, and inferential error” (National Center for the Disseminatio n of 
Disability Research, 2018, retrieved from: 
http://ktdrr.org/ktlibrary/articles_pubs/ncddrwork/focus/focus9/Focus9.pdf) 
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the Science Policy Blog.,” 2009). Thus, findings from scientific investigations, 
published in the form of peer-reviewed research reports, greatly influence national 
Public Health policy and, ultimately, the health behaviors/outcomes of entire 
populations. Put bluntly, research guides policy, and policy guides the public.  
 Most policy makers are aware of this fact. What they may not be as keenly 
attuned to, however, is that reliance on published research ultimately binds Public 
Health policies to all other features of the studies generating those findings, such as: 
the methodological and analytical decisions made by the researchers, researchers’ 
personal or professional biases, the idiosyncratic weaknesses of each study, and the 
potential inaccuracy or purposeful manipulation of a study’s findings. (Tunis, Stryer, & 
Clancy, 2003). 
   Policy makers and the lay public, however, are not trained to evaluate the 
mechanisms underlying scientific research and, thus, are ill-equipped to distill quality 
science from problematic science, which is often infused with confusing language and 
scientific jargon (Popay & Williams, 1996). Therefore, non-scientists who turn to 
scientific literature to make informed decisions could be scaffolding support with 
faulty material.  
 There are several instances in the history of Public Health in which research of 
poor quality was used as credible evidence by the lay public and policy makers. One 
case, for instance, occurred in 2008, when decades of biased research were used as 
evidence to approve a mandate that hospitals and doctors spend trillions of dollars on 
expensive high-technology databases (known as the HITECH law) to mitigate rising 
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patient mortality (Soumerai & Koppel, 2017). However, almost all evidence used to 
support the HITECH law relied on poor research designs (t-tests comparing death rates 
between high-tech versus low-tech hospitals, for instance) that failed to control for 
confounding variables such as patient and regional neighborhood wealth and wellness 
(i.e. healthy lifestyle habits, such as diet and exercise), among others. 
 The lay public and journalists also share blame for unintentionally 
sensationalizing misinformation derived from poor research. For example: Several 
studies reported between 2010-2016 found a link between newer, advanced-life-
support ambulances, and increased risk of mortality when compared to basic 
ambulances (Sanghavi, Jena, Newhouse & Zaslavsky, 2016). Headlines were quick to 
broadcast that link, which prompted activists to lobby Congress to fund research that 
further explored the link between ambulance quality and mortality (Kane, 2014). The 
studies, however, relied only on anecdotal evidence— and failed to disclose that newer 
ambulances were dispatched only in situations where the patient was five times more 
likely to die of a life-threatening condition (Soumerai & Koppel, 2017). 
Kairney & Oliver (2016) contend that to prevent the spread of misinformation, 
policy makers should work in tandem with scientists to forward policy-agendas. 
However, those authors further state, there is limited evidence on how to streamline 
communication among scientists, policy makers, and the lay public. In the Institute of 
Education’s 2016 report on the science of using science, Langer, Tripney and Gough 
argue that the barrier to communication between policy makers and scientists stems 
from professional differences and foci. Specifically, scientists spend weeks, months, 
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and even years drawing objective conclusions based on collected data and tested 
hypotheses to produce knowledge. Legislators, journalists, and the lay public on the 
other hand, are users of that knowledge and may not engage with the content as 
critically or as objectively. Chan and Altman (2005) add that the relationship between 
scientists and policy makers is further complicated when sensationalized headlines or 
news titles clash with lackluster titles from scientific reports.  
 Medical ethicist Altman (2002) argues that, due to the spread of poor-quality 
information and general inability to find consensus on what represents quality work, all 
research should undergo a systematic process to parse out poor-quality science. 
Creating and implementing a systematic approach to detect bias, however, should not 
fall to the lay public and policy makers, but to scientists, themselves (Altman, 2002). 
Innovative Approaches/Tools to Capture Number/Numerical Bias 
 Increased retraction rates, the impact of poor-quality research on public policy 
and the public’s wellbeing, alongside heightened awareness of number bias have 
sparked renewed interest in the study of bias, among scholars. More importantly, 
scholars find themselves increasingly determined to create means/methods to: (1) better 
detect bias, and (2) promote transparency within research, with the ultimate purpose of 
bolstering the credibility of scientific investigations. 
 Marcus & Oransky (2014), for instance, claim one such tool prompting 
renewed interest in promoting quality science is their own initiative, Retraction 
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Watch,22 which serves as an academic watchdog to notify when an editorial board has 
retracted a study from publication, and for what reason(s).  Though certainly not 
without its detractors (e.g. Teixeira da Silva, 2016), platforms such as Retraction 
Watch are credited, primarily, with promoting transparency in science by providing a 
better glimpse of (1) how the scientific process operates, and (2) whether science is 
operating according to strong ethical standards.  
 While Retraction Watch and similar venues have renewed and improved bias 
vigilance in academic research, these can only inform readers about instances of 
retraction. In other words, Retraction Watch cannot capture bias, but instead relies on 
reports from journal editors when they post a notice of retraction. Thus, Retraction 
Watch is inherently limited regarding what the initiative can contribute. Today, 
however, scholars can utilize various tools to scan printed text to determine if the 
presentation of findings contains embedded bias.  
GRADEpro and “statcheck” (sic) are two such tools that rely on computer-
based technology to reach evidence-driven decisions about the quality of the numeric 
evidence in scientific investigations (Kavanagh, 2009; Meader et al., 2014; Puhan et 
al., 2014; Nuijten, Assen, Hartgerink, Epskamp, & Wicherts, 2017). GRADEpro, for 
example, relies on a set of pre-specified criteria to up-grade or down-grade the quality 
of evidence supporting tested hypotheses in studies. The specified criteria, intended to 
find flaws within study procedures are: (1) Risk of Bias, (2) Imprecision, (3) 
                                                 
 
22 The website can be found at:www.retractionwatch.com 
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Inconsistency, (4) Indirectness, (5) and Publication Bias. Depending on the overall 
evaluation score on each of those domains, the tested hypothesis receives one of the 
four following grades: (1) High, (2) Moderate, (3) Low, and (4) Very Low. 
“statcheck” (sic) uses an algorithm to explore numeric data (i.e. significance 
tests, the corresponding F-statistic, and any confidence intervals) to determine if the 
reported p-value on a given significance test is accurate or inaccurate. If the p-value is 
inaccurate, the algorithm will recalculate the reported finding and provide a corrected 
p-value that reflects the reported F-statistic and sample size. The final output generated 
from statcheck provides an overall assessment on how trustworthy the results are, 
based on the ratio of accurate to non-accurate p-values. 
 An added benefit of platforms like GRADEpro and statcheck is their validation 
via research and subsequent endorsements by the scientific community. Harbour & 
Miller (2001), for example, propose that GRADEpro’s consistent, systematic approach 
to evaluating literature make it an attractive tool to enhance systematic literature 
reviews and meta-analyses— especially as GRADEpro becomes more widely used and 
adopted. Baker (2016) adds, while programs like statcheck are new, “in the long run 
[they] could keep scientists honest [especially] if researchers made raw data available” 
(p.151).  
 With the growing call for transparency in science and increased availability of 
tools intended to address bias such as GRADEpro and statcheck, scholars are better 
equipped to study and mitigate bias than ever before. And, though GRADEpro has 
been applied has been widely applied to systematic literature reviews to evaluate 
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evidence quality, the tool has yet to be applied to a Public Health audience. Therefore, 
testing the tool with a timely, data-driven heuristic example could elucidate whether 
GRADEpro is an adequate tool to add to the bias-detection arsenal.   
A Heuristic Example: Using GRADEpro to Assess Potential Numeric Bias in 
Clinical Trials 
Background 
In December 2011, the journal Science named “HIV Treatment as Prevention” 
its Scientific Breakthrough of the Year (Alberts, 2011). This “HIV Treatment as 
Prevention” initiative — known as pre-exposure prophylaxis, or PrEP— comprises a 
fixed-dose combination of two anti-retroviral drugs: tenofovir disoproxil fumarate and 
emtricitabine. A single pill combining both drugs— popularly known by its brand 
name Truvada— received FDA approval in 2004 for treating HIV, and in 2012 as a 
prophylactic measure to prevent infection (CDC, 2017, retrieved from: 
https://www.cdc.gov/hiv/basics/prep.html). As PrEP, physicians prescribe Truvada to 
persons who test negative for HIV but are at high risk of contracting the virus (Galea et 
al., 2011). 
 Despite the novelty of PrEP, treatment as prevention (i.e., the main application 
of PrEP) is not a new phenomenon. There are numerous examples of treatment as 
prevention in the medical and Public Health literatures; including: (1) daily aspirin 
regimen for heart health (Juul-Moller et al., 1992), (2) psychiatric medication for 
mental health in patients with a documented family history of mental illness (Jellinek, 
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2003), and (3) prescription-strength multi-vitamins for preventable diseases, such as 
osteoporosis (Ooms et al., 1995).  
 As with other medications and therapies, PrEP’s promise to improve quality of 
life easily captures the attention of HIV activists and policy makers who aim to make 
the medications more accessible through public policy recommendations and other 
government-related initiatives (Bongaarts & Over, 2010; Fauci, 2011; Cockcroft, 
Masisi, Thabane, & Andersson, 2014). For example, shortly after PrEP received 
approval from the Food and Drug Administration (FDA), the National Alliance of State 
and Territorial AIDS Directors (NASTAD) released a policy statement (2012) on PrEP 
arguing, in part: 
The opportunities afforded by PrEP are unprecedented in the Public Health 
response to the epidemic. The daily utilization of Truvada as a mechanism to 
prevent HIV acquisition would allow for an individually-controlled, moderately 
effective prevention tool that [should] be used alongside other proven 
prevention methods, with or without the knowledge and cooperation of a sexual 
partner. In the scope of prevention science, it may be the closest we have come 
to a vaccine. (Retrieved from: 
https://www.nastad.org/sites/default/files/resources/docs/PrEP-Policy-
Statement-FINAL-6.25.12.pdf) 
 In 2015, support for PrEP reached new levels when for the first time it was 
addressed in the US President’s Emergency Plan for AIDS Relief (PEPFAR). 
Particularly, a PrEP regimen was billed as a legitimate prevention drug that needed 
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immediate prioritization among HIV high-risk groups, including: (1) international 
young women geographically in the 10 PEPFAR DREAMS23 countries with high HIV 
prevalence, (2) HIV serodiscordant couples, (3) female sex workers, (4) men who have 
sex with men, and (4) people who inject drugs. PEPFAR’s stance on PrEP concludes: 
…with strong evidence for the efficacy and effectiveness of daily oral PrEP 
across multiple studies, it is a Public Health priority for PEPFAR to make PrEP 
available in high HIV prevalence settings in a strategic fashion to people at 
substantial risk, including adolescent girls and young women, HIV 
serodiscordant couples, female sex workers, men who have sex with men, and 
injection drug users, based on their risk. (p.2, emphasis added) retrieved from: 
https://www.pepfar.gov/documents/organization/250044.pdf 
 Though certainly an unprecedented advancement in HIV research, PrEP use has 
also sparked concerns from individuals questioning its safety. In a New York Times 
column (2012) Denise Grady outlines potential risks associated with, “a drug that 
healthy people take once a day to prevent HIV infection” (p.D5, emphasis added).  Her 
concerns stem from a potentially misleading logic that an oral pill is the equivalent of 
other proven safe sex practices, such as condom use. Costa-Roberts (2015) further 
addresses the often undiscussed long-term adverse effects of daily PrEP uptake among 
healthy adults, including: “lactic acidosis, …liver problems, kidney issues — including 
                                                 
23 The Determined, Resilient, Empowered, AIDS-free, Mentored and Safe women 
(DREAMS) initiative is a partnership with PEPFAR intended to reduce HIV infection 
in ten Sub-Saharan African countries(Chasela et al., 2010).  
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kidney failure — and bone density loss” (Retrieved from: 
https://www.pbs.org/newshour/health/8-things-didnt-know-truvadaprep).  
 Concerns over PrEP’s safety came under more scrutiny after two lawsuits were 
filed against Gilead Sciences, the company that manufactures Truvada, due to adverse 
effects from continued, exposure to Truvada (Peterson, 2018). The lawsuits claim: 
…instead of continuing to develop a safer alternative, [Gilead Sciences] 
decided to hide tenofovir’s risks [bone density loss and kidney failure] while 
earning billions of dollars as it became one of the world’s most prescriptible 
medicines for HIV (retrieved from:  http://www.latimes.com/business/la- fi-
gilead-hiv-drug-lawsuit-20180509-story.html). 
Therefore, the timeliness of this example can serve as a strong heuristic tool 
with which to test the application of GRADEpro. Employing the GRADE framework 
for evaluating investigations studying PrEP will help determine if GRADE (a) serves 
as a tool for detecting bias and (b) can be adopted more commonly as a novel tool with 
which to detect number bias. 
Methods 
Sample 
 To exemplify the use of GRADEpro for evaluating the quality of evidence 
generated by large clinical trials I utilized the four investigations upon which the FDA 
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grounded its approval of PrEP for prophylactic use24: (1) Preexposure 
Chemoprophylaxis for HIV Prevention in Men who Have Sex with Men, also known 
as ‘iPrEX’ (Grant, et al., 2010), (2) Antiretroviral Preexposure Prophylaxis for 
Heterosexual HIV Transmission in Botswana, or ‘TDF-2’, for short (Thigpen, et al., 
2012), (3) Antiretroviral Prophylaxis for HIV Prevention in Men and Women, referred 
to as ‘Partner’s PrEP’ (Baeten, et al., 2012), and (4) Antiretroviral Prophylaxis for HIV 
Infection in Injecting Drug Users in Bangkok, Thailand, or the ‘Bangkok Tenofovir’ 
study (Choopanya, et al., 2013).  
 These studies were selected for analysis for several reasons. First, each clinical 
investigation is considered ‘pioneer’ research for PrEP.  In other words, these 
investigations were the first to support, and eventually endorse the approval of Truvada 
as a prophylactic drug by the Food and Drug Administration. Further, despite the 
availability of numerous studies on PrEP’s effectiveness among various populations, 
the four aforementioned studies were the studies showcased as evidence for PrEP on 
the CDC website.  
Second, the studies were planned and conducted as Randomized Control Trials 
(RCT), often considered the most valid design for clinical research (Bothwell, Greene, 
Podolsky, & Jones, 2016). It is important to note, however, that despite being touted as 
the ‘gold standard’, RCTs are currently under increased scrutiny for potentially biased 
                                                 
24 The FDA’s statement can be found on the Gilead Sciences home page under ‘Press 
Releases’ at: http://www.gilead.com/news/press-releases/2012/7/us-food-and-drug-
administration-approves-gileads-truvada-for-reducing-the-risk-of-acquiring-hiv 
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applications  (Rastrollo, Schulze, Ruiz-Canela, & Martinez-Gonzalez, 2013; Chan & 
Altman, 2005; Chopra, 2003). Therefore, PrEP is a strong heuristic example with 
which to test GRADEpro as a valid measure to parse out important information on the 
quality of PrEP’s supporting research. 
Analysis 
 Once identified, the studies underwent a two-step analytic process involving: 
(1) descriptive analysis of the presentation of findings, and (2) application of 
GRADEproGDT software to rate evidence quality. The purpose of using a two-step 
analysis was to help generate a well-rounded understanding of the quality of the 
investigations’ findings. Specifically, rating the quality of evidence solely via 
GRADEpro alone would only provide information on evidence quality and not a 
thorough report on common reporting practices. Conversely, discussing only the 
number of p-values relative to effect sizes and confidence intervals might not paint a 
comprehensive and accurate picture of the evidence’s quality.   
Analysis - Step 1: Descriptive Analysis. The descriptive portion of this 
analysis was used to answer the question: What are some of the common reporting 
patterns in this sample of PrEP clinical trials regarding: (a) efficacy, and (b) side 
effects? The purpose of this question was to assess common traits and patterns used to 
relay information to readers. To answer this question, I extracted and examined 
pertinent information related to: (1) the number of significance tests in each study, (2) 
the proportion of significant to non-significant findings, and (3) the use of other 
measures to convey importance of findings (e.g. confidence intervals or effect sizes). 
 72 
 
Among other factors, these data can highlight the degree to which certain practices are 
favored over others (i.e. how many p-values versus confidence intervals, types of effect 
sizes, among others).  
The rationale for extracting this information from each of the studies assessed is 
as follows. First, Lambdin (2012) contends the nature of significance testing can only 
dichotomously inform researchers about the non/significance of a finding. In other 
words, the p-value tests the null/nill hypothesis that the effect studied is equal to zero. 
Therefore, a significance tests can only inform whether the effect is equal to zero or not 
equal to zero— but not how far away from zero (or strong) the effect is (Thompson, 
2003).   Thus, what is presented as a significant finding is less informative than other 
statistics such as confidence intervals and effect sizes.  
Even though p-values relay little information, their ease of interpretation make 
them popular in today’s academic climate and they are often viewed as the academic 
gold standard (Nuzzo, 2014). Continued reliance on significance tests, however, 
downplays the role of other important measures, such as confidence intervals and effect 
sizes, which are better indicators of overall effectiveness (Lee, 2016).  Therefore, in 
today’s academic climate we have a collection of literature, reliant on p-values, that 
fails to pay adequate attention to what those significant and non-significant findings 
mean. 
Analysis – Step 2: The Application of GRADEpro. For the second step in the 
analysis, I utilized the Cochrane Institute’s GRADEproGDT (otherwise known as 
GRADEpro) software to answer a second question: What is the quality of the numeric 
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evidence regarding: (a) the efficacy of PrEP, and (b) its reported side effects25? I 
purposefully elected to use GRADEpro over other open source software packages, such 
as “statcheck”, for two reasons. First, the algorithm used in statcheck can only identify 
study findings if they are formatted in the American Psychological Association (APA) 
format.  The articles reporting on the PrEP clinical trials were formatted following the 
American Medical Association standards (AMA) and, thus, statcheck could not 
recognize the data. Second, when compared to statcheck, the GRADEpro software is 
more commonly used and its testing and validation have been reported through 
publications authored by the GRADE Working Group— an international, open 
collaboration dedicated to promoting transparency in research— and in other 
systematic reviews implementing the software (Kavanagh, 2009; Puhan et al., 2014; 
Zhao, Liang, Fang, & Liu, 2017).  
GRADEpro’s software interface allows users to create an Evidence Table from 
an aggregate collection of numeric data. Each evidence table consists of two 
components: (1) the assessment of quality, and (2) the summary of findings. The 
assessment of quality section evaluates five dimensions of the overall study, 
qualitatively: (a) Risk of Bias, (b) Imprecision, (c) Inconsistency, (d) Indirectness, and 
(e) Publication Bias. The summary of findings table determines overall precision of 
individually tested hypotheses within a study by (a) extrapolating results per hypothesis 
                                                 
25 The rationale for selecting efficacy and side-effects as the two testable hypotheses 
was (1) the generally touted effectiveness of PrEP, and (2) concerns about long-term 
side effects due to daily dosing. 
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(e.g. number of events that occurred within treatment and control groups, the Hazard 
Ratio [HR], and the confidence interval about that HR).  
Analysis – Step 2 (a): Assessment of Quality.  Because GRADEpro evaluates 
the inputted results systematically, results derived from this analysis will elucidate the 
level of evidence quality among five key dimensions: (1) Risk of Bias, (2) Imprecision, 
(3) Inconsistency, (4) Indirectness, and (5) Publication Bias. The evaluator then 
determines the extent of ‘risk’ associated with each dimension, by evaluating potential 
infractions as: (a) not serious, (b) serious, and (c) very serious (see Appendix B).  
Per Cochrane’s definition, dimension one, risk of bias, refers to any internal or 
external factor that could influence a study’s results. Internally (i.e. pertaining to study 
design), the GRADE working group has a series of preferences regarding how a study 
should be designed. For the working group, studies are at no risk of bias if they use 
randomized, double-blind, controlled trials. Studies can lose up to two points, if a study 
deviates from that standard— (e.g. does not blind, does not use RCT design, does not 
disclose methodology). External risk of bias refers to factors that can sway findings 
(e.g. attrition, ending the study early, source of funding, among others). 
   Indirectness refers to the extent to which the sample used in the clinical trial 
reflects the population for which the drug/intervention is intended. In other words, the 
medication should be tested among the most likely users, only. Imprecision, refers to 
the ‘tightness’ of findings. Studies with congruent, homogenous findings are upgraded, 
while sporadic findings are downgraded— one recommendation by Cochrane is to look 
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at confidence intervals. Large confidence intervals are indicative of sporadic findings 
that mar interpretation of the data.  
Inconsistency refers to the research question matching the analysis— i.e., did 
the study measure what it intended to measure? Publication Bias is a category designed 
to capture the evaluator’s subjective suspicions of publication bias. Studies interpreted 
as exhibiting publication bias are downgraded. The last criterion, dose-response 
gradient, can help a study recover one deducted point if a gradient is included in the 
study— a dose response gradient is a chart, or graph, the measures the least amount of 
medication necessary to have an effect.  
After each of the five dimensions receives a quality score, GRADEpro 
aggregates those scores to calculate overall level of evidence quality. Those levels are: 
(1) High: There is ample evidence the true effect lies close to the estimated effect, (2) 
Moderate: There is modest evidence the estimated effect lies close to the true effect, 
but there is some possibility the true effect is different, (3) Low: There is little evidence 
to support the estimated effect reflects the true effect, and (4) Very Low: There is 
limited or no evidence to suggest the estimated effect is remotely near the true effect.  
Analysis – Step 2 (b): Summary of Findings. The summary of findings table 
uses information from tested hypotheses in each study to calculate an absolute 
confidence interval. The purpose of the absolute confidence interval is to put a 
relatively misunderstood statistic, Hazard Ratio (Spruance, Reid, Grace, & Samore, 
2004), into a statistic that lay readers can better interpret. For example, in a double 
blind 1:1 randomized control trial testing the efficacy of a medication, the evaluator 
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would extrapolate the number of events— infections— within the total sample for both 
treatment and control groups.  
The number of events, total sample, and corresponding HR and CI would then 
be entered into GRADEpro. The program then uses that data to calculate what 
Cochrane calls an “absolute confidence interval”, which presents those findings in 
terms of number of cases per ‘x’ events. In other words, within our current example, 
rather than interpret the following HR: .56, 95% CI: [.22-.68], the absolute CI is 
phrased as: per 1,000 cases there would theoretically be 150 fewer instances of 
infection, with a range of 110-180.   
Results 
1. Step 1 - Descriptive Analysis: What are some of the common reporting patterns in 
the PrEP clinical trials regarding (a) efficacy and (b) side effects?  
For the descriptive analysis on both the efficacy and side-effects hypotheses, 
the four clinical trials were evaluated on the following criteria: (1) the prevalence of 
significance tests for each hypothesis-- (a) overall efficacy, and (b) side effects; (2) the 
proportion of significant to non-significant findings; (3) the use of confidence intervals 
and effect sizes, and (4) sample size of the overall study.  
With regard to efficacy (i.e. the main hypothesis of the studies), there were a 
total of 12 significance tests among the four clinical trials (see Table 3.1). Of the 12 
significance tests, approximately 95% (n = 11) were statistically significant at p<.05. 
Each significance test had one corresponding effect size, HR, and a corresponding 
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interval around each HR. The sample sizes were as follows: (1) iPrEX n= 1,248, (2) 
TDF-2 n= 1,219, (3) Partner’s PrEP n=1,534, and (4) Bangkok Tenofovir n= 4,823.  
For side effects there was a combined total of 74 reported p-values testing 
differences among treatment and control groups over a variety of side effects (e.g. 
nausea, headache, diarrhea, vomiting, among others). Of those p-values, approximately 
85% (n=60) were non-significant at the .05 level of probability, and 15% (n=14) were 
significant. None of the studies used other metrics to substantiate findings— such as 
confidence intervals or effect sizes.    
2. Step 2 - The Application of GRADEpro 
The GRADE approach to evaluation is unique because it is divided into two 
separate components: (1) assessment of quality, and (2) summary of findings. Using 
the GRADE approach, then, allows one to evaluate the study overall (assessment of 
quality) and each individual hypothesis (summary of findings). Below, I assess the 
quality, overall, and in the summary of findings section I evaluate two hypotheses: (1) 
efficacy and (2) side effects.   
For the assessment of quality, GRADEpro prompts users to evaluate studies on 
five dimensions: (1) Risk of Bias, (2) Imprecision, (3) Inconsistency, (4) Indirectness, 
and (5) Publication Bias. For each dimension, there are three options on a point-and-
click menu interface the evaluator can choose: (1) not serious, (2) serious, and (3) very 
serious. Evaluators employ the Cochrane criteria for ‘upgrading’ or ‘downgrading’ 
studies by making value judgements when determining the severity of infraction of 
those domains (see Appendix B for details on the grading system/criteria).  
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In the summary of findings table, evaluators must input information on the 
selected hypotheses into the program, manually. In other words, comparisons between 
treatment and control, the corresponding p-value, and any CIs or HRs must be typed 
into the appropriate boxes. From that information, GRADEpro produces the absolute 
confidence interval, which interprets HRs, RRs, and ORs in a different language. For 
example, rather than say HR: .54, 95% CI [.22-.88], the absolute CI would read: “For 
every 1,000 cases, there were ‘x’ fewer cases ranging from ‘y’ fewer cases to ‘z’ 
fewer.”  
Step 2 (a) - Assessment of Quality. Per Cochrane’s evaluation criteria, all 
studies began with a grade of ‘high’ because each one employed a RCT design (refer to 
Appendix B for a detailed description of Cochrane’s evaluation criteria). Each study, 
however, was downgraded by one or two points along the evaluation process resulting 
in the final grades: (1) High—iPrEX, (2) Moderate— Partner’s PrEP & Bangkok 
Tenofovir, and (3) Very Low— TDF2 (See Table 3.2). 
For risk of bias, both iPrEX and TDF-2 were downgraded one point each, but 
for different reasons. IPrEX disclosed several of its investigators received financial 
compensation from Gilead, the manufacturer of Truvada, while the TDF-2 study was 
terminated early due to large attrition rates. Therefore, the researchers did not report 
any findings on efficacy. Further, because TDF-2 did not present general findings or 
conclusions on the efficacy of PrEP, that study also was downgraded on inconsistency 
(defined as the testing of hypotheses in a similar manner). 
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Studies are indirect, according to Cochrane, when they are conducted on 
samples that are not the intended population. Therefore, because TDF-2, Partner’s 
PrEP and Bangkok Tenofovir did not include US participants— and PrEP is often 
viewed as a US-centered medication—those studies were downgraded one point. 
IPrEX, however, did not lose points because it included a small sub-sample of US 
participants (n=247) as part of a larger, international sample (n=2499).  
Three of the four studies, iPrEX excluded, were downgraded one point on 
imprecision into the ‘serious’ category, because of concerns with large confidence 
intervals marring the interpretability of any hypothesis. In TDF-2, Partner’s PrEP, and 
Bangkok Tenofovir, there were multiple examples in which the confidence intervals 
throughout the document, as part of small sub-tests within the grand efficacy 
hypothesis, were notably large and reported without any accompanying explanation 
(e.g., iPrEX— “the odds of HIV infection were lower by a factor of 12.9 (95% CI, 1.7 
to 99.3; p<0.001”; TDF-2— “the protective efficacy was 61.7% (95% CI, 15.9 to 82.6 
p=0.03; and Partner’s PrEP— there was a 75% relative reduction due to Truvada, 
“95% CI, 55 to 87, p<.0.001”).  
Upon completing the evaluation, and per Cochrane’s criteria, studies are to be 
awarded one additional point if they reported a dose-response gradient— consisting of 
a chart that determines lowest dosage level for needed effectiveness of treatment drugs. 
All studies, except for TDF-2, reported a dose-response gradient and, therefore, were 
awarded the extra point. 
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Step 2 (b) - Summary of Findings  
PrEP Efficacy. The summary of findings for the overall efficacy hypothesis 
(see Table 3.4) shows that, in each study, regardless of its final grade, there was a 
marked reduction in the number of HIV infections among the treatment group. Each 
study, further, reported a Hazard Ratio (HR), and CI, to substantiate findings. The 
corresponding HRs for efficacy were: iPrEX— HR: .53 (.36 to .85); TDF-2— N/A; 
Partner’s PrEP – HR: .27(.16-.48); and Bangkok Tenofovir— HR: .35 (.21 to .56). (See 
Table 3.3). 
Because the studies reported HRs and CIs to substantiate findings, when that 
information is typed into GRADEpro, GRADEpro calculates an absolute confidence 
interval for each study. An absolute confidence interval is, generally, used in meta-
analysis to aggregate various HRs and CIs into a general statistic intended to make 
sense (i.e. interpret) of what all HRs mean as an aggregate. However, the absolute CI 
can also be used for individual HRs and CIs, to make HR easier to interpret.  
The absolute CI for iPrEX, the study reporting an HR of .53 (.36 to .85), is 27 
fewer cases per 1,000 with a range of 8 to 37 fewer cases. TDF-2, again, did not report 
any findings; therefore, I could not calculate the absolute CI. Partner’s PrEP (TDF 
Only) reported an HR of .27(.16-.48), which translates to an absolute CI of 23 fewer 
cases per 1,000 ranging from 19 to 31 fewer. Parter’s PrEP (TDF-2), HR .27 (.16 to 
.48), translates to 27 fewer cases per 1,000, ranging from 19 to 31 fewer. Finally, 
Bangkok’s Tenfovir study reported HR for efficacy   as .35 (.21 to .56), translating to 
an absolute CI of 4 fewer cases for 1,000, ranging from 3 fewer cases to 5 fewer cases.    
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Side Effects. A second summary of findings was also created for the following 
hypothesis—There are no statistical differences between treatment and control groups 
in observed increases in creatinine levels26. Creatinine— which is a kidney-damaging 
chemical waste molecule generated by muscle metabolism and measured via blood 
tests (Davis, 2017) — was the side effect considered for analysis, here, because it was 
the only common serious side effect found in each of the four studies. For this 
hypothesis, the Hazard Ratios for each study were calculated by hand27, as none of the 
studies reported HRs when presenting the findings related to adverse events (see Table 
3.4). 
TDF-2, iPrEX, Partner’s PrEP, and Bangkok Tenofovir all reported non-
significant differences (p >.05) between treatment and control groups in observed 
increases of creatinine blood-levels.  The p-value was the only statistic used to relay 
information. None of the studies reported a corresponding HR and CI for this 
hypothesis. Therefore, the HRs presented in Table 3.5 were calculated by hand, to 
allow GRADEpro to provide an absolute CI.  
When comparing iPrEX’s treatment and placebo groups, there were 13 more 
people with increased creatinine, representing a HR of 1.96 and an absolute CI of 5 
                                                 
26 Creatinine is measured via a common blood test. A healthy amount of creatinine in 
the blood can range from .87 to 1.2. Study protocols for the 4 studies indicated using 
DAIDS AE grading table as set criteria to determine the severity of increased 
creatinine among patients in their respective samples.  
 
 27 Because HR was calculated by hand and there is no other information about the data, 
such as standard deviations, there is no confidence parameter for the HR’s associated 
with increased creatinine. 
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more cases per 1,000. In the TDF-2 study, there was 1 fewer documented case when 
comparing treatment and placebo groups (HR .95; Absolute CI 1 fewer per 1,000 
cases). Bangkok Tenofovir, had 85 more cases of increased creatinine in the blood (HR 
3.36; absolute CI 67 more cases per 1,000). 
Discussion 
1. Descriptive Analysis: What are some of the common reporting patterns in the 
PrEP clinical trials regarding (a) efficacy and (b) side effects? 
 The reporting practices in the PrEP clinical trials exhibit some of the 
problematic patterns documented previously by several scholars (Thompson, 1999; 
Ioannidis, 2005; Nuzzo, 2013; Hubbard, 2015). Two patterns, however, stand out in the 
presentation of findings in each report: (1) overreliance on p-values and (2) selective 
reporting of CIs and effect sizes.  
 Both hypotheses in each study (i.e., efficacy and side effects) primarily 
presented findings via p-values— findings for efficacy were reported with 11 
significant and 1 non-significant test; side effects, with 14 significant and 60 non-
significant tests. Based on the criteria of statistical significance, these findings support 
the hypothesis that PrEP is more effective than a placebo for preventing HIV infections 
among people at risk, with low risk of side-effects.  
Though using p-values to report effectiveness is not necessarily problematic, it is 
important to qualify that the studies assessed here relied on large sample sizes: 1,248 
for iPrEX; 1,219 for TDF-2, 1,534 for Partner’s PrEP, and 4,823 for Bangkok 
Tenofovir. As Thompson (2003) contends, p-values have a unique mathematical 
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relationship with sample size, in which, considering the analysis employed, will almost 
always return a significant p-value. 
 To mitigate p-value bias associated with large sample sizes, the American 
Psychological Association Task Force for Statistical Inferencing (1999) recommends 
scholars report effect sizes and confidence intervals to assist in the interpretation of a 
significant p-value. Though the PrEP clinical trials did report CIs and effect sizes— in 
this case Hazard Ratios (or, number of events/infections in the control group divided 
by events in the treatment group)— they were reported selectively. In fact, p-values 
were the primary metric for reporting findings, and they were reported twice as 
frequently than other metrics for the side-effects hypotheses. 
For efficacy, the results were presented with a p-value, HR, and corresponding 
confidence interval for the HR. Though none of the studies interpreted the HR or CI, 
these metrics still represented more information than what was provided for the testing 
of the side effects hypotheses. Treatment and control comparisons for side effects were 
only reported with a p-value, in each study. There was no reporting of CIs or HRs to 
contextualize and substantiate findings. Further, there were no other descriptive data 
for the side-effects hypothesis— such as means or standard deviations—that would 
allow readers/evaluators to calculate appropriate CIs. Therefore, it was not possible to 
calculate confidence intervals from the data provided.  
The selective reporting of CIs is problematic. In three of the four studies, with 
regard to increased creatinine levels, specifically, there were more cases in the 
treatment group than the control group. Though some of the numbers of patients 
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experiencing increased levels were small— e.g. iPrEX 5 additional cases per 1,000— 
the Bangkok Tenofovir’s 67 more cases per 1,000, with a HR of 3.36, is alarming, 
despite the non-statistical-significance of the finding. However, as Thompson (2002) 
argues,  
Statistical significance [and non-significance] is not sufficiently useful to be 
invoked as the sole criterion for evaluating noteworthiness in 
research…[we]…should expect a literature in which the results of a single 
study are explicitly interpreted using effect sizes in direct comparisons with the 
typical effect sizes from previous studies (p.66). 
2. The Application of GRADEpro: What is the quality of numeric evidence 
regarding: (a) the efficacy of PrEP, and (b) side effects? 
 Assessment of Quality. Based on Cochrane’s evaluation criteria, the PrEP 
clinical trials raise two important concerns: indirectness and imprecision. Indirectness, 
specifically, refers to concerns regarding the nation in which a study was conducted. 
Imprecision, on the other hand, refers to large gaps in confidence intervals, which taint 
the interpretation of a tested hypothesis. In other words, during the qualitative 
assessment of each study, I determined, via Cochrane’s evaluation sheet, if infractions 
within each category were severe enough to downgrade the quality of each study 
(downgrading meant deducting one point, and lowering the overall grade).  
 With regard to indirectness, Shunemann (2011) states studies should be 
downgraded at least one point (into the “serious” category) if a medication intended for 
use in low income countries is tested exclusively with samples from high income 
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countries and vice-versa. In other words, the medication should be tested with the 
population the medication intends to treat. 
Of the four PrEP clinical trials, only one study, iPrEX, relied on a sub-sample of US 
participants as part of a larger, international sample. The remaining studies, TDF-2, 
Partner’s PrEP, and Bangkok Tenofovir selected study sites, and used a sample of 
individuals, from the following countries: Thailand, Botswana, Kenya, and Uganda, 
respectively. Those studies did not sample from a US population.  
Though the practice of selecting samples from other nations may not seem 
problematic, by Cochrane’s standards, studies that do so are considered “indirect”.  In 
the case of PrEP, this finding is especially important because PrEP is viewed as a US-
centered phenomenon. The website www.prepwatch.org (2018), for example, recently 
published global PrEP uptake rates. These rates reveal the United States is the leading 
nation in number of PrEP prescriptions, at an estimated 220,000-250,000 unique 
prescriptions written for Truvada, to date. These numbers stand in sharp contrast to the 
prescriptions written in countries where the original trials were conducted— (1) 
Thailand, (4,000-5,000), Botswana (0-200), Uganda (4,000-5,000), and Kenya (25,000-
26,000). Even in other, more affluent nations, numbers on PrEP uptake remain 
similarly low— England (4,500-55,000), China (500-700), and Canada (900-1,100). 
Imprecision was a second major factor affecting the overall quality rating 
(defined by Cochrane as large confidence intervals marring the interpretation of the 
data). I elected to downgrade studies one point (into the “serious” bias risk category) 
because many reported confidence intervals from sub-tests (those other than the overall 
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hypothesis for efficacy) were notably large and unexplained. For example along with 
large CI’s mentioned previously, in TDF-2 “the overall protective efficacy of TDF–
FTC in the modified intention-to-treat analysis (comprising 1,216 participants) was 
62.2% (95% CI, 21.5 to 83.4; p=0.03) 28” (Thigpen et al., 2122)”. Further, in Partner’s 
PrEP, “reductions in the rates of HIV-1 acquisition of 67% due to [Tenofovir] (95% 
confidence interval [CI], 44 to 81; P<0.001) and 75% due to Truvada (95% CI, 55 to 
87; P<0.001)” (Baeteen et al., 2012, p. 1223). 
The problem with large confidence intervals, contends Thompson (1999), is 
that one cannot have as much faith in the point estimate as one would with narrow 
confidence intervals. In other words, CIs with a narrower range between upper and 
lower bound limits infer a more stable treatment effect. Therefore, contends Field 
(2011), one should also (1) rely on other effect sizes to convey meaning, and (2) 
explain the reported statistics. Failure to do so will prompt readers to come to a 
potentially incorrect conclusion.   
 Another issue, present in two of the studies (iPrEX and TDF-2), was potential 
risk of bias in the risk of bias domain.  The risk of bias domain, according to 
Cochrane’s evaluation criteria, is defined as any systematic or outside influences that 
sway the credibility of the evidence (Cochrane 2013). Two of the studies were rated as 
“serious risk” due to questionable funding relationships: The TDF-2 and iPrEX studies.  
                                                 
28 Though TDF-2 reported this finding in-text, they did not report the frequency of 
infection, along with corresponding HR and CI, as did the other studies. This was not 
done because the study terminated early and could make conclusions. 
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Chopra (2003) contends one of the strongest promoters of bias in clinical 
research is funding source— particularly when that funding stems from industry or 
corporations. Though all four clinical studies obtained the tested medications, free of 
charge, from Gilead Sciences (the pharmaceutical company manufacturing Truvada), 
the iPrEX and TDF-2 studies disclosed information in their respective 
acknowledgement sections that warranted further concern and evaluation. The iPrEX 
authors, for example, disclosed financial support from Gilead beyond the study 
medication. Specifically, some investigators were currently funded by Gilead via 
unrelated grant mechanisms, such as support for studies other than PrEP. Others 
disclosed being on Gilead’s payroll, or holding stock in the company: 
Dr. Mayer reports receiving grant support from Gilead, Merck, and Bristol 
Myers Squibb; Dr. Kallás reports serving on a data and safety monitoring board 
for Merck; Dr. Schechter reports receiving consulting fees and grants from 
Gilead; Drs. Liu and Anderson report receiving donations of study drug from 
Gilead for various PrEP projects; and Drs. Jaffe and Rooney report being 
employees of Gilead Sciences and owning stock in the company. No other 
potential conflict of interest relevant to this article was reported (iPrEX; Grant 
et al., 2010, pg. 2598). 
 Though certainly not to the extent of iPrEX, the authors of the TDF-2 study 
disclosed distinct information, as well, suggesting that members of the team had prior 
exchanges with Gilead, beyond the scope of the clinical trial: 
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Dr. Hart reports receiving royalties from Roche Diagnostics; the agreement 
with Roche pays the Centers for Disease Control and Prevention and project 
investigators annually for the rights to use a molecular clone in the test kits. Dr. 
Hendrix reports receiving grant support from Gilean (sic) Sciences (Thigpen et 
al., 2012, p.433). 
The remaining two investigations’ (Partner’s PrEP and Bangkok Tenofovir) 
interactions with Gilead were limited to receiving the study medication as a donation.  
 Summary of Findings: Efficacy. The CDC (2017) touts, “Daily PrEP reduces 
the risk of getting HIV from sex by more than 90%. Among people who inject drugs, it 
reduces the risk by more than 70%” (retrieved from: 
https://www.cdc.gov/hiv/basics/prep.html). All four studies listed on the CDC website 
support this statement— PrEP is more effective than a placebo at preventing the \ 
infection by HIV in each of the following groups: (1) men who have sex with men 
(iPrEX), (2) heterosexual serodiscordant couples (TDF-2), (3) active drug users 
(Bangkok Tenofovir), and (4) heterosexual men and women (Partner’s PrEP). 
 To support the findings related to efficacy, the investigators appropriately 
reported a corresponding HR— but HRs were reported only for the efficacy 
hypotheses. Authors failed to report an HR for the other important hypotheses tested, 
such as side effects. However, regardless of the level of significance, researchers 
should be more concerned with the size of the effect (Thompson, 2002). More often 
than not, a non-significant finding will have some treatment effect that warrants 
concern or further evaluation (Thompson, 1999). 
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 GRADEpro uses the HRs provided in each study to calculate an absolute 
confidence interval for that HR — which phrases the imputed HR in more interpretable 
language. All absolute confidence intervals calculated by GRADEpro comprised larger 
deviations from the point estimate than the original HRs, suggesting the studies’ effects 
might be smaller than perceived. The iPrEX study reported an HR of .53, which 
translated into27 fewer cases per 1,000 with a range of 8 fewer to 37 fewer. For the 
Bangkok Tenofovir’s study, the HR of .35 translated into 4 fewer cases per 1,000, with 
a range of 3 fewer to 5 fewer. Thus, while the medication appears to prevent infection 
in the experimental groups at levels that exceed chance, the HR effect size allowed for 
a more accurate picture. Coupled with the corresponding absolute Cis, the resulting 
image becomes even clearer.  
 Though each study’s absolute CI and HR indicated PrEP was more effective 
than a placebo for the groups studied, it is worth noting there were at least two other 
trials — conducted around the same time and funded by similar grant mechanisms — 
not listed on the CDC website: FEMPrEP and Vaginal and Oral Interventions to 
Control the Epidemic (VOICE) (See Figure 3.1).  These two studies, published in the 
New England Journal of Medicine, tested the efficacy of PrEP among heterosexual 
women in Africa. Unlike the CDC-listed trials, however, these studies found no 
significant differences between treatment and control groups in PrEP’s efficacy (See 
Table 3.5).  
Because FEMPrEP and VOICE completed their respective trials and included 
overall efficacy results, I elected to calculate an absolute CI from the HRs reported for 
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the overall efficacy hypothesis tested in each study. In both studies, more people were 
infected in the treatment group resulting in an absolute CI highlighting the 
ineffectiveness of Truvada among those samples. Specifically: FEM-PREP — HR .94 
(.59 to 1.52), or 2 fewer cases per 1,000 (from14 fewer to 17 more) and VOICE 
Tenofovir— HR 1.49 (.97 to 2.29) 20 more cases per 1,000 (from1 fewer to 51 
more). Despite the documented ineffectiveness, however, PEPFAR still recommends 
PrEP uptake for women in Africa and for female sex workers. 
Though the omission of FEMPREP and VOICE from the CDC website is 
certainly grounds for downgrading the other four studies into the ‘serious’ category 
(due to selectivity bias), I elected to not do so, as there is no evidence these studies 
were intentionally omitted. However, acknowledging their existence, and their 
contradictory findings, is important when promoting PrEP.  
Summary of Findings: Side Effects. Despite all studies reporting a list of mild 
and moderate side-effects, each investigation relied exclusively on p-values to report 
findings. HRs were not reported for side-effects, nor was the statistical test used to 
arrive at the significant/non-significant findings disclosed. Though the studies listed 
many side-effects (nausea, headache, fatigue, among others), increases in creatinine 
blood-levels were reported in all four studies.  This side-effect raises concerns, because 
increases in creatinine can lead to renal failure (Herget-Rosenthall et al., 2004).  It is 
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worthy of noting that renal failure is one of the side-effects at the center of a recent 
class-action lawsuit filed against Gilead Sciences29 in the US. 
 The frequencies of increased creatinine, alone, show that, in most studies, there 
were more cases of increased creatinine in the treatment group, than in the control 
group. By calculating the HR for those frequencies, and then calculating an absolute CI 
from those HRs, we arrive at generalized findings that examine how many more cases 
of creatinine we would expect per 1,000 cases. As with the efficacy hypothesis, the HR 
and absolute CIs for the side-effects varied.  Specifically, iPrEX had 5 more cases of 
increased creatinine per 1,000; TDF-2, was not estimable; Partner’s PrEP revealed 1 
fewer per 1,000; and Bangkok Tenofovir 67 more per 1,000.  
These analyses indicate that reliance on statistical significance testing, alone, 
can obscure important clinical findings.  While increased creatinine levels in PrEP 
patients is documented and accepted within the medical community as a side-effect, the 
actual kidney effects and damage are often ignored in discussions of PrEP. Such 
dismissal is grounded in part, in the findings reviewed here. Most health care providers 
take at face value the claim that the “PrEP clinical trials did not find significant 
negative effects on kidney function” (Highleyman, 2018, retrieved at: 
https://betablog.org/new-research-at-croi-2016-how-prep-changes-kidney-function/). 
                                                 
29 “Two Southern California men filed suit against Gilead Sciences [in May 2018] 
…The lawsuit says that HIV positive patients suffered from as many as 10 years of 
additional accumulated kidney and bone toxicity while using the drug…sold 
under…brand names, including Atripla, Truvada, Stribilb and Complera” (Peterson, 
2018, retrieved from: http://www.latimes.com/business/la- fi-gilead-hiv-drug- lawsuit-
20180509-story.html). 
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However, as more cases of creatinine rising-levels and renal damage occur, the issue is 
gaining attention. At the 2018 Conference on Retroviruses and Opportunistic Infections 
(CROI), for instance, researchers convened a panel dedicated to discussing the 
‘modest’ kidney changes associated ‘mild’ kidney damage resulting from PrEP uptake 
(CROI, 2018). 
 However, with no effect size presented in the studies for this hypothesis, we do 
not have an accurate perspective. As evidenced by the externally calculated absolute 
confidence intervals, even non-significant p-value provide valuable information; they 
should, therefore, never be ignored and always be reported (Thompson, 2003).  
Conclusion 
In this chapter, I argued for the importance of detecting numeric bias in 
academic scientific work, and demonstrated the utility of employing a tool such as 
GRADEpro to help identify potential numeric biases in research reporting. To 
accomplish that task, I opted to use a modern, heuristic example of a medication that is 
currently being promoted (via policy and activism) and evaluate seminal studies of that 
medication using GRADEpro. The evaluation comprised two components: (1) a 
descriptive analysis, and (2) a GRADEpro evaluation.  
While the descriptive analysis yielded important and insightful information, it 
was the GRADEpro tool that provided a well-rounded and thorough evaluation of each 
study on five domains: (1) Risk of Bias, (2) Imprecision, (3) Inconsistency, (4) 
Indirectness, (5) and Publication Bias. Using the Cochrane Evaluation criteria to 
determine if mild or severe infractions occurred in those domains, studies could receive 
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one of the following GRADES: (1) High (strength of evidence), (2) Moderate, (3) 
Low, and (4) Very Low.  
For various reasons, studies included in the heuristic example were downgraded 
on one or more issues among the five domains. Thus, GRADEpro, and the criteria used 
to evaluate studies, successfully--and more objectively-- assisted in identifying 
problematic issues: (a) within study execution and (b) other suspect situational factors 
potentially influencing the outcome of one, or more, investigations. Further, 
GRADEpro’s ability to calculate an absolute CI from reported data proved useful to 
help further interpret the effect size used in the analyzed studies— Hazard Ratios. The 
information derived from the absolute confidence interval added further context, and 
meaning, to otherwise un-discussed effect sizes.  
Despite its utility, it is important to bear in mind the inherent limitation in the 
GRADEpro tool. While the tool is more objective that current measures, such as self-
evaluation, interpretation of the Cochrane criteria and decisions on to downgrade for 
various infractions ultimately rests with the researcher. Therefore, we cannot be one 
hundred percent certain our own biases influenced the decision to downgrade studies 
into the ‘serious’ or ‘very serious’ categories. 
Overall, GRADEpro did what researchers at Cochrane intended— provide an 
accessible, open source software platform with which to assess the quality of large-
scale investigations and promote transparency in research. Results from this example 
further highlight the importance, and utility, of programs such as GRADEpro for future 
efforts in numeric bias detection and mitigation. 
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Table 3.1. The number of total reported significant/non-significant p-values, confidence intervals, 
effect sizes, and sample sizes for each of the four PrEP clinical trials testing the overall efficacy 
hypothesis. 
  
Significant 
p-values 
Non 
Significant 
p-values 
Total p-
values 
Confidence 
Intervals 
Effect 
Sizes 
Sample 
Size 
iPrEX 3 1 4 4 4 1248 
 
TDF-2 - - - - - 
 
1219 
 
Partner's PrEP 4 - 4 4 4 1534 
 
Bangkok 
Tenofovir 4 - 4 4 4 4823 
             
Total 11 1 12 12 12 8824 
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Table 3.2. Assessment of Quality using the Cochrane Criteria to determine the overall strength of evidence of 4 clinical 
trials studying PrEP’s efficacy.  
  
Study 
Design 
Risk of Bias Inconsistency Indirectness Imprecision Grade 
iPrEX (TDF-FTC) RCT Serious Not-Serious Not-Serious 
Not-
Serious **** (High) 
TDF-2 (TDF-FTC) RCT Serious Serious  Serious Serious * (Very Low) 
Partner's PrEP (TDF-FTC)* RCT Not-Serious Not-Serious Serious Serious ***(Moderate) 
Partner's PrEP (TDF)* RCT Not-Serious Not-Serious Serious Serious ***(Moderate) 
Bangkok Tenofovir (TDF-FTC) RCT Not-Serious Not-Serious Serious Serious ***(Moderate) 
* Partner's PrEP has two rows because they used a 1:1:1 design, which tested (1) Tenofovir versus Placebo, and (2) 
Truvada versus placebo. 
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Table 3.3. Summary of Findings for the efficacy hypothesis tested in 4 clinical trials of PrEP, 
examining: (1) the number of HIV-infections among treatment and control groups, the corresponding effect 
size (Hazard Ratio) and (2) a computer-calculated absolute confidence interval. 
Number of 
Patients Effect 
PrEP Placebo Relative Absolute 
iPrEX (TDF-FTC) 38/1251 72/1248 HR .53 (.36 to .85) 
27 fewer cases per 1,000 
(from 8 to 37 fewer) 
TDF-2 (TDF-FTC) - - - - 
Partner's PrEP (TDF-FTC) 22/1584 58/1584 HR .38 (.23 to .62) 
23 fewer cases per 1,000 
(from 14 fewer to 28 fewer) 
Partner's PrEP (TDF) 16/1579 58/1584 HR .27 (.16 to .48) 
27 fewer cases per 1,000 
(from19 to 31 fewer 
Bangkok Tenofovir (TDF-
FTC) 17/4843 33/4823 HR .35 (.21 to .56) 
4 fewer cases per 1,000 
(from 3 to 5 fewer 
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Table 3.4. Summary of findings regarding PrEP side-effects comparing observed blood 
levels of creatinine (> 1.2 per mm) between treatment and control groups in four clinical 
trials.  
  Number of Patients Effect 
p-value 
  PrEP Placebo Relative   Absolute  
iPrEX (TDF-FTC) 28/1251 15/2611 HR 1.86 5 more cases per 1000 0.08 
TDF-2 (TDF-FTC) - - - - - 
Partner's PrEP  19/1584 20/1579 HR .95 1 fewer case per 1,000 0.28 
Bangkok Tenofovir (TDF-FTC) 121/1204 36/1209 
HR 
3.36  
67 more cases per 
1,000 0.09 
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Table 3.5. Summary of Findings Table for two additional studies of PrEP’s efficacy -- not listed on the 
CDC website.  
  
Number of 
Patients Effect 
  PrEP Placebo Hazard Ratio Absolute CI 
FEMPReP 33/1024 35/1032 HR .94 (.59 to 1.52) 
2 fewer cases per 1,000 (from14 
fewer to 17 more) 
VOICE TDF 52/823 35/838 HR 1.49 (.97 to 2.29) 
20 more cases per 1,000 (from1 
fewer to 51 more) 
VOICE TDF-FTC 61/1284 60/1308 HR 1.04 (.73 to1.49) 
2 more cases per 1,000 (from 12 
fewer to 22 more) 
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Figure 3.1. A screenshot of the CDC website, last updated February 12, 2018, listing  
the four clinical trials assessing PrEP’s efficacy: (1) iPrEX, (2) TDF-2, (3) Partner’s 
PrEP, and (4) Bangkok Tenofovir.  
 
*Absent from the screen shot are two additional studies listed as ‘PrEP evidence’ from 
aidswatch.org. 
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CHAPTER IV  
LANGUAGE BIAS AND TOPIC MODELING 
 Though there are numerous documented cases in which numeric data do not 
reflect the sample from which they are drawn— e.g. the misrepresented data from 
renowned Harvard scientist Marc Hauser30 — such cases are almost exclusively 
discussed within the context of statistical analyses (Aschwanden & King, 2015). 
Rarely, if ever, is the language used to report and supporta problematic numeric data 
addressed. However, failing to associate problematic language with problematic data 
unduly ignores an important nuance within problematic science — that language, itself, 
can be used to misrepresent research data.   
 Specifically, written language is the medium scientists use to communicate 
their work. In that communication, contends Gambrill (2012), there are numerous 
intentionally selected, and unintentionally embedded language patterns that influence 
how the intended message is interpreted. How the language is contextualized (i.e. 
rhetorical strategies, surreptitious wording, and withholding of details, among others) 
directly influences the quality and direction of the resulting message. Therefore, if the 
written language used for reporting scientific work intends to mislead or misdirect an 
audience, serious implications may result, given the implicit assumptions among the 
audience that the language used by scientists is both factual and objective. 
                                                 
30 In 2010, Marc Hauser was charged with scientific misconduct due to falsification of 
data on primate cognition. He would later step down from his professorship at Harvard 
University, as a consequence of his actions. 
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 Studies on misleading or biased language used to report scientific research is 
uncommon (Gambrill, 2011). Therefore, how extensive is the use of problematic 
language in published scientific work is, currently, unknown. However, in a publishing 
environment in which one science-related article is published every twenty seconds 
across thousands of academic journals (Bowman, 2014), language bias can be a 
concern that should not be ignored. Especially, as Sirbu (2015) articulates, it is 
“writing…[that] plays an important role in the preservation of…realities” (p.405) 
making the quality of language much more important.  
 Therefore, the purpose of this chapter is to explore an understudied component 
of research bias— language bias— by answering the following research question: Do 
common bias-inducing factors such as time, funding source, and country of origin, 
influence latent language patterns in published research? To answer this question, I 
will employ technological tools, namely topic modeling, to dissect language via 
computer algorithms. The overall aims of this chapter are to discuss the prevalence of 
language bias and answer the research question in a more thorough and objective 
manner.  
Language and Bias 
 Linell (2012) contends our understanding of language is abstract—that is, 
language is abstract due to its social construction. Thus, there is no universal way to 
utilize written or spoken language, as language is bound by different cultural and social 
norms. Because language is abstract (Evans, 2014), it has a unique power to 
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communicate anything; ranging from hand-written letters, public speeches, or 
dissertations.  
The degree of power, or influence a given message has when it is 
communicated is closely tied to how that message is presented (Gambril,2011). In 
other words, in a written text, or in speech, there are numerous rhetorical strategies and 
linguistic devices one can employ to sway attitudes and opinions on varying subjects. 
Oftentimes, however, communicators may not be fully aware they are using these 
strategies in their communication (Andreas 2017).  
In all written and spoken language, there are imbedded patterns of word 
choices. These so-called latent language patterns often have characteristics of 
misleading or false rhetorical strategies, as they attempt to create a veneer of 
credibility— especially when the intended message is driven by hidden motives 
(Abraham, 1995). Gambrill (2011) posits there are two categories of latent language 
patterns: (1) those that are unintentionally applied in written or spoken language 
(which she views as unintentional bias), and (2) those that are deliberately placed (what 
she terms ‘propaganda’). 
The distinction between conscious and unconscious latent language patterns is 
important as both can pose harmful consequences.  Unconscious langue bias, for 
example, can be emblematic of ignorance (Banks & Ford, 2009). For example, if a 
researcher holds prejudicial attitudes against a certain minority group, but studies 
health disparities, there is the potential for manifested language patterns to address 
certain groups differently, ignore them all together, or provide assessments that do not 
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accurately reflect that group. Therefore, because of latent prejudicial attitudes that 
researcher may be, unintentionally, writing about certain groups differently. 
Conscious language bias is, more often than not, emblematic of manipulation 
(Jones, 2016). In conscious language bias, rhetorical strategies, linguistic devices, and 
withholding of information, among other practices, are deliberately applied to 
misdirect or mislead an audience (Bricocoli & Cucca, 2016). For example, as it relates 
to problematic numeric data, several linguistic strategies may be used to mitigate the 
weaknesses of flawed data. Therefore, conscious language bias offers the potential to 
deliberately promote false or misleading information to attain some sort of gain (be it 
prestige or financial, among others) (Lakoff, 1995).  
One aim of science, however, is to promote a research agenda that is accurate, 
impartial, and objective, in its relentless pursuit of knowledge (Gordon, 2006). 
Hubbard (2015) cautions, however, that while such objectivity in science is ideal, not 
all research agendas are created equally. Some agendas seek to actively mislead, 
misdirect, or legitimize fraudulent findings as credible science (Ioannidis, 2005).  
Only recently, however, have these issues come to light so forcefully (McArdle, 
2011). Today, contrasted with the prior history of academia, there are more 
documented cases in which fraudulent science has been identified— evidenced by (1) 
growing retraction rates (Steen, Casadevall, & Fang, 2013), and (2) a mounting 
inability to replicate findings (Pashler & Wagenmakers, 2012). In both cases (i.e., 
replication and retraction) numeric data are, more often than not, identified as the 
primary area of concern (Earp & Trafimow, 2015).  
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The language employed to communicate those data is often ignored (Egger et 
al., 1997). According to Linell (2004), however, ignoring how language is 
contextualized is detrimental to understanding the scope of bias in published research. 
In any academic study, for example, several linguistic devices can be surreptitiously 
used to alter a message— for supporting fabricated data, for instance. Therefore, by 
identifying numeric data as the only factor in manifestations of bias – and ignoring 
language as another important component of bias --  is detrimental to more 
comprehensive investigations and understanding  of research bias (Fairclough, 2013). 
As previously mentioned, science should be transparent and objective in all 
aspects of the research process—reporting included. If instances of fraudulent data 
passed as credible science are increasing (Marcus & Oransky, 2014), then it stands to 
reason that language biases may also be prevalent in published research.  
Bias-inducing Factors 
 A bias-inducing factor is anything in the research process that can potentially 
influence language and create language bias (McArdle, 2011). Though there are 
certainly numerous bias-inducing variables that can influence language patterns (e.g. 
see the work of (Delgado-Rodríguez & Llorca, 2004) ), I will purposefully explore 
three of these variables: (1) time, (2) funding source, and (3) nation of origin. 
 The justification for selecting time, funding source, and nation of origin as bias-
inducing factors is as follows. First, I included time because of the ease in which 
language changes along with research advances (Swaminathan, 2007). Specifically, as 
new innovations replace older practices, language tends to incorporate and reflect these 
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changes, over time. Second, I selected funding source as a bias-inducing factor because 
funding’s influence on language patterns is one of the most visible sources of 
contamination in research (Chopra, 2003; Barden, Derry, McQuay, & Moore, 2006). 
Finally, I selected nation of origin as a bias-inducing factor for two reasons: (1) there 
are regulatory differences in research across nations (Van Norman, 2016), and (2)  
those regulations promote differing opinions and perceptions on medication uptake, 
which often manifest in language (Arrow & Aronson, 2016). 
Current Methods for Detecting Language Bias 
 As stated previously, in studies of research bias, language is not studied as 
frequently or as carefully as numeric bias (Gambril, 2011). Two reasons may explain 
why language bias is understudied: (1) it is not as well-understood as numeric bias, and 
(2) there are, to date, no systematic approaches to detect biased language.  
 The primary reason language bias is not as well-understood as numeric bias is 
the general lack of linguistics training in other social sciences (Linell, 2004). In the 
social sciences, many fields are primarily data driven and utilize quantitative designs in 
their research. Therefore, language is not as critically assessed and scrutinized as 
“hard” numeric data (King, 2011). Linguists, however, are trained to dissect language, 
and are more attuned to rhetorical devices used to sway language. Therefore, without 
specific linguistic training, many social scientists are prone to overlooking intentional 
and unintentional linguistic choices that alter research-reporting language.  
 Unlike numeric bias— which has objective tools for its detection and 
measurement (Barden et al., 2006; Chan & Altman, 2005; McArdle, 2011)— for 
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language bias, currently, no such measures exist. Therefore, identifying something as 
being biased, with regard to language, remains subjective (Drapeu, 2002). In that 
subjectivity, if one scholar brings about accusations of bias against another scholar, no 
matter how credible the evidence, the accused scholar stands on a very stable platform 
to argue the accuser is biased, him/herself.  Therefore, without a more objective and 
systematic approach to diagnose language bias, accusations of biased work likely 
amount to little more than contentious arguments amongst scholars seeking to discredit 
one another’s work. 
 Though an objective approach to detect language bias in research reporting is 
unavailable in Public Health, Health Education, and Health Promotion, one 
methodology that could be adapted — popular within the field of Computer Science — 
is Topic Modeling. 
Topic Modeling 
 What is Topic Modeling? Topic modeling  (TM) is a form of text mining via 
computer algorithms, used to aggregate and segment a large collection of text (known 
as a corpus31) into smaller manageable subsets (Wallach, 2006). The theoretical logic 
of topic modeling assumes that, in any corpus, there are underlying latent patterns and 
thematic structures that are difficult to detect due to the sheer volume of information 
available online and in print (Maldarelli et al., 2014). Topic modeling can be used to 
                                                 
31 A corpus can be a collection of books, peer-reviewed articles, an aggregate collection 
of social media posts, or any other form of large-scale textual content. Generally 
speaking, the larger the corpus of data, the easier to interpret the latent topic.  
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effectively consolidate such large collections of text and automatically identify only the 
most important themes embedded within them.   
 While there are many different forms of topic modeling (Latent Semantic 
Analysis [LSA], Topic Evolution Model [referred to as CTM], among others), the most 
popular, widely used, and consistently cited is Latent Dirichlet Allocation or LDA 
(Blei, Ng, & Jordan, 2003). Unlike other topic modeling algorithms, LDA has been 
more widely validated in computer science research, and has been used most 
commonly in topic modeling applications (Hoffman, Bach, & Blei, 2010). Therefore, 
while other topic modeling algorithms perform nearly the same function, the focus on 
this section will be on LDA, a math-free discussion of its calculations, and its current 
applications. 
 Latent Dirichlet Allocation or LDA. LDA is unique among other types of 
topic models, because it utilizes Bayesian inferencing as part of its calculus and not 
basic matrix algebra. As part of Bayes logic, LDA primarily utilizes Gibbs sampling, 
an iterative inferencing technique that guarantees all data points (in this case words) are 
represented in the corpus equally (Griffiths, 2002). LDA relies, therefore, on complex 
probability distributions to compare each word (X) with every other word (Y) in a vast 
collection of documents, to determine which words are probabilistically most 
associated with other words (Wallach, 2006; Steyvers & Griffiths, 2007; Porteous, 
Newman, Ihler, & Asuncion, 2008).  
 Words with high probabilities of association are grouped together in a three-
dimensional vector space to form latent thematic clusters,  while words that provide no 
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structural meaning – such as prepositions and articles -- are eliminated from the corpus 
(Wang & Grimson, 2008).  The words in each cluster, ideally, are similar enough that 
one can interpret the thematic meaning of the grouped words with little effort. For 
example, if we created a corpus on every book written on the topic of pet care, we 
would likely find several word clusters related to different types of animals. In our 
hypothetical pet-care corpus, if words such as bark, woof, bone, and fetch were 
clustered as one latent theme, we would interpret that cluster, or topic, to be about 
dogs. The same can be said for words such as meow, purr, mice, and feline, being 
interpreted as a topic about cats. 
 The logic behind LDA is not unlike the one underlying Exploratory Factor 
Analysis (EFA), a common technique in exploratory statistics (Péladeau & Davoodi, 
2018). EFA, in its purest form, seeks to identify a structure within answers to a survey, 
for example, based on response patterns from participants (Carroll, 1985). In other 
words, EFA identifies survey questions answered in a similar enough pattern to group 
them as a latent factor. Topic modeling, essentially, performs the same task — but 
rather than use numeric data to create a set of grouped survey items, it relies on 
patterns among text data to create the latent topics.   
 Along with being compared to common statistical procedures such as EFA, 
to help non-computer scientists understand how the algorithm calculates topics, LDA is 
also equated to a pixelated image (Griffiths & Steyvers, 2004). Below, the readers can 
see three photos of the Mona Lisa (see Figure 4.1). Each photo, from left to right, is 
more pixelated than the last. The original unaltered photograph (left) is composed of 
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millions of individual pixels to provide clarity to the image. The subsequent photos are 
more pixelated— i.e., pixels have been removed from the original portrait 
(paradoxically, more pixilation means fewer pixels in the image, overall). 
Even with less pixels in the subsequent images, most individuals would feel 
confident identifying the image as the Mona Lisa. LDA is engaging in an analogous 
process with a corpus. In other words, the corpus is very large and complex (i.e. the 
unaltered Mona Lisa). Through the iterative Gibb’s sampling process, words are 
systematically removed until only the most important ones remain. The topics 
remaining after the LDA procedure is applied, still reflect the original corpus and, more 
importantly, its content remains identifiable, even with far less information— (i.e. 
onlookers can still identify the pixelated portrait as the Mona Lisa). 
 Despite its intuitive similarity with well-established analytic techniques such 
as EFA, topic modeling is, only now, beginning to be implemented as a valid 
methodological tool in applied and social sciences (Valdez, Pickett & Goodson, 2018). 
In other words, though applicable to the social and applied sciences, topic modeling 
remains, primarily, a methodological tool in Computer Science. Therefore, a brief 
discussion of existing topic modeling applications is enlightening, before examining 
how topic modeling can be used as a method/tool for capturing language bias in Public 
Health and health promotion research. 
Topic Modeling Applications 
 Blei and associates (2003) wrote the LDA algorithm to capitalize on, and 
assign structural meaning to, the explosive growth of online content. Due to its ability 
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to consolidate large amounts of language with little human input, LDA quickly became 
noted as the primary platform for text dissection and text mining in the early 2000’s 
(Srivastava & Sahami, 2009). 
  In its home-field, Computer Science, topic modeling was generally used to 
explore how the Internet was growing and to assess trends in online content, as 
websites were spawning daily (Perrin & Duggan, 2015). Today, in Computer Science, 
little has changed in terms of how LDA is applied in research. Many recent 
publications (e.g. Suominen & Toivanen, 2016)) focus, specifically, on social media 
platforms and advances in LDA’s mathematical design. 
 Nearly two decades after its initial launch, few fields outside Computer 
Science have adopted topic modeling as a methodological tool. Academic fields that 
have done so, however, have realized how useful tools such as LDA can be for 
analyzing large collections of text data. In Business, for example, marketers use topic 
modeling procedures as a faster and more efficient way to analyze product reviews, 
such as those on Amazon— something that, at one time, could only be accomplished 
via focus groups (Titov & McDonald, 2008).  
 Because TM is not well-known in the social sciences, Valdez, Pickett & 
Goodson (2018) have called for the adoption of topic modeling as a legitimate 
methodological tool in social and applied science fields such as Health Promotion, 
Public Health, and Health Education. More importantly, however, is Valdez and 
colleagues’ contention for not only increased applications of topic modeling in the 
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social sciences, but also for an increase in the sophistication regarding how the method 
is employed:  
To date, the use of TM [topic modeling] has been limited, and mostly 
exploratory in nature. However, given its ability to unearth the underlying 
thematic structure of large amounts of data, we contend TM is a powerful tool, 
applicable to a number of research contexts, especially in the social 
sciences….While not exhaustive, here we propose three social sciences 
domains in which researchers could employ and expand the use of TM: (1) as a 
tool for reducing unintentional reviewer bias in systematic literature reviewing, 
(2) for practical thematic exploration of qualitative data and thematic analysis 
validation, and (3) for comparing similar corpora to explore semantic 
similarities and differences. (In-Press, Social Science Quarterly). 
 According to Valdez and colleagues, topic modeling can be used to answer 
specific questions by comparing corpora for similarities and differences. These newer 
applications of topic modeling (e.g. using topic modeling to test specific hypotheses) 
support the work of Computer Science scholars seeking to innovate topic modeling 
further, for addressing more complicated and sophisticated research questions (e.g. 
topic modeling as a form of regression (Wang & Blei, 2011), as well as topic 
modeling, or pixel modeling, of images (Zeng, et al., 2017), among others).  
 Although TM is a method to detect nuances of language patterns, its current 
applications are, mostly, limited to exploratory analyses seeking to identify meaning in 
a large collection of text. Therefore, the utility, and application of topic modeling in 
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this investigation will move beyond LDA’s intended exploratory roots to answer the 
following question — Do common bias-inducing factors such as time, funding source, 
and country of origin, influence latent language patterns in published research, in 
ways that can be detected with topic modeling procedures?  
Methods 
 To answer this research question, I created one grand corpus of data for each 
bias-inducing factor. Each grand corpus, (1) time, (2) funding source, and (3) nation of 
origin, was composed of published abstracts from different subjects in Public Health 
and Health Promotion and Behavior, namely: (1) ADHD medication (to test time), (2) 
sugar and the human diet (to test funding source), and (3) pediatric/perinatal Highly 
Active Anti-Retroviral Therapy (P-HAART) (to test nation of origin).  
  I selected different content for each corpus for several reasons. Chief among 
them is: each of these subjects, has, at some point, been met with conflicting, divergent 
public opinion32. Therefore, the grand corpora for each bias-inducing variable could 
easily be divided into competing sub-corpora for subsequent analysis in LDA to detect 
language shifts, or language bias (Linell, 2004).  A second reason I purposefully 
selected these topics was the volume of publications available in each group. With a 
more robust corpus, the topics are clearer and more concise than with smaller corpora 
(Hoffman et al., 2010). Finally, topic modeling, as a method is not biased by topics or 
content and should be equally useful for any and all subjects.  
                                                 
32 The rationale will be discussed at length in subsequent sections. 
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 Below, I present the composition of each corpus and how each one was 
treated. Each description provides: (1) a brief justification for its inclusion in this study, 
(2) the search terms used as inclusion criteria for each corpus, (3) how each corpus was 
subdivided into a smaller sub-corpus, and (4) the final number of journal article 
abstracts33 (the units of analysis, here) in each corpus or sub-corpus.  
Corpora  
ADHD Medication to Test Time. To observe the effects of time on language, I 
selected research on the flagship brand name medication used to treat Attention Deficit 
Hyperactivity Disorder (ADHA):  Ritalin. In the early 1970’s Ritalin was frequently 
and widely administered, without a full psychiatric diagnosis, to children exhibiting 
signs of hyperactivity in classroom and home settings (Morton & Stockton, 2000). 
Today, due to concerns with prescription drug abuse by teens and over-medicating of 
children, Ritalin is only prescribed, as a controlled substance, after extensive 
psychiatric evaluation in severe cases of ADHD (Shillington, Reed, Lange, Clapp, & 
Henry, 2006).  
The specific purpose of the corpus of Ritalin-related research was to determine 
if research language across time would reflect attitude changes toward 
pharmacotherapy for ADHD. To compose the corpus, I searched four major databases 
(1) PubMed, (2) EbscoHost, (3) Web of Science, and (4) Medline. In each database 
search, I downloaded articles using the following search terms: (1) Ritalin, (2) 
                                                 
33 I elected to analyze abstracts and not entire journal articles because abstracts can be 
downloaded and stored in MS Excel in a more concise and efficient manner. 
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Methylphenidate, (3) Concerta, (4) Daytrana, (5) Ritalin LA, and (6) Metadate. These 
words were used as inclusion criteria because they are the most commonly used brand 
names associated with Ritalin and Ritalin’s generic name, Methylphenidate.  
My analysis focused on the text of the research reports’ abstracts. The final 
number of abstracts included for analysis was 5,216 ranging in dates from 1970 to 
2018. Those abstracts were, then, further subdivided into decades. In other words, 
every abstract published between 1970-79, 80-89, 90-99, 2000-09, 10-18, was indexed 
into a different and unique sub-corpus – one sub-corpus for each decade. Each of these 
decade sub-corpora was run as a separate topic model to assess (1) how language 
changed throughout the history of Ritalin research, and (2) if language changes 
reflected current attitudes regarding Ritalin prescriptions (i.e. over-used and abused 
study drug).    
Funding Source. To observe how sources of funding for research influence 
latent language patterns, I sought to compare industry- versus federally-funded corpora 
of studies investigating the role sugar plays in the human diet. The rationale for 
selecting sugar studies was due to the Sugar Industry’s documented history of 
attempting to sway public attitudes about sugar via questionable and non-replicable 
research34 (Aubrey, 2017).  
                                                 
34 In the 1960’s and 70’s the Sugar Industry funded a group of researchers at Harvard to 
downplay the negative health outcomes associated with heavy sugar consumption. The 
research conducted at Harvard was, then, used as evidence to lobby for dietary 
recommendations in support of a high carbohydrate, low fat diets (Domonoske, 2016).  
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More important in my decision to include funding source as a bias-inducing 
variable, is the academic and medical community’s widely supported consensus that 
chronic sugar consumption leads to poor health outcomes (Fischler, 1987). Therefore, 
any language differences between industry- and federally-funded studies that 
advocated for, or mitigated the risk of, sugar consumption could be due to the sugar 
industry’s financial involvement in research.  
To compose this corpus, I searched four major databases (1) PubMed, (2) 
EbscoHost, (3) Web of Science, and (4) Medline. In each database search, I included 
the following search terms to find articles examining the role of sugar in the human 
diet: (1) Sugar Diet, (2) Sugar and Diet, (3) Sugar in Diet, and (4) Sugar in Human 
Diet. The searches yielded a total of 828 abstracts.  
Subsequently, I conducted a second and third searches to further eliminate 
abstracts that did not exactly match the inclusion criteria. Search number two, 
specifically, sought to find abstracts funded exclusively by large-scale, federal national 
institutes, such as: (1) NIH, (2) CDC, (3) FDA, and (4) NSF— n = 212 abstracts. The 
third search within the original 828 abstracts also sought to find studies, or articles, 
funded by the sugar industry (common funders included, but not limited to: PepsiCo, 
Coca Cola, Nestle Inc., Kraft Food Brands, and the National Corn Refiners 
Association)— n = 71. Therefore, the final number of abstracts included for analysis 
was 283, with the federally-funded studies (n = 212) and industry-funded ones (n=71). 
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Nation of Origin. To observe rhetorical, English language differences between 
nations, I compared abstracts studying P-HAART conducted, funded, published and 
based either in the United States or in Europe. The reasons for choosing the United 
States and European nations as moderating variables were: (1) the general credibility of 
US and European research within the international science community (Grunert & 
Wills, 2007) and (2) the potentially different attitudes regarding long-term medication 
interventions for children and adults35.  
 To compose this corpus, I searched the same databases as for the previous 
corpora:  (1) PubMed, (2) EbscoHost, (3) Web of Science, and (4) Medline. In each 
database, I searched the following terms to only include investigations studying P-
HAART: (1) Pediatric HAART, (2) Perinatal HAART, (3) Paediatric36 HAART, (4) P-
HAART, (5) infant HAART, and (6) Pediatric Highly Active Anti Retro-Viral 
Therapy. The searches yielded a total of 1,149 abstracts.  
Each abstract was further sorted into one of two sub-corpora depending on their 
nation in which the study was conducted and published in — (1) United States, and (2) 
European nations. For inclusion in the US sub-corpus, specifically, studies had to have: 
(1) US authors, exclusively and (2) studied/examined a US-based sample.  Europe had 
                                                 
 
35 In the United States, generally, pharmacotherapy is more trusted and widely applied 
across a large spectrum of physical ailments. The attitudes in the US stand in contrast 
to those of European nations who often view pharmacotherapy as a last option, 
especially with regard to children (Marazzi et al., 2006). 
 
36 Paediatric HAART is the correct spelling for ‘Pediatric” in the United Kingdom. 
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the same criteria: for inclusion in the European Union sub-corpus, studies had to (1) be 
written by authors from the EU, exclusively, and (2) have obtained their sample(s) 
from EU nations. 
However, few of the indexed abstracts conducted investigations on individuals 
in either the United States or in Europe— the majority of the studies were executed 
either by an international team, or among populations outside of the US or Europe 
(Rosen & Fox, 2011). If this was the case, or if there was any ambiguity where the 
studies originated, they were eliminated from the analysis. Therefore, the final corpus 
was significantly smaller than the preceding two corpora (assessing time and funding 
source): United States, 74 abstracts, and 56 European abstracts. Fortunately, according 
to Blei (2003), the overall word count in each sub-corpus was enough to generate an 
interpretable topic model. 
Analyses 
 I ran a separate topic model for each sub-corpus addressing the three bias-
inducing variables. For time, a total of five topic models were generated (one for each 
decade: 1970-79, 80-89…2010-2018). Funding source required two topic models 
(industry- and federal-funding) and nation of origin also required two topic models for 
comparative analysis (United States-based studies and European-based studies). 
 All analyses were conducted using statistical programming software R version 
3.4.2 and the following downloadable R packages: (1) topicmodels (sic), and (2) tm 
(sic). Both packages —which are specialized program extensions for R—allow 
researchers to run text data through a multi-step process to prepare for analysis. Such 
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preparation includes: (1) removing punctuation, numbers, special symbols (e.g. *, <, >, 
&, among others), (2) stemming the document (i.e. removing all suffixes from words 
so that only the root word remains), and (3) creating a document term matrix (dtm), 
which is an aggregate calculation of how many times every word is used in a corpus, or 
sub-corpus.  
 For ease of interpretation, clarity, and consistency, I generated a similar 5x10 
structure topic model for every sub-corpus. In other words, each sub-corpus, regardless 
of the actual final word count, was stripped down to only include the five most 
important topics with the top ten associated words in each topic. The decision to utilize 
a 5x10 matrix structure is supported by the theoretical positioning of Blei and 
colleagues (2003) who contend that, due to the lack of ‘fit’ statistics in topic modeling 
methodologies, researchers have full right to generate any number of topics per topic 
model deemed necessary to accurately interpret its structure.  
 To account for a lack of fit statistics, I opted to, instead, assess inter-rater 
reliability of the results— which is a check for overall consistency among scholars in 
interpretations of qualitative data, such as interviews (Armstrong, Gosling, Weinman, 
& Marteau, 1997). I presented the topic models, without prior discussion, to a 
qualitative methodology researcher. Upon finding a mutually agreeable interpretation 
of the context of each topic model, extraneous words deemed unnecessary to the 
overall dialogue were removed from a final analysis. The final models were transposed 
into Excel, and saved as one file along with the original text file for each respective 
sub-corpus.  
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Results 
Time 
  The purpose of this analysis was to assess how language employed in the 
reporting of Ritalin studies changed over time, and to speculate on the reasons fueling 
the changes. For ease of detection, I divided the corpus into decade-spanning sub-
corpora to compare differences among decades (see Table 4.1).  
 Across each decade, the most important theme (i.e. all topics listed in bold) was 
consistent. In other words, probabilistically speaking, in each decade, each sub-corpus 
was primarily over the same content— an obvious finding considering the corpus was 
built from Ritalin research. More important was the general stability of the content 
over time. 
 Specifically, each of the most important topics (i.e. the topics in bold) across all 
decades contained a fairly similar amount of words in their respective models: methyl, 
disord, adhd, mph, effect, behavior, drug, among others. Other words in the most-
important topics contained similar clinical-type language, narrowing in on Ritalin’s 
effects on behavior, dosing, stimulants, other cognitive functions. Therefore, the 
general composition of the corpus reflects, primarily, concerns with testing and Ritalin 
effects. 
  The remaining topics throughout the span of Ritalin research (i.e. other topics 
that are not the topic in bold), changed gradually. In the 1970’s and 1980’s children 
and boy were the populations most frequently addressed in the studies; frequent enough 
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to emerge as part of a thematic latent topic. Beginning in the 1990’s however, other 
populations began to emerge often enough to appear within other latent topic (e.g. 
parent, human, and rodent) and, in the 2010-18 sub-corpus, the term adult appears.  
Other words, such as abuse, toxic, addict, begin appearing in the 1990’s and were 
absent in older sub-corpora topic models (see Table 4.2).  Below, Table 4.2 from the 
document term matrix, depicts the rankings of words by importance (i.e. how often 
words are used in a sub-corpus). 
 At the beginning of the Ritalin era, for example, the 79th most important word, 
boy, reflected the only population being tested— girl, adolescent and adult did not 
appear in that decade’s sub-corpus at all; during that time few studies focused on 
groups other than boys. Subsequent decades saw diversification regarding who was 
tested, eventually including girls, adults, and adolescents. Beginning in the late 90’s, 
and extending into the 2010-18 decade, the terms adult and adolescent became more 
important (i.e., more frequent) than the original 1970’s term ‘boy.’ Further, words such 
as abuse, adverse, and side (as in “side- effect”) also gained importance and became 
much more visible over time.  
Funding Source 
 This analysis sought to determine if the source of funding (i.e. industry versus 
federal funding) would have an effect on latent topics when studies reported testing the 
same hypothesis— Increased sugar intake is not associated with negative health 
outcomes. Overall, the language in both topic models was notably different (see Table 
4.3.). 
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 In the topic model for federally-funded reports, the most important topic (in 
bold) contains the words diet, food, sugar, intake, increase, weight, high consumption, 
energy, and risk. Further, the other topics in that model, particularly Topics Two, Four, 
and Five, contain clinical-type language associated with outcomes related to sugar 
consumption (e.g. metabolism, disease, insulin, effect, mice, liver, link, bod, tumor, 
among others). Topic Three was notably different from the other topics. Rather than 
language reflecting clinical outcomes, Topic Three centered on interventions and cost 
(e.g. program, nutrient, polici, cost, ssb (a frequently used acronym for sugar 
sweetened beverages), ses (socio-economic status), and regress.  
 The industry-funded topic model, had a different emphasis altogether. The 
computer-identified most important topic, Topic Five, contained the following words: 
intake, sugar, diet, cosum, food, energy, beverage, consumpt, dietary, and pattern. 
Diet, as in food consumed daily, was a recurrent theme in the majority of the remaining 
topics, especially observable in topics Two, Three and Four. In those topics, food 
related words such as, calori, effect, baseline, promote, breakfast, fruit, juice, eat, 
among others, were also common.  
Topic one in the industry-funded topic model, was notably different from topics 
Two, Three, Four, and Five. Rather than emphasize diet— as in food consumption37— 
Topic One uniquely discussed outcomes of sugar consumption such as increased 
                                                 
37 A cursory read-through of the articles composing the industry-funded topic model 
will show the majority of the articles define diet as ‘daily food consumption.’ 
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adiposity and heart function (e.g. total, increase, fructose, reduce, eat, obes, cvd 
(cardiovascular disease), among others). Therefore, though the most recurring theme in 
the topic models was diet, there was still some mild variation in published content in 
the industry funded topics, as well. However, the industry model was generally less 
specific, overall with regard to physical outcomes of sugar consumption, than the 
federally funded model. 
Nation of Origin 
 This analysis sought to determine if P-HAART studies conducted, funded, and 
published in the United States and other European nations would produce differing 
topic models. As with the previous analyses, the language for both models differed (see 
Table 4.4). 
 Language from the US-based studies centered on two foci: (1) the prescribing 
and administering of P-HAART to infants, and (2) general recommendations for 
infants potentially exposed to HIV. The computer-identified most important topic for 
US-based studies contained the following words: HIV, infect, children, pediatr, health, 
report, care, youth, infant, and disease. The remaining topics (e.g., topics Two through 
Five) were similar to Topic One with regard to population and scope in their respective 
topics. In other words, much of the content in the corpus supporting this topic model 
was primarily centered on uptake. 
 Specifically, Topics Two and Three in the US-based model focused on HIV 
transmission and pharmacotherapy applications, using words such as: drug, medic, 
birth, issue, viral, test, aid, born, recommend, high, dose, exposure, matern, among 
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others. Topics Four and Five used slightly different words to convey a focus on general 
recommendations and federal guidelines, such as: regimin, factor, cdc, human, 
research evalu, adult, and patient. Much of the language in the US-based topic model 
also reflects the national recommendations for PHAART in the United States: 
The uses of ARV regimens in newborns include:  
• ARV Prophylaxis: The administration of one or more ARV drugs to a 
newborn without confirmed HIV infection to reduce the risk of HIV 
acquisition.  
• Empiric HIV Therapy: The administration of a three-drug combination 
ARV regimen to newborns at highest risk of HIV acquisition. Empiric 
HIV therapy is intended to be preliminary treatment for a newborn who 
is later confirmed to have HIV but also serves as prophylaxis against 
HIV acquisition for those newborns who are exposed to HIV in utero, 
during the birthing process or during breastfeeding and who do not 
acquire HIV.  
• HIV Therapy: The administration of a three-drug combination ARV 
regimen at treatment with HIV diagnosis” (National Institutes of Health, 
2017, pg. H-1, retrieved at 
https://aidsinfo.nih.gov/contentfiles/lvguidelines/PediatricGuidelines.pd
f) 
 The European studies also had two foci: (1) management and diagnosis of HIV, 
and (2) guidelines and recommendations for P-HAART. The computer-identified most 
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important topic contained the following words: art, parent, manage, status, diagnos, 
drug, screen, europ, hundred. The remaining topics (e.g. Topics One, Three, Four and 
Five) were notably different from one another, with little overlap in content.  
 Topic Three, for example, discusses guidelines using the words guideline, 
health, recommend, provid, migrant, aid, adolescent, and disease. Topic One, on the 
other hand, as addresses national reports of HIV infection: year, present, patient, 
country, and, report. Topic Five can further be interpreted as care for children living 
with HIV: HIV, children, infect, paediatri, care, age, women, clinic, follow, European.  
 Overall, much of the language in the European topic model also reflected 
European recommendations for P-HAART from the Paediatric European Network for 
Treatment of AIDS (PENTA) revised 2015 guidelines: 
PENTA guidelines seek to optimize treatment for children in Europe. However, 
particularly during adolescence, care may need to be individualized. This 
document should not be seen as a standard for litigation as individualization of 
case management and departure from this guidance may be necessary and 
indicated. Significant changes since the 2009 guidelines include: 
 decreased frequency of laboratory monitoring in clinically stable 
children both on and off ART; 
 consideration of ART initiation in all children aged 1–3 years in order to 
minimize the risks of disease progression or death; 
 consideration of ART initiation at higher CD4 thresholds in children > 5 
years of age in order to optimize potential for immune reconstitution; 
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 additional clinical indications for ART initiation at all ages; 
 addition of newer protease and integrase inhibitors to first‐line preferred 
and alternative third agent options, respectively; 
 update on specific guidance in the context of hepatitis B and C virus and 
tuberculosis (TB) coinfection in light of new ART options at younger 
ages; 
 a summary of new drugs [including new fixed dose combinations 
(FDCs)] that can be considered for second‐ and third‐line options and of 
the ‘pipeline’ of new drugs likely to become available; 
 an emphasis on the needs of older children and adolescents as they 
approach transition to adult care (Bamford, et al., 2015, p. e5) 
Discussion 
 The purpose of this chapter was to explore an understudied component of 
research bias, namely, language bias, by answering the following research question— 
Do common bias-inducing factors such as time, funding source, and country of origin, 
influence latent language patterns in published research, in ways that can be detected 
with topic modeling procedures?  
To varying extents, the language examined for each bias-inducing variable 
changed among rival sub-corpora, as highlighted above. However, in order to 
appreciate the nuances in the language differences among the topic models, one must 
also understand the potential underlying factors. The discussion to follow will 
highlight, among other points of consideration, what factors, circumstances, or events 
 126 
 
may have influenced or swayed language patterns to create the documented differences 
among the topic models.  
Time 
 One source of language changes in Ritalin research may be the growth in 
research publications, and evolution of research trajectories, on Ritalin and 
Methylphenidate over time (see Figure 4.2). In the 1970’s there were less than one 
hundred scientific publications on Ritalin, the majority of which were clinically 
focused (e.g. the most important topic for that decade contained the words 
methylphenidate, dose, patient, effect, interv, among others). In the 2010 decade, the 
number of publications increased to nearly 3,000 clinical, psychological, sociological, 
and epidemiological research studies on Ritalin and other ADHD pharmacotherapies.  
Thus, there were inherently more discoverable latent topics in more recent years of 
Ritalin research.  
 The prolific growth/evolution of methylphenidate research, itself, along with 
subsequent language changes, can be explained through varying historical contexts. 
Chief among them is the changing demographics of the first cohorts administered 
Ritalin to treat hyperactivity. Specifically, the first children to whom Ritalin was 
administered in the early 1980’s, grew into adulthood in the 1990’s and early 2000’s 
(Schacter, Pham, King, Langford & Moher, 2001). While this drug was intended 
primarily to treat children (specifically, boys), the shift in demographics prompted 
renewed testing to determine if Ritalin regimens should continue into adulthood (Cox, 
Merkel, Kovatchev & Seward, 2000). The desire to increase the scope of Ritalin was 
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equally reflected in the topic models— in later years, the terms girl, adolescent, and 
adult eventually emerge as salient enough to be captured by the models.  
 Due to successful efficacy and safety testing among adolescent and adult 
populations, guidelines governing Ritalin and other ADHD pharmacotherapy adapted 
to include a patient population that did not consist merely of children (Gamble, 2011). 
For example, in 2001, guidelines published in the Journal of Pediatrics noted the 
appropriate age for Ritalin use was no younger than six years of age and no older than 
twelve. In an update to those guidelines (in 2011) there were two major changes: (1) 
ADHD was now reclassified from a psychological disorder into a chronic condition 
and (2) the appropriate ages to administer Ritalin were changed to include children as 
young as four and adults eighteen and over (Journal of Pediatrics, 2011). 
 With adults, adolescents, and children now using Ritalin, the amount of 
prescriptions written for ADHD pharmacotherapy doubled within one decade (Boffey, 
2015). And, due to the wide availability and administrations of Ritalin and other 
ADHD pharmacotherapies, researchers were further able to document new aspects of 
Ritalin that were previously unstudied— such as its negative outcomes. Specifically, in 
the 1990’s Ritalin—once considered a safe drug intended to treat hyperactivity in 
children— was now classified as a high-risk study drug linked to abuse (Babcock & 
Byrne, 2000; Morton & Stockton, 2000). More importantly, the topic model was able 
to capture this important nuance— the term abuse would first appear as a topic in the 
1990’s model. 
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 The topic models in every decade, therefore, were able to accurately capture 
changes in perceptions, as well as current events within Ritalin research. For example, 
the changes in scope (e.g. changing populations from children only, to children, teens, 
and adults), the link to its abuse, and concerns over safety. Though the evolution of 
Ritalin research, itself, is not indicative of bias within the field, the important take-
away is that technological tools, such as topic modeling, correctly assisted in creating 
latent topics reflecting important events at that time, and within a given decade. TM’s 
ability to detect these changes can be useful for historically assessing a given field’s 
bias(es) regarding overall perspectives, targeted population groups, treatment 
preferences, and other important patterns governing research and practice at different 
times.  
Funding Source 
The topic model for federally-funded research contained more medically-styled 
language that was more critical of sugar than its industry- funded counterpart 
Specifically, in the model for the federally-funded studies, words such as risk, weight, 
gain, tumor, insulin, metabol, and disease can be interpreted as emblematic of 
consensus within the health care community, regarding sugar— excessive consumption 
has negative health outcomes (Rodearmel et al., 2007). Further, similar medical-style 
language is also seen in federal guidelines, such as those from the CDC, to call for 
decreased sugar consumption by children and adults (Park et al., 2014).  
This clinical language, however, is absent altogether in the topic model for the 
industry-funded research. Instead, language in that topic model appears to treat sugar 
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merely as another variable. In this model, sugar is treated as a normal part of the human 
diet, to be enjoyed in moderation. More importantly, language in each of the topics in 
the model for industry-funded research tended to pair sugar with other household items 
and behaviors often billed as healthy— such as fruit, juice, grain, and breakfast.  
Gambrill (2011), who contends industry-based investigations are inherently 
biased, calls diverting attention away from serious outcomes, “oversimplification [used 
to] dull critical thinking” and mask lingering controversies (p.289). Wolfson (2017) 
further adds that oversimplification is common among many types of research funded 
in-house, in a bid to mitigate a bad reputation. For example, in 1993 Congress was set 
to pass legislation banning public smoking across all public establishments. Major 
tobacco manufacturers, concerned over potential profit loss, funded their own 
investigations intending to downplay the role of second hand smoke for adults and 
children. As with the sugar industry’s diverting away from outcomes and, instead, re-
directing sugar to associations with health foods, tobacco manufacturers sought to 
divert attention away from health consequences of second-hand smoke and contended 
smoke-free establishments will only lead to decreased profit margins for public 
establishments, such as bars and restaurants. Thus, it is apparent the sugar industry, 
similar to the tobacco industry, is attempting to misdirect the audience by shifting the 
narrative away from health implications of sugar consumption, to focus, instead, on 
healthy foods and healthy behaviors, such as eating breakfast.  
Also absent from the model for industry-funded research, but evident in the 
federally funded studies, are the words SES, cost, and ssb. Though those words could 
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be interpreted in various ways, their absence in the model for federally-funded studies 
may indicate the industry’s lack of concern for general societal-level implications of 
sugar consumption.   Park et al., (2014) contend sugar consumption is highest among 
lower-income, minority families due to its affordability. In other words, because 
processed foods and sugar-sweetened beverages are often more affordable than natural, 
less-sugary products, families of lesser means are more likely to purchase these goods. 
Consequently, contends Pechey (2016), these families are likely to suffer more co-
morbidities and sugar-related chronic conditions than individuals who consume less 
sugar. Therefore, the words obes, metabol, liver, disease, appearing alongside, ssb, 
SES, and cost in the federally-funded model indicates federally-funded research may 
have focused more on the psychosocial and economic aspects of sugar than their 
industry-funded counterparts.  
When examining the remaining topics in the topic model for federally- funded 
research, one can infer that discussing SES and cost is a small part of the larger 
narrative— with its nearly-exclusively focus on negative effects of sugar in the human 
diet. In the industry-funded model there is an absence of vocabulary describing co-
morbidities and important information on cost, alongside the presence of language 
pairing sugar with healthy products. Topic modeling was able, therefore, to capture 
these bends in the research agendas and their manifestations in latent writing patterns.  
Nation of Origin 
The US topic model for Nation of Origin was clear regarding the targeted 
population: infants and children (e.g. birth, issue, virus, transmiss, infant, hiv, 
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children). More evident was the sense of urgency in administering P-HAART at the 
time of birth: birth, issue antiretrovir, prophylaxi, receive. In the European TM, 
however, the target population was not as clear, as there were more emergent groups 
throughout the corpus and final topic model: provid, migrant, aid, adolesc, women, 
children. Absent altogether from the European model was the word infant despite this 
corpus being composed of studies regarding pediatric HAART.  
As mentioned previously, these distinctions most likely stem from the 
regulatory differences between the United States and other nations in the EU. Some of 
those differences, discussed below, lead to conflicting attitudes regarding medication 
uptake, and shape the type of research being done. In the US, medication uptake is 
viewed favorably, as evidenced by the fact 70% of Americans report taking at least one 
prescription drug daily (Mayo Clinic, 2018). In most nations in the EU, less than 40% 
of their populations report taking  at least one prescription drug, daily—suggesting, 
perhaps, a more cautious and skeptical stance toward medications (Eurostat, 2014, 
retrieved at: 
http://ec.europa.eu/eurostat/statisticsexplained/index.php/Medicine_use_statistics#Pres
cribed_medicines.) 
EU pharmaceutical research and medication distribution are regulated heavily 
by the government. This is done, in part, to de-incentivize profiteering by 
pharmaceutical companies (Eger & Mahlich, 2014). For example, when compared to 
the United States, almost all major medications are significantly cheaper in the EU 
(Danzon & Chao, 2000). More importantly, less research and development of 
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pharmaceuticals occurs in Europe due to smaller profit margins when compared to the 
US (Filson & Masia, 2007). Therefore, due to regulations in which profit incentives are 
removed, any tested medication in Europe will be more widely scrutinized, evaluated, 
and thoroughly tested before ever being approved for use among the general population 
(Eger & Mahlich, 2014).  
The United States’ federal regulations allow for more competition between 
governmental outlets, such as the NIH and CDC, and industry-based counterparts— 
which infers more of an open-market structure (Spiegel, 1991). In fact, over the last 
several decades, US-based companies outspent the federal government’s budget by 
over 1 billion USD (Pharmaceutical Manufacturer’s Association Annual Report (1989; 
2017). And, because industry is outspending the federal government, many 
governmental agencies such as the FDA and CDC will often defer to findings from 
industry-funded clinical trials (Carr, 2017). Such actions result in medications that are 
heavily marketed, more expensive, and difficult to obtain without private insurance 
(Lyles, 2014).  
Returning to the topic models I presented, those for the US seem to reflect the 
same sense of urgency characterizing the National Institutes of Health’s guidelines for 
P-HAART, which recommend “Empiric HIV therapy is intended to be preliminary 
treatment…without consent to newborns who are exposed to HIV in utero, during the 
birthing process or during breastfeeding and who do not acquire HIV” (NIH, 2017, H-
5) . Such urgency may well stem from the prevailing view to “hit HIV hard and early” 
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and prevent HIV transmission as early as possible (Ho, 1995, p.450) but may also be 
shaped by the market-oriented culture of drug policies in the US.  
On the other hand, the European model also reflected European national 
guidelines which, unlike the US guidelines’ focus on newborns, suggest, 
“consideration of ART initiation in all children aged 1–3 years in order to minimize the 
risks of disease progression or death …and considerations of older children into 
adulthood” (Bamford et al., 2015, p.e5) . The different emphasis on who should receive 
care most likely stems from the more regulated and scrutinized style of EU-driven 
research, in tandem with the culture of skepticism toward over-use (and, most likely, 
early-uptake) of medications. In this case, as with time and funding source, the topic 
models were able to capture those nuances, peculiar to each geographic region and 
culture(s).  
Conclusion 
Though authors such as Monroe (2013) contend embedded messages and 
surreptitious wording are acceptable in the scientific literature, continued reliance on 
such practices have the potential to lead to further erosion in the credibility of science. 
As Hubbard (2015) cautions, while all scientists have an agenda, not all agendas are 
created equally, and certain agendas seek profit over progress. Therefore, in a world 
full of problematic biased language, we should be better equipped to address and 
mitigate biased language from science-based literature, if and when it is present. One 
methodology presented in this chapter, topic modeling, is a tool that can assist scholars 
in dissecting and interpreting language in ways that help identify biased patterns.  
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This chapter sought to elucidate the importance of an overlooked component of 
bias— language. To further cement language bias as a legitimate component of 
research bias (see Chapter 2 for further development), I briefly outlined examples of 
three bias-inducing factors: (1) time, (2) funding source, and (3) nation of origin. After 
outlining the importance of each factor, I tested topic modeling, a method common in 
Computer Science, for detecting language biases associated with these (and other) bias-
inducing factors.  
 I used topic modeling to accomplish two objectives: (1) frame topic modeling 
as a legitimate methodological option in Public Health and all fields conducting health-
related research, and (2) to answer an important question— Do common bias-inducing 
factors such as time, funding source, and country of origin, influence latent language 
patterns in published research, in ways that can be detected with topic modeling 
procedures?  
After the analyses of various topic models for each of the factors, the answer is 
yes, those factors do influence language patterns. Yet, most important was how I 
arrived at the answer— by using technology to parse out only the most important 
information from a large collection of research. The most salient finding from the 
analyses presented here is:  not only was topic modeling able to identify differences, 
but these differences also indicated time-related trends, policy recommendations, and 
rhetorical strategies used to highlight or down-play researchers/scholars’ preferences. 
In other words, the findings from each topic model demonstrated how scientific 
language aligns itself with the larger narratives in which it is embedded. These findings 
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suggests topic modeling is successful at consolidating a large amount of information 
into manageable chunks, and in capturing nuances of meanings, as well as preferred 
patterns of language used to communicate this information.  
Therefore, at the very least, findings from this dissertation chapter support the 
notion that topic modeling should be studied further as a valid tool with which to detect 
language bias and, ultimately, identify potentially harmful research biases. Though still 
unique for Public Health, tools such as topic modeling have assisted Computer Science 
scholars with assigning meaning to abstract “noises”, such as online content. Thus, we 
should continue borrowing this and other potentially useful tools to further advance 
studies of bias— both numeric and language based.  
Though language bias is certainly a newer (and less studied) component of 
research bias, its novelty does not imply lack of importance. As Gambrill (2011) 
contends— the key to making an informed choice is access to quality information. She 
further adds, many consumers are unable to distinguish varying levels of information 
quality, due to the saturation of ‘propaganda,’ or misleading messages. Because the lay 
public cannot differentiate between good and bad quality science, that obligation-- 
contends Ioannidis (2005)— falls upon scientists who must uphold the credibility of 
their endeavors. Fortunately, with tools such as topic modeling, studies on language 
bias are now much more accessible, and if ever so slightly, a little less subjective.  
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Figure 4.1. A progressively pixelated Mona Lisa is an analogy showcasing how topic modeling takes a large collection of 
text content, simplifies it to only the most important parts, but still maintains the overall structure of the original text data. 
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Table 4.1. Topic Models on Methylphenidate Research by Decade 
  1970-79    1980-1989 
  Topic 1 Topic 2 Topic 3 Topic 4 Topic 5    Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 
1 children methyl attent perform group  1 studi methyl measur drug attent 
2 hyperact effect behavior learn rate  2 task hyperact behavior disord differ 
3 drug behavior medic normal motor  3 test children respons treatment rate 
4 hyperkinet find measur ritalin found  4 condit effect hour activ stimul 
5 improv stimul condit treat height  5 assess boy cognit concentr pharmacolog 
6 arous abstract control differ subject  6 ritalin deficit improv subject present 
7 respons hyperact problem compar affect  7 administr perform process medic meal 
8 report physiolog test neurolog present  8 mgkg dose prolactin add time 
9 treatment show dose task case  9 reaction increas interact growth effect 
10 weight respond age dextroamp cognit  10 group studi control posit design 
             
  1990-1999    2000-2009 
  Topic 1 Topic 2 Topic 3 Topic 4 Topic 5    Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 
1 parent diagnosi function effect methyl  1 focus methyl mode attent fluoxetin 
2 abus academ three children disord  2 pfc adhd extens patient conflict 
3 assess diagnos human drug adhd  3 characterist effect afternoon dose secondari 
4 amplitud remain stimulus hyperact attent  4 neuropsycholog mph error hyperact communic 
5 experiment latenc sensit deficit behavior  5 distribut children noradrenerg improv neurotransmiss 
6 potenti addit consist ritalin stimul  6 place disord randomis differ rodent 
7 appear edsub stimuli medic respons  7 biolog drug sexual year selfreport 
8 attribut emiss therapeut patient dose  8 toxic increas pathway assess bid 
9 comparison issu tomogra test mgkg  9 locat medic therebi suggest blind 
10 deficit lower addict cocain report  10 valu stimul antidepress includ continu 
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Table 4.1 Continued Topic Models on Methylphenidate Research by Decade 
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Table 4.2. Word Ranking by Decade on Methylphenidate 
Research:  
1970-
1979 
1980-
1989 
1990-
1999 
2000-
2009 
2010-
2018 
Boy 79 14 37 173 233 
 Girl - 581 373 426 606 
Adult - 275 71 32 21 
Adolescent - 430 97 51 33 
Toxic 673 - 551 704 931 
Side 220 - 26 169 169 
Adverse 179 - 231 97 129 
Abuse - - - 3219 104 
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Table 4.3. Topic Models for Industry- and Federally-Funded research reports on sugar’s role in the human diet 
Industry Federal 
Topic 
1 Topic 2 Topic 3 
Topic 
4 Topic 5 Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 
1 total fruit chang calori intak 1 diet fructos genet resist famili 
2 increas weight product effect sugar 2 food beverag program signal individu 
3 fructos mean reduct calor diet 3 sugar metabol nutrient term random 
4 reduc breakfast design lower consum 4 intak diseas lower larg women 
5 eat women effect trial food 5 increas obes polici home store 
6 obes blood baselin free energi 6 weight mice regress link amount 
7 well contribut promot examin beverag 7 high effect cost bodi insulin 
8 cvd school measur obes consumpt 8 consump insulin ssb gain loss 
9 loss carbohydr breakfast respect dietari 9 energi relat ses progress analyz 
10 grain juic either observ pattern # risk liver analys tumor healthi 
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Table 4.4. Topic models for research on P-HAART in Europe and the United States 
  Europe            United States         
  
Topic 
1 Topic 2 Topic 3 Topic 4 Topic 5    Topic 1 Topic 2 Topic 3 Topic 4 Topic 5   
1 year art therapi guidelin hiv  1 hiv drug test antiretrovir prevent  
2 present parent unit health children  2 infect medic aid prophylaxi research  
3 patient manag survey recommend infect  3 children birth born expos compar  
4 countri status pediatr provid paediatr  4 pediatr issu differ receiv evalu  
5 report diagnos count migrant care  5 health virus recommend increas adult  
6 start drug develop aid age  6 report famili high guidelin particip  
7 antenat escmid four adolesc women  7 care mhps behavior regimen physician  
8 acquir screen time diseas clinic  8 youth transmiss caregiv factor present  
9 activ europ case live follow  9 infant viral exposur cdc patient  
10 differ hundr childhood mortal european  10 diseas resist matern human assess  
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Figure 4.2. Number of published studies on Ritalin by decade. 
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CHAPTER V 
CONCLUSION 
This dissertation sought to raise awareness of the complexity of bias in today’s 
research climate. More importantly, this dissertation also aimed to introduce, and 
subsequently test, novel technological tools for bias detection in published health-
focused research. To accomplish these objectives, I utilized a journal-article formatted 
dissertation encompassing the following content: Chapter 1— introduced the 
dissertation, its format, and each chapter’s general content area; Chapter 2— called for 
an expansion of scope of research ethics, to include bias—both numeric and language-
related--as a component as worthy of attention as the ethics surrounding human and 
animal subjects participating in research; Chapter 3— demonstrated the utility and 
effectiveness of GRADEpro as a tool for detecting numeric bias in published reports, 
and Chapter 4—demonstrated Topic Modeling as a language-bias detection tool. 
Below is a brief conclusion of each study followed by practical recommendations for 
future researchers. 
Bias as a Component of Research Ethics 
Chapter 2 sought to argue that bias, defined as any factor that influences the 
quality of research in both published and unpublished work, is a contemporary ethical 
concern in today’s research climate—as vital for the credibility of the scientific 
enterprise as concerns with the rights of humans and animals participating in research. 
A secondary goal of this study was to spotlight two types of bias— namely, numeric 
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and language bias-- and examine how these biases manifest themselves and influence 
research quality. 
After a brief discussion of current problematic issues in science— such as the 
replicability crisis, among others— I sought to argue bias can potentially manifest 
within numeric bias and language bias. More importantly, I further argued how current 
measures intended to address such biases are insufficient, because bias detection, itself, 
can be inherently subjective. 
Precisely because bias detection is subjective, and the overall goal of this 
dissertation is to promote the discussion around bias mitigation, I introduced two tools 
that could more objectively assist in the detection of bias— GRADEpro, for detecting 
numeric bias, and Topic Modeling, for language bias. Chapter 2 concluded with a call 
to better understand bias and to further test GRADEpro and Topic Modeling as “bias 
detectors”. This call further served as the launching point for the studies presented in 
Chapters 3 and 4. 
Numeric Bias Identification with GRADEpro 
The purpose of Chapter 3 was to elaborate on numeric bias— or the bias that 
can be embedded in the reporting of numeric data. This chapter also sought to test 
GRADEpro, and the Cochrane Evaluation criteria, as a potential tool for detecting 
numeric bias. To test and exemplify the use of GRADEpro, I assessed a total of four, 
large-scale, randomized control trials. These studies tested the effectiveness of PrEP to 
prevent HIV transmission among non-infected people at high risk for infection. I 
employed the GRADEpro criteria and software to (1) determine the overall quality of 
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the evidence presented in the studies’ reporting, and (2) to develop a summary of 
findings table. In tandem, these two steps provide a more objective “picture” of the 
studies’ reporting quality, and constitute the main features of the GRADEpro 
assessment. 
The four studies varied in quality. Studies with lower quality were identified as 
having one, or more, infractions in one or more of the five evaluation domains: (1) 
Risk of Bias, (2), Imprecision, (3) Indirectness, (4) Inconsistency, and (5) Publication 
bias. The summary of findings table served to further interpret data presented in the 
four studies. Findings from this analysis indicated the efficacy of PrEP varied and, 
because only p-values were reported when comparing treatment and control groups on 
side-effects, the studies lacked important information (such as CIs and ES) on the 
clinical significance of the differences detected (all group differences regarding side-
effects were reported as not statistically significant). 
Though not entirely objective— much of the assessment of quality involves 
making value judgements based on a set of criteria, GRADEpro still proved useful for 
analyzing large clinical trials, systematically. More importantly, the analysis 
engendered by using GRADEpro elicited important findings within the four analyzed 
trials that would not have otherwise been visible. Therefore, as it relates to numeric 
bias and problematic reporting of numeric data, GRADEpro is an appropriate tool and 
should be utilized in health-focused research in both the social and medical sciences. 
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The purpose of Chapter 4 was to test Topic Modeling as a potential tool for 
detecting language bias— defined as the observable and non-observable language 
structures that shape a message with the intent of misleading the message recipients. 
To determine if Topic Modeling was an appropriate tool to detect language bias more 
objectively, I selected three factors commonly associated with language bias— (1) 
time, (2) funding source, and (3) nation of origin—to test the tool’s performance. 
I further selected three research topics (Ritalin, sugar and the human diet, and 
the Pediatric Highly Active Anti-Retroviral Therapy [P-HART]) with which to test 
changes in language when parsed out among the bias inducing factors. In other words, 
I examined: (1) changes in language used in Ritalin research over time, (2) differences 
in how language is used when reports regarding the role of sugar in the human diet are 
funded by industry or federal sources, and (3) differences in language used by US and 
European researchers to report on and recommend P-HAART. 
Within each of the bias inducing factors, language changes were observable. 
With Ritalin, there was clear change in language, over time, as more populations are 
prescribed Ritalin. More importantly, vocabulary changes also attested to the drug’s 
association, currently, with abuse and long-term neurological effects. Regarding 
funding source, studies funded by the sugar industry employed language that 
downplayed the harms of long-term sugar consumption. Federally funded studies, 
however, were more likely to associate sugar with long-term chronic illnesses. 
Regarding P-HAART, US-based studies were more likely to recommend onset at birth 
Topic Modeling as a Language Bias Detection Tool 
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and without consent. Language in European studies emphasized, instead, older age 
groups and different populations (e.g., adolescents and immigrants).  
Overall, Chapter 4 had two main findings: (1) language bias can be objectively 
detected, and (2) topic modeling, a set of computer-based algorithm, can assist in bias 
mitigation when large collections of text are parsed out into different groups and 
compared to one another. Therefore, regarding studies of language bias, topic modeling 
can and should be implemented as a valid method in the health sciences, capable of 
providing unique and important insights into various factors that shape scientific 
reporting.  
Concluding Remarks 
This dissertation is a valuable asset to the literature due to its multifaceted 
approach to studying and identifying bias in published reports via more objective 
technology-driven tools such as GRADEpro and Topic Modeling. Further, this 
dissertation’s thorough theoretical and conceptual treatment of bias adds a layer of 
complexity regarding how bias is perceived in today’s academic climate. 
Moving forward, researchers should work to continue studies of bias— 
especially as it relates to potential errors within their own work. More importantly, 
scholars should not be afraid to test tools such as GRADEpro and Topic Modeling, 
themselves. Once such tools are incorporated more into Public Health, Health 
Education, and Health Promotion discourse and research, we, as social scientists, can 
contribute our small part to reduce problematic practices hampering the quality of the 
scientific enterprise.  
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Though eliminating all bias from research is an impossible task, starting a 
dialogue and raising awareness of intentional and unintentional biases are ideal starting 
points. By bringing bias, and studies of bias, to the forefront of the scientific literature, 
and not relegating them to the commentary sections of academic journals, we stand to 
frame bias as a constantly evolving and complex issue that warrants continual 
vigilance. Further, as studies of bias increase, researchers may discover (or come to 
develop) newer tools and techniques to assist the scientific community with even better 
bias detection and mitigation beyond the tools presented in this dissertation. Overall, 
however, we should strive to uphold the integrity of science and the scientific 
enterprise. Science can promote much knowledge for the greater good. Undetected bias 
in science, however, stands to achieve exactly the opposite.  
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APPENDIX A 
ETHICS IN THE APPLIED SCIENCES 
 
Ethics 
 Ethics is broadly defined as a normative evaluation used to distinguish right 
from wrong based on varying dimensions, such as: morality, justice, obligation, and 
self-righteousness (Baier, 1958).  Ethics provides a set of rules or guidelines that, when 
upheld, attempt to protect the fundamental interests of the greater good (Corrigan, 
n.d.). Many professional fields uphold codes of ethics to guide their professionals (e.g. 
law, education, medicine, health education, among others) due to the varying emergent 
issues for which (a) no single, clear-cut answer exists, and (b) some form of moral 
reasoning regarding context- specific dilemmas is warranted (Benson, 1989).  
Codes of ethics are intended to assist decision-making related to ethical 
dilemmas using rational and logical processes to arrive at the best course of action. 
Allen (2012) argues three conditions, at least, must be satisfied for a situation to be 
classified as an ethical dilemma: (1) A person, or agent, must choose a course of action 
on a subject. If a situation does not require an agent to make a choice, the situation is 
not a dilemma. (2) There must be varying options for the agent to choose, with 
numerous potential outcomes. And, perhaps most importantly, (3) regardless of the 
decision made by the agent, there will, at some level, be some loss. In other words, a 
perfect solution is not available.  
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In his book “Moral Reasoning” (1980), Graissing gives several such examples 
to illustrate the nature of theoretical ethics and the inherent difficulty associated with 
solving ethical dilemmas. Perhaps one of the most famous examples of a classic 
dilemma is the Prisoner’s Dilemma (Nowak & Sigmund, 1993). In this example, 
imagine you and a colleague are arrested on unspecified charges, but there is not 
enough evidence to convict both. You are, then, given two potential options to escape 
sentencing: (1) remain silent, or (2) betray your colleague. Your actions have one of the 
outcome conditions: (1) If you betray your colleague and he/she stays silent, you go 
free and the colleague serves three years in prison, if your colleague betrays you and 
you stay silent, your colleague goes free and you serve a three-year prison term. (2) If 
both you and your colleague betray each other, you both serve three years in prison, 
and (3) If you and your colleague both remain silent, each will only serve one year in 
prison. Regardless of the decision, there is loss at some level, to either you as the 
primary agent, or to your colleague. 
 When presented with an ethical dilemma such as the one above, the agent must 
rely on a series of cognitive processes to arrive at a perceived optimal answer— these 
processes can be facilitated by invoking professional codes of ethics or personal ethics 
as guidelines (Wilshere, 1997). The purpose of the Prisoner’s Dilemma, for example, is 
to explore the complexity of cooperative behavior through an example in which, 
logically, the prisoner’s optimal solution would be to betray the other partner (Fehr & 
Fischbacher, 2003). However, despite appearing to be the optimal solution, there 
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remains the risk of both partners betrayed each other and both get sent to prison 
(Molovsky, 2014). There is, therefore, no solution in which all parties benefit equally. 
 
Applied Ethics 
 While theoretical situations such as the Prisoner’s Dilemma are some of the 
most notably popular examples of exercises in ethical thought, they cannot escape one 
central concern— the dilemmas and solutions themselves, like much work in classical 
ethics, are merely conceptual (Son, 2014).  Rarely, if ever, do these theoretical ethical 
dilemmas occur in real world scenarios or applications, posing problems for fields in 
which its professionals’ interactions with people warrant much practice and training.  
Professional fields in the applied sciences, such as Health Promotion, Public 
Health, and Medicine, among others, are ethically driven and stem from classic ethics 
theory, but they embody inherent needs that cannot be met by theoretical/classic ethics, 
alone. In other words, the ethical choices being made by agents in applied sciences 
have real-world ramifications for living populations. Therefore, those fields find 
themselves resorting to more practical applications of ethical principles. In other 
words, the formal and informal codes that guide normative decisions in the applied 
fields are rooted in a popular mid-20th century shift in ethical discourse to what is now 
commonly known as ‘applied ethics.’  
Applied ethics is a branch of ethical thought that departs very slightly from 
traditional Western ethics theory (Rest, 1994). First popularized in the mid-20th 
century, applied ethics specifically seeks to apply available ethics theory and 
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frameworks to controversial intra-personal, inter-personal, technological, professional 
and governmental contexts (Peterson & Ryberg, 2016). Because applied ethics goes 
beyond classical thought and is centered on decision-making that affects populations, 
the propositions of applied ethics were eventually incorporated into applied sciences 
and social sciences (as they deal almost exclusively with human populations), such as 
Public Health, Medicine, Education, and Health Education, among others.  
Bioethics, for example, is one field in applied medical sciences with varying 
degrees of frameworks, protocols, and debates, aimed at keeping medical research 
sound and participants in research, or patients, safe from harm. Today the majority of 
medical policies enacted in the US are inherently following various codes of bioethics 
(Mbidde, 1998). These codes have been shaped by several advances, dilemmas, and 
ethical breaches among groups, which forced discourse on ethical rights and 
considerations (e.g. abortion, stem cell research, euthanasia, among others) (Marshall, 
2000). In effect, when a situation warrants ethical discussion within the medical field 
(due, in part, to concerns over someone’s ethical rights), protocols and policies 
established via bioethical criteria serve as shields to protect certain groups’ basic 
human rights. 
 
Ethics and Human Subjects in Research 
Tuskegee Syphilis Study. Perhaps the most notorious and highly studied 
domestic example of an ethical breach that led to policy development is the Tuskegee 
Syphilis Study (TSS) and the lasting impact it had on patient rights (Brandt, 1978, 
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Smith, 1999, Daughtery-Brownrigg, 2012). TSS was a 40-year federally-funded (U.S. 
Public Health Service) clinical investigation examining the spread and progression of 
untreated syphilis among rural African American men in Alabama. The participants 
were deceived into believing their involvement in the investigation would result in free 
governmental health care and access to medication that was too expensive for that 
population.  
The brazen withholding of information and treatment of participants, once 
penicillin became available, and the direct and purposeful exposure to harm was 
viewed as a cruel ethical breach (once the public became aware of the experiment, in 
1972; McCallum, Arekere, Green, Katz & Rivers, 2006). The long-term effect of the 
study eventually led to a congressional court-filed class-action lawsuit settling for 10 
million dollars, lifetime medical care, and one of the most important components of 
future bioethics and research policies: informed consent (Faden & Beauchamp, 1986). 
The TSS is an important example, of several, regarding how applied bioethics 
is used to address a moral dilemma in a real-world situation. In this case, the dilemma 
was a clear case of deception, withholding of information, and withholding treatment 
from a curable disease. Unknowing participants were harmed directly by being exposed 
to untreated syphilis without full disclosure of the intended outcomes of the study. 
From an ethics standpoint, the moral debate centers on what does one value more: the 
pursuit of knowledge and science for the sake of science or the promotion of health for 
the sake of human life? (Katz, 1993).  
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In effect, the resulting probe, discourse, and debate deemed the harm to 
participants was so high it moved beyond a threshold of acceptability.  Thus, using 
ethical consideration as a moral code, coalitions of professionals were formed in the 
19070’s to generate policy to protect future human subjects from experiencing similar 
harm (Jonsen & Butler, 1975). Today, for example, academic institutions’ Institutional 
Review Board and its oversight of studies, along with informed consent forms used to 
indicate voluntary participation in research studies, are mainstays in the bioethical 
process of conducting scientific experiments involving human subjects (Corrigan, 
2003). 
 
Abortion. A more modern, yet still highly contentious example of bioethical 
dilemmas influencing policy in the US is abortion (Jafe, Lindheim & Lee, 1981). 
Abortion had been a point of contention country=wide since the late 1800’s, yet it 
garnered national spotlight only in the 1960’s when it became a felony to terminate a 
pregnancy without special circumstance, in 49 states and in Washington DC 
(Petchesky, 1984). After numerous attempts by coalitions to reverse the anti-abortion 
positions, the US Supreme Court eventually agreed to review the landmark abortion 
case Rowe vs. Wade in 1971, and ultimately ruled that criminalizing abortion was 
unconstitutional; women had the right to both choice and privacy when seeking an 
abortion (Garrow, 2015). 
Though the Supreme Court issued a ruling on Row versus Wade, the backlash, 
debate, and attempts to overturn the decision remain. The resulting aftermath centered, 
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primarily, on the ethical considerations from two opposing sides: (1) one side claiming 
it is unethical to terminate a pregnancy, as the fetus is a person from the moment of 
conception and, thus, has the right to live, and (2) the other, that is an ethical violation 
to criminalize women’s decisions about their own bodies (Garrow, 2015).  
As with all ethical dilemmas, it is important to note that arriving at a fair ethical 
judgement involves a lot of time and consideration into distilling right from wrong. 
Regardless of whether ethics helped someone arrive at a certain position, others are 
prone to disagree with that decision. Therefore, if there are moral differences, which, 
more often than not, there are, a perfect solution is not possible (Hanson, 2014). With 
abortion, for example, policy recommendation can always be overturned if a new 
governing body’s moral compass differs from the one preceding it. 
What TSS and abortion both exemplify is that, within the context of applied 
sciences, there are serious, sustained ethical concerns — quite different from those 
explored in classic ethics –  affecting human populations. Therefore, when approaching 
an ethical dilemma in the context of Health-related research there must be 
consideration for all sides involved in the dilemma before making a judgement on 
which position an agent morally aligns. Failure to properly think and reason through an 
ethical dilemma could pose undue harm on certain groups— especially as newer ethical 
dilemmas continue to push boundaries over what is and is not morally acceptable (e.g. 
stem-cell research, euthanasia, cloning, among others). 
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Ethics and Research Methods 
While science continues to, and will constantly face ongoing ethical debates 
regarding human subjects (and animals) who take part in scientific experiments, it is 
also continually facing new ethical challenges related to the practice of science, itself 
(Ioannidis, 2005). In other words, the manner in which science is conducting itself in 
the 21st century is raising eyebrows among scientists and ethicists, above and beyond 
concerns with the well-being of research study participants (Hubbard, 2015). 
 Concerns with the practice of science began back in the 1980’s when Shweder 
& Fiske (1984) argued there had to be some level of reform to prevent the spread of 
unscrupulous science. Three decades later, and little has changed to assuage concerns 
of an emergent crisis in the social sciences on multiple fronts— such as problematic 
reporting metrics, fabricating data, among other concerns. More contemporary voices 
have posited similar concerns about the future of science38. Further, editorial boards 
such as the American Psychological Association (APA) and the Basic and Applied 
Social Psychology Journal (BASP) have requested modest reforms to prevent a crisis. 
For example, the APA Special Task for Statistical Inferencing (1999) argued for the 
inclusion of confidence intervals and effect sizes in research reports to uphold overall 
credibility. BASP, on the other hand, opted to make significance tests optional if (a) 
data were made open-access to all interested parties and (b) authors reported effect 
sizes to substantiate results.   
                                                 
38 E.G. Nuzzo, 2014; Ioannidis, 2005; Epstein 2014; and Hubbard, 2015. 
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 However, such recommendations for editorial reform are just that— 
recommendations. Researchers have full liberty to abide by or to ignore suggestions 
made by editorial groups or by other scholar seeking reform to the current system 
(Resnik, n.d.). Further, researchers also have full academic freedom to construct and 
execute a study as they see fit. Even if the recommendation is intended to help 
scientists, and the credibility of science, it is still likely some will continue with 
practices and protocols and practices that have been used for decades— even if those 
protocols have been deemed outdated or problematic (e.g. over-reliance on significance 
testing). 
 Scientists, however, should aim to produce ethically sound studies across all 
areas of research— such as patient and animal rights and accurate reporting of 
information. Today, there are continued concerns within the scientific community— 
especially regarding methodological decision making and reporting practices— that 
science, as an enterprise, is facing a growing lack of legitimacy (Hubbard, 2015). 
Those concerns stem from an emergent ethical dilemma—  in which the pressure to 
produce sharp, cutting edge science prompts many to choose: (a) career? Or (b) 
rigorous science? 
And, as science continues facing poor credibility, there are further ethical 
implications for the greater public who rely on the production of science to improve 
quality of life and potentially guide public policy.  Therefore, I contend what we, as 
scientists, are facing is an emergent ethical dilemma regarding methodological 
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reporting and decision making.  One that should be studied further in order to fully 
understand the unique complexity by methodological reporting and decision making. 
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APPENDIX B  
ASSIGNING A GRADE 
 
The text below is transcribed from an online-published, 2013 University of Exeter 
Power Point presentation on GRADE and how to assign a GRADE on five key 
dimensions: (1) Risk of Bias, (2) Inconsistency, (3) Indirectness, (4), Imprecision, and 
(5) Publication Bias. Since this presentation, the Cochrane Institute has developed a 
point-and-click interface, GRADEpro, intended to make the process of assigning a 
GRADE more efficient (Long, 2018).  
For each domain, listed below, users of GRADEpro can choose, based on value-
judgement, one of the following from a drop-down menu: (1) Not Serious, (2) Serious, 
or (3) Very Serious. The selection from each domain’s drop-down menu will affect the 
computer-calculated GRADE automatically. In other words, GRADEpro calculates the 
final GRADE for users. 
 • STEP 1 Assign an a-priori ranking of “high” to randomized controlled trials and 
“low” to observational studies. Randomized controlled trials are initially assigned a 
higher grade because they are usually less prone to bias than observational studies— on 
GRADEpro, users select the study design from a drop-down menu, and the a-priori 
GRADE appears on screen.  
• STEP 2 “Downgrade” or “upgrade” initial ranking. It is common for randomized 
controlled trials and observational studies to be downgraded because they suffer from 
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identifiable bias. Also, observational studies can be upgraded when multiple high-
quality studies show consistent results Using GRADEpro. 
 • Reasons to “downgrade”  
• Risk of bias – Lack of clearly randomized allocation sequence – Lack of 
blinding – Lack of allocation concealment – Failure to adhere to intention-to-
treat analysis – Trial is cut short – Large losses to follow-up—external factors, 
such as funding source and conflicts of interest.  
• Inconsistency:  When there is significant and unexplained variability in results 
from different trials Using GRADEpro.  
• Indirectness of evidence can refer to several things: – An indirect comparison 
of two drugs. – An indirect comparison of population, outcome or intervention.  
• Imprecision: When wide confidence intervals mar the quality of the data. 
 • Publication bias: When studies with “negative” findings remain unpublished 
Using GRADEpro.  
• Reasons to “upgrade”  
• Large effect: When the effect is so large that bias common to observational 
studies cannot possibly account for the result.  
• Dose-response relationship: When the result is proportional to the degree of 
exposure. 
• All plausible confounders would have reduced the treatment effect: When all 
possible confounders would only diminish the observed effect and it is thus 
likely that the actual effect is larger than the data suggests. 
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• STEP THREE Input value judgements into GRADEpro. Based on decisions to 
upgrade or downgrade quality of evidence, GRADEpro will automatically calculate a 
final GRADE: 
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